| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.974 | 0.001 | 0.974 | Vasodilator, peripheral | 0.678 0.008 DBMET02011 0.947 0.002 DB00654 0.489 0.03 DB01955 0.303 0.095 DBMET01480 0.865 0.003 DBMET02014 0.765 0.004 DBMET02015 0.613 0.015 DB01440 0.621 0.014 DBMET01477 | ||
| 0.897 | 0.003 | 0.897 | Platelet antagonist | 0.888 0.004 DBMET02011 0.843 0.004 DB00654 0.419 0.024 DB01955 0.879 0.004 DBMET02014 0.751 0.005 DBMET02015 0.779 0.004 DB01440 0.864 0.004 DBMET01477 | ||
| 0.894 | 0.003 | 0.894 | Spasmolytic | 0.628 0.01 DBMET02011 0.65 0.009 DB00654 0.351 0.052 DB01955 0.438 0.033 DBMET02014 0.442 0.032 DBMET02015 0.374 0.046 DB01440 0.337 0.057 DBMET01477 | ||
| 0.881 | 0.003 | 0.881 | Antithrombotic | 0.458 0.036 DBMET02011 0.834 0.004 DB00654 0.397 0.05 DB01955 0.207 0.169 DBMET01480 0.72 0.007 DBMET02014 0.66 0.011 DBMET02015 0.555 0.022 DB01440 0.547 0.023 DBMET01477 | ||
| 0.86 | 0.001 | 0.86 | Thromboxane antagonist | 0.126 0.006 DBMET02011 0.514 0.002 DB00654 0.091 0.014 DB01955 0.604 0.002 DBMET02014 0.388 0.002 DBMET02015 0.15 0.005 DB01440 0.141 0.005 DBMET01477 | ||
| 0.851 | 0.002 | 1 | Vasodilator | 0.954 0.001 DBMET02011 0.606 0.005 DB00654 0.344 0.035 DB01955 1 0 DBMET01480 0.572 0.007 DBMET02014 0.515 0.011 DBMET02015 0.385 0.026 DB01440 0.385 0.026 DBMET01477 | DBMET01480 | |
| 0.806 | 0.004 | 0.806 | Cholesterol antagonist | 0.68 0.009 DBMET02011 0.677 0.01 DB00654 0.599 0.019 DB01955 0.328 0.075 DBMET01480 0.564 0.023 DBMET02014 0.601 0.019 DBMET02015 0.686 0.009 DB01440 0.674 0.01 DBMET01477 | ||
| 0.8 | 0.001 | 0.8 | Thromboxane A2 antagonist | 0.095 0.009 DBMET02011 0.514 0.002 DB00654 0.083 0.013 DB01955 0.61 0.001 DBMET02014 0.388 0.002 DBMET02015 0.137 0.004 DB01440 0.127 0.005 DBMET01477 | ||
| 0.771 | 0.004 | 0.815 | Platelet aggregation inhibitor | 0.815 0.004 DBMET02011 0.603 0.005 DB00654 0.306 0.034 DB01955 0.589 0.005 DBMET02014 0.487 0.01 DBMET02015 0.603 0.005 DB01440 0.649 0.005 DBMET01477 | DBMET02011 | |
| 0.77 | 0.019 | 0.874 | Antiinflammatory | 0.874 0.007 DBMET02011 0.61 0.051 DB00654 0.421 0.127 DB01955 0.574 0.061 DBMET02014 0.506 0.085 DBMET02015 0.527 0.077 DB01440 0.589 0.057 DBMET01477 | DBMET02011 | |
| 0.749 | 0.003 | 0.749 | Non-steroidal antiinflammatory agent | 0.498 0.007 DBMET02011 0.422 0.011 DB00654 0.271 0.035 DB01955 0.345 0.02 DBMET02014 0.314 0.025 DBMET02015 0.382 0.016 DB01440 0.354 0.019 DBMET01477 | ||
| 0.641 | 0.005 | 0.723 | Hypolipemic | 0.368 0.031 DBMET02011 0.701 0.005 DB00654 0.427 0.021 DB01955 0.723 0.004 DBMET02014 0.723 0.004 DBMET02015 0.494 0.013 DB01440 0.524 0.011 DBMET01477 | DBMET02015 | |
| 0.62 | 0.001 | 0.764 | Prostaglandin F2 alpha antagonist | 0.711 0.001 DB00654 0.092 0.015 DB01955 0.764 0.001 DBMET02014 0.677 0.001 DBMET02015 0.19 0.004 DB01440 0.298 0.003 DBMET01477 | DBMET02014 | |
| 0.611 | 0.047 | 0.652 | Apoptosis agonist | 0.652 0.039 DBMET02011 0.496 0.076 DB00654 0.303 0.17 DB01955 0.501 0.074 DBMET02014 0.305 0.168 DBMET02015 0.335 0.148 DB01440 0.363 0.132 DBMET01477 | DBMET02011 | |
| 0.56 | 0.004 | 0.748 | Platelet adhesion inhibitor | 0.748 0.003 DBMET02011 0.408 0.011 DB00654 0.27 0.043 DB01955 0.39 0.013 DBMET02014 0.351 0.019 DBMET02015 0.364 0.017 DB01440 0.39 0.013 DBMET01477 | DBMET02011 | |
| 0.58 | 0.034 | 0.601 | Transcription factor NF kappa B inhibitor | 0.287 0.102 DBMET02011 0.601 0.031 DB00654 0.34 0.08 DB01955 0.497 0.045 DBMET02014 0.461 0.051 DBMET02015 0.37 0.071 DB01440 0.373 0.07 DBMET01477 | DB00654 | |
| 0.551 | 0.009 | 0.807 | Angiogenesis stimulant | 0.807 0.004 DBMET02011 0.404 0.021 DB00654 0.516 0.011 DB01955 0.39 0.023 DBMET02014 0.338 0.036 DBMET02015 0.596 0.007 DB01440 0.525 0.01 DBMET01477 | DBMET02011 | |
| 0.543 | 0.001 | 0.956 | Nitric oxide donor | 0.956 0 DBMET02011 0.12 0.004 DB00654 0.097 0.01 DB01955 0.071 0.032 DBMET01480 0.114 0.004 DBMET02014 0.11 0.005 DBMET02015 0.102 0.008 DB01440 0.092 0.013 DBMET01477 | DBMET02011 | |
| 0.545 | 0.011 | 0.733 | Vasodilator, coronary | 0.733 0.004 DBMET02011 0.317 0.074 DB00654 0.45 0.023 DB01955 0.512 0.014 DBMET01480 0.269 0.115 DBMET02014 0.37 0.046 DBMET02015 0.427 0.028 DB01440 0.374 0.045 DBMET01477 | DBMET02011 | |
| 0.545 | 0.012 | 0.723 | Hypoglycemic | 0.723 0.005 DBMET02011 0.456 0.02 DB00654 0.396 0.028 DB01955 0.391 0.029 DBMET02014 0.501 0.015 DBMET02015 0.535 0.013 DB01440 0.59 0.009 DBMET01477 | DBMET02011 | |
| 0.523 | 0.003 | 0.67 | Prostaglandin EP2 antagonist | 0.601 0.002 DB00654 0.062 0.04 DB01955 0.67 0.002 DBMET02014 0.617 0.002 DBMET02015 0.262 0.005 DB01440 0.469 0.003 DBMET01477 | DBMET02014 | |
| 0.535 | 0.024 | 0.577 | Immunosuppressant | 0.23 0.166 DBMET02011 0.577 0.016 DB00654 0.538 0.023 DB01955 0.575 0.016 DBMET02014 0.55 0.021 DBMET02015 0.535 0.024 DB01440 0.509 0.031 DBMET01477 | DB00654 | |
| 0.528 | 0.043 | 0.765 | Cyclophilin D inhibitor | 0.653 0.019 DBMET02011 0.521 0.044 DB00654 0.541 0.039 DB01955 0.542 0.039 DBMET02014 0.672 0.017 DBMET02015 0.696 0.014 DB01440 0.765 0.009 DBMET01477 | DBMET01477 | |
| 0.457 | 0.001 | 0.742 | Prostaglandin agonist | 0.742 0 DB00654 0.07 0.008 DB01955 0.614 0.001 DBMET02014 0.489 0.001 DBMET02015 0.166 0.004 DB01440 0.147 0.004 DBMET01477 | DB00654 | |
| 0.432 | 0.001 | 0.74 | Prostaglandin E2 agonist | 0.74 0 DB00654 0.037 0.008 DB01955 0.551 0.001 DBMET02014 0.497 0.001 DBMET02015 0.106 0.004 DB01440 0.102 0.004 DBMET01477 | DB00654 | |
| 0.445 | 0.028 | 0.657 | Apoptosis antagonist | 0.421 0.033 DBMET02011 0.41 0.035 DB00654 0.322 0.071 DB01955 0.381 0.044 DBMET02014 0.455 0.027 DBMET02015 0.57 0.013 DB01440 0.657 0.005 DBMET01477 | DBMET01477 | |
| 0.475 | 0.07 | 0.736 | Caspase 9 stimulant | 0.485 0.066 DBMET02011 0.477 0.07 DB00654 0.642 0.031 DB01955 0.481 0.068 DBMET01480 0.461 0.077 DBMET02014 0.406 0.107 DBMET02015 0.708 0.023 DB01440 0.736 0.02 DBMET01477 | DBMET01477 | |
| 0.397 | 0.004 | 0.714 | Prostaglandin antagonist | 0.562 0.004 DB00654 0.714 0.003 DBMET02014 0.478 0.004 DBMET02015 0.332 0.005 DB01440 0.6 0.004 DBMET01477 | DBMET02014 | |
| 0.385 | 0.001 | 0.481 | Prostaglandin D2 agonist | 0.453 0.001 DB00654 0.058 0.005 DB01955 0.481 0.001 DBMET02014 0.396 0.001 DBMET02015 0.09 0.003 DB01440 0.113 0.003 DBMET01477 | DBMET02014 | |
| 0.413 | 0.033 | 0.519 | Antioxidant | 0.519 0.018 DBMET02011 0.335 0.05 DB00654 0.313 0.057 DB01955 0.278 0.071 DBMET02014 0.275 0.072 DBMET02015 0.35 0.046 DB01440 0.387 0.037 DBMET01477 | DBMET02011 | |
| 0.423 | 0.043 | 0.539 | Immunostimulant | 0.201 0.119 DBMET02011 0.539 0.024 DB00654 0.377 0.056 DB01955 0.167 0.141 DBMET01480 0.428 0.042 DBMET02014 0.449 0.037 DBMET02015 0.436 0.04 DB01440 0.402 0.049 DBMET01477 | DB00654 | |
| 0.378 | 0.008 | 0.418 | Insulin sensitizer | 0.248 0.036 DBMET02011 0.418 0.005 DB00654 0.252 0.033 DB01955 0.162 0.117 DBMET01480 0.294 0.017 DBMET02014 0.367 0.008 DBMET02015 0.313 0.013 DB01440 0.321 0.012 DBMET01477 | DB00654 | |
| 0.368 | 0.007 | 0.474 | Gastrin inhibitor | 0.279 0.049 DBMET02011 0.417 0.004 DB00654 0.355 0.009 DB01955 0.267 0.06 DBMET01480 0.474 0.004 DBMET02014 0.366 0.008 DBMET02015 0.418 0.004 DB01440 0.398 0.005 DBMET01477 | DBMET02014 | |
| 0.37 | 0.011 | 0.484 | Bone formation stimulant | 0.238 0.027 DBMET02011 0.443 0.008 DB00654 0.452 0.008 DB01955 0.484 0.006 DBMET02014 0.458 0.008 DBMET02015 0.451 0.008 DB01440 0.399 0.01 DBMET01477 | DBMET02014 | |
| 0.365 | 0.017 | 0.379 | Hepatoprotectant | 0.373 0.016 DBMET02011 0.379 0.015 DB00654 0.219 0.055 DB01955 0.305 0.028 DBMET02014 0.29 0.032 DBMET02015 0.301 0.029 DB01440 0.347 0.019 DBMET01477 | DB00654 | |
| 0.35 | 0.039 | 0.727 | Cardiotonic | 0.727 0.005 DBMET02011 0.204 0.115 DB01955 | DBMET02011 | |
| 0.362 | 0.055 | 0.42 | Caspase 3 stimulant | 0.42 0.039 DB00654 0.413 0.041 DBMET02014 0.248 0.114 DBMET02015 0.19 0.185 DB01440 0.288 0.085 DBMET01477 | DB00654 | |
| 0.314 | 0.011 | 0.351 | Phospholipase A2 inhibitor | 0.199 0.043 DBMET02011 0.283 0.016 DB00654 0.247 0.024 DB01955 0.217 0.035 DBMET02014 0.268 0.019 DBMET02015 0.351 0.008 DB01440 0.302 0.013 DBMET01477 | DB01440 | |
| 0.342 | 0.041 | 0.52 | Free radical scavenger | 0.52 0.014 DBMET02011 0.21 0.09 DB00654 0.216 0.086 DB01955 0.168 0.125 DBMET02014 0.191 0.105 DBMET02015 0.265 0.063 DB01440 0.343 0.04 DBMET01477 | DBMET02011 | |
| 0.322 | 0.028 | 0.585 | Anesthetic general | 0.585 0.005 DBMET02011 0.48 0.009 DB01955 0.25 0.05 DBMET01480 0.138 0.127 DBMET02014 0.303 0.032 DBMET02015 0.524 0.006 DB01440 0.512 0.007 DBMET01477 | DBMET02011 | |
| 0.297 | 0.018 | 0.74 | Cyclooxygenase inhibitor | 0.74 0.003 DBMET02011 | DBMET02011 | |
| 0.284 | 0.005 | 0.412 | Gastric antisecretory | 0.412 0.004 DB00654 0.167 0.02 DB01955 0.404 0.004 DBMET02014 0.246 0.007 DBMET02015 0.183 0.015 DB01440 0.148 0.027 DBMET01477 | DB00654 | |
| 0.283 | 0.013 | 0.462 | Cholesterol synthesis inhibitor | 0.113 0.072 DBMET02011 0.408 0.004 DB00654 0.243 0.019 DB01955 0.129 0.057 DBMET01480 0.419 0.004 DBMET02014 0.462 0.003 DBMET02015 0.288 0.013 DB01440 0.295 0.012 DBMET01477 | DBMET02015 | |
| 0.31 | 0.049 | 0.31 | Tumour necrosis factor alpha release inhibitor | 0.254 0.073 DBMET02011 0.304 0.052 DB00654 0.188 0.12 DB01955 0.172 0.132 DBMET02014 0.219 0.093 DBMET02015 | ||
| 0.258 | 0.003 | 0.445 | Prostaglandin EP3 antagonist | 0.341 0.003 DB00654 0.445 0.002 DBMET02014 0.432 0.002 DBMET02015 0.059 0.008 DB01440 0.203 0.004 DBMET01477 | DBMET02014 | |
| 0.26 | 0.008 | 0.37 | Cyclooxygenase 3 inhibitor | 0.37 0.004 DBMET02011 0.156 0.043 DB00654 0.206 0.017 DB01955 0.161 0.039 DBMET01480 0.152 0.046 DBMET02015 0.222 0.013 DB01440 0.219 0.013 DBMET01477 | DBMET02011 | |
| 0.266 | 0.019 | 0.772 | Cyclooxygenase 1 inhibitor | 0.772 0.003 DBMET02011 0.13 0.071 DBMET01477 | DBMET02011 | |
| 0.308 | 0.068 | 0.548 | Interleukin 2 agonist | 0.294 0.078 DBMET02011 0.361 0.041 DB00654 0.469 0.012 DB01955 0.413 0.024 DBMET02014 0.403 0.026 DBMET02015 0.525 0.005 DB01440 0.548 0.005 DBMET01477 | DBMET01477 | |
| 0.256 | 0.019 | 0.676 | Cyclooxygenase 2 inhibitor | 0.676 0.003 DBMET02011 | DBMET02011 | |
| 0.28 | 0.044 | 0.324 | Nitric oxide antagonist | 0.138 0.108 DBMET02011 0.324 0.036 DB00654 0.214 0.063 DB01955 0.311 0.038 DBMET02014 0.296 0.041 DBMET02015 0.203 0.066 DB01440 0.203 0.066 DBMET01477 | DB00654 | |
| 0.274 | 0.054 | 0.496 | DNA synthesis inhibitor | 0.496 0.014 DBMET02011 0.217 0.098 DB00654 0.416 0.02 DB01955 0.298 0.044 DBMET01480 0.193 0.133 DBMET02014 0.227 0.086 DBMET02015 0.459 0.016 DB01440 0.434 0.018 DBMET01477 | DBMET02011 | |
| 0.216 | 0.003 | 0.602 | Prostaglandin EP4 antagonist | 0.562 0.002 DB00654 0.023 0.022 DB01955 0.602 0.001 DBMET02014 0.5 0.002 DBMET02015 0.058 0.007 DB01440 0.09 0.005 DBMET01477 | DBMET02014 | |
| 0.214 | 0.002 | 0.546 | Prostaglandin EP2 agonist | 0.546 0.001 DB00654 0.049 0.006 DB01955 0.394 0.001 DBMET02014 0.3 0.001 DBMET02015 0.088 0.003 DB01440 0.082 0.004 DBMET01477 | DB00654 | |
| 0.212 | 0.005 | 0.466 | Prostaglandin E2 antagonist | 0.37 0.004 DB00654 0.466 0.004 DBMET02014 0.433 0.004 DBMET02015 0.086 0.018 DB01440 0.208 0.005 DBMET01477 | DBMET02014 | |
| 0.2 | 0.002 | 0.283 | Prostacyclin agonist | 0.257 0.002 DB00654 0.019 0.009 DB01955 0.283 0.002 DBMET02014 0.24 0.002 DBMET02015 0.101 0.003 DB01440 0.189 0.002 DBMET01477 | DBMET02014 | |
| 0.241 | 0.044 | 0.325 | P-glycoprotein inhibitor | 0.318 0.026 DB00654 0.217 0.055 DB01955 0.325 0.025 DBMET02014 0.268 0.036 DBMET02015 0.179 0.081 DB01440 0.159 0.104 DBMET01477 | DBMET02014 | |
| 0.226 | 0.032 | 0.469 | Lipid peroxidase inhibitor | 0.469 0.006 DBMET02011 0.156 0.065 DB00654 0.259 0.025 DB01955 0.127 0.087 DBMET02015 0.234 0.03 DB01440 0.224 0.033 DBMET01477 | DBMET02011 | |
| 0.206 | 0.017 | 0.241 | Bronchodilator | 0.211 0.017 DBMET02011 0.155 0.03 DB00654 0.241 0.014 DB01955 0.138 0.036 DBMET02014 0.151 0.031 DBMET02015 0.147 0.033 DB01440 | DB01955 | |
| 0.217 | 0.035 | 0.396 | Melanin inhibitor | 0.396 0.012 DB00654 0.199 0.041 DB01955 0.159 0.071 DBMET01480 0.368 0.014 DBMET02014 0.387 0.013 DBMET02015 0.205 0.039 DB01440 0.263 0.027 DBMET01477 | DB00654 | |
| 0.209 | 0.029 | 0.393 | Hemostatic | 0.393 0.008 DB00654 0.186 0.039 DB01955 0.284 0.017 DBMET02014 0.221 0.026 DBMET02015 0.228 0.025 DB01440 0.232 0.024 DBMET01477 | DB00654 | |
| 0.215 | 0.036 | 0.34 | Interferon gamma antagonist | 0.164 0.062 DBMET02011 0.323 0.017 DB00654 0.281 0.023 DB01955 0.177 0.052 DBMET01480 0.34 0.015 DBMET02014 0.33 0.016 DBMET02015 0.321 0.017 DB01440 0.336 0.015 DBMET01477 | DBMET02014 | |
| 0.21 | 0.038 | 0.516 | Phospholipase C inhibitor | 0.198 0.045 DBMET02011 0.239 0.027 DB00654 0.409 0.01 DB01955 0.188 0.053 DBMET01480 0.249 0.025 DBMET02014 0.292 0.019 DBMET02015 0.516 0.005 DB01440 0.487 0.006 DBMET01477 | DB01440 | |
| 0.212 | 0.041 | 0.22 | Antipruritic | 0.187 0.059 DBMET02011 0.211 0.042 DB00654 0.203 0.047 DB01955 0.147 0.098 DBMET02014 0.22 0.037 DBMET02015 0.219 0.037 DB01440 0.218 0.038 DBMET01477 | DBMET02015 | |
| 0.201 | 0.032 | 0.26 | Arachidonic acid antagonist | 0.208 0.026 DBMET02011 0.22 0.017 DB00654 0.247 0.006 DB01955 0.214 0.021 DBMET01480 0.208 0.026 DBMET02014 0.224 0.015 DBMET02015 0.26 0.004 DB01440 0.259 0.004 DBMET01477 | DB01440 | |
| 0.169 | 0.002 | 0.387 | Prostaglandin EP4 agonist | 0.387 0.001 DB00654 0.019 0.009 DB01955 0.286 0.001 DBMET02014 0.218 0.001 DBMET02015 0.085 0.004 DB01440 0.118 0.003 DBMET01477 | DB00654 | |
| 0.206 | 0.039 | 0.397 | Protein kinase stimulant | 0.152 0.067 DBMET02011 0.381 0.009 DB00654 0.332 0.013 DB01955 0.142 0.074 DBMET01480 0.238 0.03 DBMET02014 0.256 0.025 DBMET02015 0.397 0.008 DB01440 0.337 0.013 DBMET01477 | DB01440 | |
| 0.166 | 0.001 | 0.4 | Prostaglandin F2 alpha agonist | 0.027 0.011 DBMET02011 0.4 0 DB00654 0.065 0.003 DB01955 0.024 0.014 DBMET01480 0.201 0 DBMET02014 0.17 0.001 DBMET02015 0.089 0.002 DB01440 0.079 0.002 DBMET01477 | DB00654 | |
| 0.166 | 0.004 | 0.195 | Leukotriene B4 antagonist | 0.054 0.036 DBMET02011 0.171 0.004 DB00654 0.088 0.013 DB01955 0.162 0.005 DBMET02014 0.195 0.004 DBMET02015 0.155 0.005 DB01440 0.113 0.008 DBMET01477 | DBMET02015 | |
| 0.181 | 0.028 | 0.34 | Farnesoid X receptor antagonist | 0.152 0.05 DBMET02011 0.199 0.022 DB00654 0.34 0.004 DB01955 0.186 0.026 DBMET02014 0.161 0.042 DBMET02015 0.311 0.005 DB01440 0.231 0.014 DBMET01477 | DB01955 | |
| 0.154 | 0.01 | 0.234 | Leukotriene antagonist | 0.216 0.005 DB00654 0.104 0.02 DB01955 0.234 0.005 DBMET02014 0.207 0.005 DBMET02015 0.178 0.007 DB01440 0.149 0.01 DBMET01477 | DBMET02014 | |
| 0.178 | 0.036 | 0.317 | DNA polymerase I inhibitor | 0.25 0.017 DB00654 0.185 0.033 DB01955 0.217 0.023 DBMET02014 0.22 0.023 DBMET02015 0.241 0.018 DB01440 0.317 0.01 DBMET01477 | DBMET01477 | |
| 0.143 | 0.004 | 0.473 | Prostaglandin EP1 antagonist | 0.332 0.003 DB00654 0.473 0.003 DBMET02014 0.38 0.003 DBMET02015 0.067 0.005 DBMET01477 | DBMET02014 | |
| 0.136 | 0.001 | 0.234 | Thromboxane agonist | 0.01 0.009 DBMET02011 0.208 0.001 DB00654 0.029 0.003 DB01955 0.01 0.009 DBMET01480 0.234 0 DBMET02014 0.165 0.001 DBMET02015 0.067 0.002 DB01440 0.061 0.002 DBMET01477 | DBMET02014 | |
| 0.168 | 0.045 | 0.397 | Neurotrophic factor | 0.184 0.035 DB00654 0.397 0.005 DB01955 0.189 0.033 DBMET02014 0.208 0.024 DBMET02015 0.245 0.013 DB01440 0.138 0.071 DBMET01477 | DB01955 | |
| 0.153 | 0.036 | 0.246 | Vanilloid 1 agonist | 0.14 0.05 DBMET02011 0.185 0.016 DB00654 0.207 0.01 DB01955 0.133 0.061 DBMET01480 0.161 0.029 DBMET02014 0.165 0.026 DBMET02015 0.246 0.005 DB01440 0.207 0.01 DBMET01477 | DB01440 | |
| 0.138 | 0.027 | 0.267 | Calcium antagonist | 0.267 0.007 DBMET02011 0.147 0.023 DB01955 0.116 0.037 DBMET01480 0.107 0.043 DB01440 0.107 0.043 DBMET01477 | DBMET02011 | |
| 0.115 | 0.005 | 0.169 | Thromboxane synthase inhibitor | 0.07 0.018 DBMET02011 0.094 0.007 DB00654 0.087 0.009 DB01955 0.116 0.005 DBMET02014 0.073 0.016 DBMET02015 0.169 0.004 DB01440 0.145 0.004 DBMET01477 | DB01440 | |
| 0.202 | 0.096 | 0.36 | Peptidyltransferase inhibitor | 0.226 0.07 DBMET02011 0.253 0.049 DB00654 0.36 0.011 DB01955 0.285 0.031 DBMET02014 0.309 0.022 DBMET02015 0.318 0.019 DB01440 0.31 0.021 DBMET01477 | DB01955 | |
| 0.242 | 0.137 | 0.474 | Sodium/bile acid cotransporter inhibitor | 0.326 0.057 DB00654 0.368 0.029 DB01955 0.378 0.025 DBMET02014 0.405 0.015 DBMET02015 0.432 0.01 DB01440 0.474 0.005 DBMET01477 | DBMET01477 | |
| 0.135 | 0.031 | 0.183 | Toll-Like receptor 4 antagonist | 0.157 0.017 DB00654 0.153 0.019 DB01955 0.133 0.032 DBMET02014 0.135 0.03 DBMET02015 0.176 0.011 DB01440 0.183 0.009 DBMET01477 | DBMET01477 | |
| 0.142 | 0.042 | 0.258 | Microtubule formation inhibitor | 0.102 0.087 DBMET02011 0.258 0.007 DB00654 0.199 0.02 DB01955 0.136 0.046 DBMET01480 0.219 0.016 DBMET02014 0.215 0.017 DBMET02015 0.193 0.021 DB01440 0.197 0.02 DBMET01477 | DB00654 | |
| 0.167 | 0.07 | 0.46 | Thrombolytic | 0.344 0.018 DBMET02011 0.246 0.034 DB01955 0.167 0.069 DBMET02015 0.392 0.012 DB01440 0.46 0.007 DBMET01477 | DBMET01477 | |
| 0.116 | 0.02 | 0.156 | Vanilloid agonist | 0.147 0.011 DB00654 0.156 0.01 DB01955 0.114 0.021 DBMET02014 0.103 0.03 DBMET02015 0.148 0.011 DB01440 0.123 0.017 DBMET01477 | DB01955 | |
| 0.145 | 0.056 | 0.28 | Toll-Like receptor 2 antagonist | 0.125 0.072 DBMET02011 0.237 0.012 DB00654 0.235 0.012 DB01955 0.137 0.062 DBMET01480 0.154 0.05 DBMET02014 0.183 0.032 DBMET02015 0.28 0.005 DB01440 0.265 0.007 DBMET01477 | DB01440 | |
| 0.145 | 0.058 | 0.368 | Acetylcholinesterase inhibitor | 0.368 0.008 DBMET02011 | DBMET02011 | |
| 0.11 | 0.023 | 0.123 | Na+ K+ transporting ATPase inhibitor | 0.11 0.023 DBMET02011 0.115 0.02 DB00654 0.119 0.017 DB01955 0.105 0.027 DBMET01480 0.113 0.021 DBMET02014 0.123 0.015 DBMET02015 0.117 0.018 DB01440 0.119 0.017 DBMET01477 | DBMET02015 | |
| 0.087 | 0.003 | 0.105 | HMG CoA reductase inhibitor | 0.036 0.02 DBMET02011 0.092 0.003 DB00654 0.036 0.02 DB01955 0.101 0.002 DBMET02014 0.105 0.002 DBMET02015 0.054 0.005 DB01440 0.075 0.004 DBMET01477 | DBMET02015 | |
| 0.11 | 0.028 | 0.134 | ATPase (Vacuolar H+) inhibitor | 0.124 0.017 DB00654 0.095 0.047 DB01955 0.134 0.012 DBMET02014 0.124 0.017 DBMET02015 0.093 0.051 DB01440 0.1 0.039 DBMET01477 | DBMET02014 | |
| 0.106 | 0.025 | 0.352 | Peroxisome proliferator-activated receptor gamma agonist | 0.141 0.015 DB00654 0.135 0.016 DB01955 0.136 0.016 DBMET02014 0.153 0.012 DBMET02015 0.246 0.005 DB01440 0.352 0.004 DBMET01477 | DBMET01477 | |
| 0.097 | 0.018 | 0.167 | Beta adrenoreceptor antagonist | 0.167 0.005 DBMET02011 0.106 0.014 DB01955 0.064 0.048 DBMET02015 0.082 0.026 DB01440 0.076 0.031 DBMET01477 | DBMET02011 | |
| 0.146 | 0.069 | 0.268 | Adenylate cyclase stimulant | 0.159 0.048 DBMET02011 0.193 0.017 DB00654 0.228 0.005 DB01955 0.185 0.022 DBMET01480 0.203 0.012 DBMET02014 0.215 0.008 DBMET02015 0.252 0.004 DB01440 0.268 0.004 DBMET01477 | DBMET01477 | |
| 0.109 | 0.035 | 0.19 | Ornithine decarboxylase inhibitor | 0.112 0.032 DBMET02011 0.1 0.045 DB00654 0.143 0.013 DB01955 0.095 0.05 DBMET01480 0.104 0.04 DBMET02014 0.114 0.03 DBMET02015 0.173 0.006 DB01440 0.19 0.005 DBMET01477 | DBMET01477 | |
| 0.117 | 0.05 | 0.146 | Electron transport complex I inhibitor | 0.146 0.023 DB00654 0.144 0.024 DB01955 0.133 0.032 DBMET02014 0.134 0.032 DBMET02015 | DB00654 | |
| 0.111 | 0.049 | 0.174 | Anabolic | 0.118 0.041 DBMET02011 0.15 0.018 DB00654 0.158 0.014 DB01955 0.145 0.021 DBMET01480 0.149 0.019 DBMET02014 0.168 0.01 DBMET02015 0.161 0.013 DB01440 0.174 0.008 DBMET01477 | DBMET01477 | |
| 0.112 | 0.052 | 0.547 | Butyrylcholinesterase inhibitor | 0.547 0.004 DBMET02011 | DBMET02011 | |
| 0.062 | 0.003 | 0.105 | Prostaglandin H2 antagonist | 0.03 0.013 DBMET02011 0.062 0.003 DB00654 0.04 0.005 DB01955 0.105 0.002 DBMET02014 0.062 0.003 DBMET02015 0.058 0.003 DB01440 0.06 0.003 DBMET01477 | DBMET02014 | |
| 0.076 | 0.02 | 0.148 | Beta 1 adrenoreceptor antagonist | 0.148 0.005 DBMET02011 0.09 0.013 DB01955 0.05 0.047 DBMET02015 0.068 0.028 DB01440 0.067 0.029 DBMET01477 | DBMET02011 | |
| 0.064 | 0.008 | 0.27 | Prostacyclin antagonist | 0.09 0.005 DB00654 0.065 0.008 DB01955 0.114 0.004 DBMET02014 0.06 0.009 DBMET02015 0.154 0.004 DB01440 0.27 0.003 DBMET01477 | DBMET01477 | |
| 0.117 | 0.062 | 0.26 | TRPA1 agonist | 0.26 0.005 DB00654 0.138 0.04 DB01955 0.13 0.048 DBMET01480 0.202 0.01 DBMET02014 0.15 0.031 DBMET02015 0.146 0.034 DB01440 0.189 0.013 DBMET01477 | DB00654 | |
| 0.064 | 0.011 | 0.086 | Squalene synthetase inhibitor | 0.041 0.018 DBMET02011 0.086 0.007 DB00654 0.05 0.014 DB01955 0.059 0.012 DBMET02014 0.058 0.012 DBMET02015 0.062 0.011 DB01440 0.076 0.009 DBMET01477 | DB00654 | |
| 0.24 | 0.187 | 0.451 | Antibacterial | 0.451 0.056 DB00654 0.343 0.106 DB01955 0.433 0.063 DBMET02014 0.382 0.085 DBMET02015 0.33 0.114 DB01440 0.36 0.096 DBMET01477 | DB00654 | |
| 0.152 | 0.102 | 0.41 | Lipocortins synthesis antagonist | 0.157 0.095 DB00654 0.278 0.026 DB01955 0.18 0.071 DBMET02014 0.221 0.045 DBMET02015 0.368 0.011 DB01440 0.41 0.008 DBMET01477 | DBMET01477 | |
| 0.05 | 0.002 | 0.095 | Thromboxane A2 agonist | 0.023 0.004 DBMET02011 0.077 0.001 DB00654 0.042 0.002 DB01955 0.022 0.005 DBMET01480 0.095 0.001 DBMET02014 0.063 0.002 DBMET02015 0.069 0.001 DB01440 0.061 0.002 DBMET01477 | DBMET02014 | |
| 0.094 | 0.046 | 0.172 | Transcription factor NF kappa B stimulant | 0.129 0.021 DB00654 0.098 0.041 DB01955 0.087 0.055 DBMET02014 0.142 0.018 DB01440 0.172 0.012 DBMET01477 | DBMET01477 | |
| 0.059 | 0.014 | 0.351 | Guanylate cyclase stimulant | 0.351 0.002 DBMET02011 0.056 0.016 DB01440 0.075 0.01 DBMET01477 | DBMET02011 | |
| 0.063 | 0.02 | 0.129 | Lysophosphatidic acid 3 receptor antagonist | 0.069 0.015 DBMET02011 0.068 0.015 DB00654 0.103 0.005 DB01955 0.068 0.015 DBMET01480 0.047 0.04 DBMET02014 0.048 0.038 DBMET02015 0.128 0.003 DB01440 0.129 0.003 DBMET01477 | DBMET01477 | |
| 0.066 | 0.024 | 0.122 | Peroxisome proliferator-activated receptor alpha agonist | 0.122 0.009 DB00654 0.069 0.023 DB01955 0.073 0.021 DBMET02014 0.12 0.009 DBMET02015 0.115 0.009 DB01440 0.113 0.01 DBMET01477 | DB00654 | |
| 0.092 | 0.05 | 0.142 | Antineoplastic antibiotic | 0.137 0.034 DB00654 0.142 0.033 DBMET02014 0.118 0.039 DBMET02015 | DBMET02014 | |
| 0.061 | 0.022 | 0.076 | Vanilloid 2 antagonist | 0.076 0.011 DB00654 0.055 0.03 DB01955 0.064 0.019 DBMET02014 0.053 0.034 DBMET02015 | DB00654 | |
| 0.102 | 0.064 | 0.425 | Adenylate kinase inhibitor | 0.204 0.014 DBMET02011 0.13 0.036 DB00654 0.339 0.005 DB01955 0.279 0.008 DBMET01480 0.165 0.022 DBMET02014 0.182 0.018 DBMET02015 0.403 0.003 DB01440 0.425 0.003 DBMET01477 | DBMET01477 | |
| 0.098 | 0.061 | 0.208 | Sphingomyelinase inhibitor | 0.122 0.04 DBMET02011 0.105 0.054 DB00654 0.208 0.008 DB01955 0.117 0.044 DBMET01480 0.103 0.056 DBMET02014 0.085 0.079 DBMET02015 0.138 0.03 DB01440 0.133 0.033 DBMET01477 | DB01955 | |
| 0.042 | 0.008 | 0.046 | Calcium-independent phospholipase A2 inhibitor | 0.041 0.009 DB00654 0.046 0.005 DB01955 0.034 0.025 DBMET02014 0.033 0.028 DBMET02015 0.046 0.005 DB01440 0.046 0.005 DBMET01477 | DBMET01477 | |
| 0.063 | 0.03 | 0.08 | Lipocortins synthesis agonist | 0.064 0.028 DB00654 0.073 0.019 DB01955 0.06 0.035 DBMET02014 0.063 0.03 DBMET02015 0.078 0.014 DB01440 0.08 0.013 DBMET01477 | DBMET01477 | |
| 0.064 | 0.032 | 0.157 | Sphingosine kinase inhibitor | 0.079 0.017 DBMET02011 0.093 0.01 DB00654 0.157 0.004 DB01955 0.055 0.049 DBMET01480 0.077 0.018 DBMET02014 0.09 0.011 DBMET02015 0.101 0.007 DB01440 0.074 0.02 DBMET01477 | DB01955 | |
| 0.071 | 0.043 | 0.217 | Leukotriene synthesis inhibitor | 0.106 0.023 DB00654 0.072 0.042 DB01955 0.111 0.02 DBMET02014 0.106 0.023 DBMET02015 0.139 0.011 DB01440 0.217 0.005 DBMET01477 | DBMET01477 | |
| 0.075 | 0.048 | 0.115 | Lipase inhibitor | 0.115 0.02 DB00654 0.077 0.046 DB01955 | DB00654 | |
| 0.059 | 0.033 | 0.103 | Leukotriene C antagonist | 0.067 0.017 DB00654 0.077 0.009 DB01955 0.055 0.045 DBMET01480 0.07 0.014 DBMET02014 0.074 0.011 DBMET02015 0.103 0.004 DB01440 0.102 0.004 DBMET01477 | DB01440 | |
| 0.065 | 0.039 | 0.236 | Caspase 9 inhibitor | 0.174 0.005 DBMET02011 0.14 0.007 DB01440 0.236 0.004 DBMET01477 | DBMET01477 | |
| 0.136 | 0.113 | 0.24 | Interleukin 6 antagonist | 0.196 0.043 DB00654 0.23 0.028 DB01955 0.175 0.059 DBMET02014 0.24 0.025 DB01440 0.239 0.025 DBMET01477 | DB01440 | |
| 0.13 | 0.107 | 0.574 | Growth hormone agonist | 0.213 0.054 DB00654 0.199 0.059 DB01955 0.228 0.049 DBMET02014 0.304 0.032 DBMET02015 0.464 0.009 DB01440 0.574 0.004 DBMET01477 | DBMET01477 | |
| 0.125 | 0.103 | 0.575 | Insulin secretagoues | 0.487 0.005 DBMET02011 0.119 0.112 DB00654 0.292 0.013 DB01955 0.119 0.113 DBMET02014 0.254 0.019 DBMET02015 0.485 0.005 DB01440 0.575 0.004 DBMET01477 | DBMET01477 | |
| 0.035 | 0.014 | 0.214 | Leukotriene B4 receptor 1 antagonist | 0.029 0.019 DBMET02011 0.031 0.017 DB00654 0.097 0.004 DB01955 0.04 0.012 DBMET02014 0.064 0.005 DBMET02015 0.214 0.003 DB01440 0.192 0.003 DBMET01477 | DB01440 | |
| 0.104 | 0.084 | 0.289 | Alkylator | 0.163 0.04 DBMET02011 0.112 0.076 DB00654 0.224 0.02 DB01955 0.12 0.068 DBMET01480 0.289 0.013 DB01440 0.241 0.018 DBMET01477 | DB01440 | |
| 0.024 | 0.005 | 0.054 | Vitamin D receptor agonist | 0.054 0.002 DB00654 0.027 0.004 DB01955 0.038 0.003 DBMET02014 0.042 0.003 DBMET02015 0.037 0.003 DB01440 0.025 0.004 DBMET01477 | DB00654 | |
| 0.169 | 0.15 | 0.494 | Interleukin agonist | 0.218 0.104 DBMET02011 0.494 0.009 DB00654 0.394 0.02 DB01955 0.281 0.058 DBMET01480 0.409 0.017 DBMET02014 0.453 0.013 DBMET02015 0.472 0.011 DB01440 0.479 0.01 DBMET01477 | DB00654 | |
| 0.123 | 0.104 | 0.37 | Cholinergic | 0.37 0.012 DBMET02011 | DBMET02011 | |
| 0.029 | 0.012 | 0.081 | Lysophosphatidic acid receptor 1 agonist | 0.034 0.008 DBMET02011 0.044 0.005 DB00654 0.071 0.003 DB01955 0.032 0.01 DBMET01480 0.024 0.02 DBMET02014 0.024 0.019 DBMET02015 0.081 0.002 DB01440 0.068 0.003 DBMET01477 | DB01440 | |
| 0.025 | 0.01 | 0.045 | Vitamin D receptor antagonist | 0.032 0.006 DB00654 0.034 0.006 DB01955 0.035 0.006 DBMET02014 0.045 0.005 DBMET02015 0.024 0.011 DB01440 | DBMET02015 | |
| 0.053 | 0.037 | 0.078 | Protein 50S ribosomal subunit inhibitor | 0.076 0.021 DB00654 0.078 0.02 DBMET02014 0.078 0.02 DBMET02015 | DBMET02015 | |
| 0.069 | 0.054 | 0.153 | Calcium channel L-type blocker | 0.153 0.01 DBMET02011 0.08 0.04 DB01955 | DBMET02011 | |
| 0.046 | 0.033 | 0.061 | Microtubule stabilization | 0.061 0.013 DB00654 0.053 0.024 DBMET02014 0.053 0.024 DBMET02015 0.049 0.03 DBMET01477 | DB00654 | |
| 0.059 | 0.05 | 0.212 | Selectin antagonist | 0.08 0.037 DB00654 0.134 0.02 DB01955 0.063 0.047 DBMET02014 0.071 0.042 DBMET02015 0.201 0.011 DB01440 0.212 0.01 DBMET01477 | DBMET01477 | |
| 0.023 | 0.015 | 0.367 | Prostaglandin D2 antagonist | 0.068 0.005 DB00654 0.132 0.004 DBMET02014 0.024 0.015 DBMET02015 0.126 0.004 DB01440 0.367 0.003 DBMET01477 | DBMET01477 | |
| 0.043 | 0.037 | 0.069 | Parathyroid hormone antagonist | 0.049 0.023 DB00654 0.044 0.033 DB01955 0.058 0.013 DBMET02014 0.069 0.007 DBMET02015 0.042 0.041 DB01440 0.042 0.041 DBMET01477 | DBMET02015 | |
| 0.013 | 0.006 | 0.015 | Calcineurin inhibitor | 0.015 0.005 DB00654 0.015 0.005 DBMET02014 0.01 0.009 DBMET02015 0.011 0.008 DBMET01477 | DBMET02014 | |
| 0.08 | 0.073 | 0.285 | Interleukin 5 antagonist | 0.095 0.047 DBMET02011 0.285 0.004 DB01955 0.086 0.061 DBMET02014 0.087 0.06 DBMET02015 0.176 0.007 DB01440 0.095 0.047 DBMET01477 | DB01955 | |
| 0.037 | 0.033 | 0.077 | Leukotriene C4 antagonist | 0.044 0.017 DB00654 0.053 0.008 DB01955 0.046 0.014 DBMET02014 0.049 0.011 DBMET02015 0.077 0.004 DB01440 0.076 0.004 DBMET01477 | DB01440 | |
| 0.207 | 0.203 | 0.472 | Calcium channel activator | 0.472 0.008 DBMET02011 0.412 0.02 DB01955 0.396 0.026 DBMET01480 0.286 0.106 DBMET02015 0.362 0.042 DB01440 0.396 0.026 DBMET01477 | DBMET02011 | |
| 0.021 | 0.017 | 0.062 | Leukotriene B4 receptor 2 antagonist | 0.025 0.012 DB00654 0.037 0.006 DB01955 0.032 0.008 DBMET02014 0.05 0.004 DBMET02015 0.052 0.004 DB01440 0.062 0.004 DBMET01477 | DBMET01477 | |
| 0.041 | 0.039 | 0.146 | Antimetabolite | 0.049 0.032 DBMET02011 0.058 0.027 DB00654 0.085 0.019 DB01955 0.041 0.04 DBMET02014 0.058 0.027 DBMET02015 0.146 0.012 DB01440 0.141 0.012 DBMET01477 | DB01440 | |
| 0.038 | 0.037 | 0.125 | Sphingosine kinase 1 inhibitor | 0.052 0.014 DBMET02011 0.057 0.011 DB00654 0.125 0.004 DB01955 0.05 0.016 DBMET02014 0.06 0.009 DBMET02015 0.061 0.009 DB01440 0.044 0.024 DBMET01477 | DB01955 | |
| 0.033 | 0.033 | 0.071 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.046 0.015 DB00654 0.071 0.005 DB01955 0.037 0.025 DBMET02014 0.044 0.016 DBMET02015 0.04 0.021 DB01440 | DB01955 | |
| 0.024 | 0.026 | 0.032 | Toll-Like receptor 4 agonist | 0.032 0.009 DB00654 0.026 0.021 DB01955 0.03 0.012 DB01440 0.03 0.012 DBMET01477 | DB00654 | |
| 0.027 | 0.032 | 0.035 | Elastase 2B inhibitor | 0.031 0.021 DB00654 0.035 0.013 DBMET01477 | DBMET01477 | |
| 0.027 | 0.032 | 0.035 | Elastase 3B inhibitor | 0.031 0.021 DB00654 0.035 0.013 DBMET01477 | DBMET01477 | |
| 0.027 | 0.032 | 0.035 | Elastase 3A inhibitor | 0.031 0.021 DB00654 0.035 0.013 DBMET01477 | DBMET01477 | |
| 0.017 | 0.022 | 0.025 | Corticosteroid-like | 0.025 0.011 DBMET02011 0.02 0.016 DB01440 0.021 0.015 DBMET01477 | DBMET02011 | |
| 0.056 | 0.064 | 0.169 | Interferon inducer | 0.081 0.023 DBMET02011 0.082 0.022 DB00654 0.169 0.004 DB01955 0.074 0.03 DBMET01480 0.067 0.039 DBMET02014 0.102 0.012 DBMET02015 0.154 0.004 DB01440 0.115 0.008 DBMET01477 | DB01955 | |
| 0.009 | 0.018 | 0.066 | Lysophosphatidic acid receptor 3 agonist | 0.023 0.004 DBMET02011 0.013 0.01 DB00654 0.066 0.002 DB01955 0.02 0.005 DBMET01480 0.065 0.002 DB01440 0.049 0.002 DBMET01477 | DB01955 | |
| 0.025 | 0.036 | 0.038 | Renin inhibitor | 0.038 0.025 DBMET02011 | DBMET02011 | |
| 0.045 | 0.061 | 0.092 | Angiotensin-converting enzyme inhibitor | 0.053 0.04 DBMET02011 0.05 0.048 DBMET02015 0.063 0.026 DB01440 0.092 0.01 DBMET01477 | DBMET01477 | |
| 0.039 | 0.055 | 0.26 | Glucose-6-phosphate isomerase inhibitor | 0.106 0.004 DBMET02011 0.054 0.024 DB00654 0.183 0.002 DB01955 0.105 0.004 DBMET01480 0.083 0.008 DBMET02014 0.1 0.005 DBMET02015 0.26 0.001 DB01440 0.256 0.001 DBMET01477 | DB01440 | |
| 0.065 | 0.082 | 0.243 | Interferon agonist | 0.097 0.032 DBMET02011 0.114 0.02 DB00654 0.239 0.004 DB01955 0.088 0.041 DBMET01480 0.088 0.041 DBMET02014 0.135 0.013 DBMET02015 0.243 0.004 DB01440 0.17 0.008 DBMET01477 | DB01440 | |
| 0.1 | 0.118 | 0.325 | Interleukin 4 antagonist | 0.325 0.007 DB01955 0.143 0.057 DBMET02015 0.238 0.015 DB01440 0.176 0.032 DBMET01477 | DB01955 | |
| 0.023 | 0.041 | 0.03 | 1,3-Beta-glucan synthase inhibitor | 0.03 0.015 DB01955 | DB01955 | |
| 0.015 | 0.037 | 0.037 | CYP24 inhibitor | 0.021 0.018 DB00654 0.029 0.011 DBMET02014 0.037 0.008 DBMET02015 | DBMET02015 | |
| 0.017 | 0.039 | 0.041 | Isoleucine-tRNA ligase inhibitor | 0.027 0.008 DBMET02011 0.023 0.015 DB00654 0.041 0.003 DB01955 0.026 0.01 DBMET01480 0.021 0.02 DBMET02015 0.041 0.003 DB01440 0.034 0.004 DBMET01477 | DB01440 | |
| 0.082 | 0.105 | 0.229 | Anesthetic local | 0.099 0.083 DBMET02011 0.146 0.051 DB00654 0.229 0.025 DB01955 0.098 0.085 DBMET02015 0.14 0.054 DB01440 0.112 0.073 DBMET01477 | DB01955 | |
| 0.027 | 0.052 | 0.038 | Antibiotic Aminoglycoside-like | 0.034 0.028 DB01955 0.034 0.029 DBMET02014 0.038 0.023 DBMET02015 | DBMET02015 | |
| 0.071 | 0.096 | 0.192 | Potassium channel activator | 0.192 0.01 DBMET02011 0.083 0.07 DB01955 | DBMET02011 | |
| 0.003 | 0.03 | 0.023 | Mannitol 2-dehydrogenase inhibitor | 0.009 0.005 DBMET02011 0.023 0.002 DB01955 0.012 0.004 DB01440 | DB01955 | |
| 0.061 | 0.089 | 0.152 | Adrenaline agonist | 0.152 0.014 DBMET02011 0.126 0.023 DB01955 0.08 0.057 DBMET02015 0.079 0.059 DB01440 0.084 0.052 DBMET01477 | DBMET02011 | |
| 0.047 | 0.074 | 0.48 | Phosphofructokinase-1 inhibitor | 0.205 0.011 DBMET02011 0.087 0.037 DB00654 0.331 0.004 DB01955 0.213 0.01 DBMET01480 0.174 0.014 DBMET02014 0.226 0.009 DBMET02015 0.461 0.003 DB01440 0.48 0.002 DBMET01477 | DBMET01477 | |
| 0.007 | 0.036 | 0.16 | G-protein-coupled receptor 120 agonist | 0.043 0.004 DB01955 0.024 0.007 DBMET02014 0.057 0.004 DBMET02015 0.16 0.002 DB01440 0.097 0.003 DBMET01477 | DB01440 | |
| 0.037 | 0.067 | 0.12 | Maillard reaction inhibitor | 0.11 0.013 DBMET02011 0.091 0.02 DB01955 0.109 0.014 DB01440 0.12 0.01 DBMET01477 | DBMET01477 | |
| 0.012 | 0.044 | 0.184 | Guanylate cyclase 1 stimulant | 0.184 0.003 DBMET02011 | DBMET02011 | |
| 0.014 | 0.046 | 0.051 | Lysophosphatidic acid 1 receptor antagonist | 0.022 0.013 DB00654 0.025 0.009 DB01955 0.022 0.013 DBMET02015 0.039 0.005 DB01440 0.051 0.004 DBMET01477 | DBMET01477 | |
| 0.033 | 0.065 | 0.283 | Aldose reductase inhibitor | 0.283 0.005 DBMET02011 0.121 0.014 DB01440 0.23 0.006 DBMET01477 | DBMET02011 | |
| 0.02 | 0.053 | 0.045 | Retinoid X gamma receptor antagonist | 0.026 0.022 DBMET02011 0.03 0.013 DB01955 0.025 0.024 DBMET02014 0.036 0.006 DB01440 0.045 0.004 DBMET01477 | DBMET01477 | |
| 0.028 | 0.062 | 0.054 | HIV-1 protease inhibitor | 0.044 0.028 DB00654 0.044 0.029 DBMET02014 0.054 0.017 DBMET02015 | DBMET02015 | |
| 0.186 | 0.22 | 0.617 | Histamine release inhibitor | 0.29 0.129 DBMET02011 0.428 0.061 DB00654 0.542 0.018 DB01955 0.388 0.082 DBMET01480 0.372 0.09 DBMET02014 0.531 0.02 DBMET02015 0.61 0.009 DB01440 0.617 0.009 DBMET01477 | DBMET01477 | |
| 0.006 | 0.04 | 0.031 | Calcium-dependent phospholipase A2 inhibitor | 0.019 0.005 DB01440 0.031 0.004 DBMET01477 | DBMET01477 | |
| 0.075 | 0.11 | 0.302 | Protein-tyrosine phosphatase 1B inhibitor | 0.091 0.088 DB00654 0.111 0.069 DB01955 0.103 0.075 DBMET02015 0.219 0.024 DB01440 0.302 0.01 DBMET01477 | DBMET01477 | |
| 0.024 | 0.059 | 0.187 | Toll-Like receptor 2 agonist | 0.045 0.026 DBMET02011 0.046 0.025 DB00654 0.132 0.012 DB01955 0.044 0.026 DBMET01480 0.187 0.008 DB01440 0.166 0.01 DBMET01477 | DB01440 | |
| 0.149 | 0.185 | 0.721 | 5 Hydroxytryptamine release stimulant | 0.199 0.122 DBMET02011 0.543 0.021 DB00654 0.586 0.016 DB01955 0.508 0.026 DBMET01480 0.564 0.018 DBMET02014 0.721 0.006 DBMET02015 0.345 0.058 DB01440 0.547 0.02 DBMET01477 | DBMET02015 | |
| 0.085 | 0.124 | 0.381 | Photosensitizer | 0.138 0.039 DBMET02011 0.1 0.088 DB00654 0.269 0.005 DB01955 0.148 0.032 DBMET01480 0.119 0.058 DBMET02014 0.207 0.011 DBMET02015 0.381 0.003 DB01440 0.334 0.004 DBMET01477 | DB01440 | |
| 0.066 | 0.105 | 0.117 | Protease inhibitor | 0.106 0.06 DB00654 0.093 0.072 DBMET02014 0.117 0.05 DBMET02015 0.115 0.051 DBMET01477 | DBMET02015 | |
| 0.013 | 0.052 | 0.205 | Leukotriene D4 antagonist | 0.029 0.016 DB01955 0.023 0.021 DBMET02014 0.137 0.005 DB01440 0.205 0.004 DBMET01477 | DBMET01477 | |
| 0.027 | 0.066 | 0.098 | Adenosine deaminase inhibitor | 0.066 0.016 DBMET02011 0.06 0.021 DB00654 0.098 0.006 DB01955 0.057 0.024 DBMET01480 0.048 0.032 DBMET02014 0.064 0.017 DBMET02015 0.093 0.006 DB01440 0.082 0.009 DBMET01477 | DB01955 | |
| 0.054 | 0.096 | 0.177 | CDC25A inhibitor | 0.067 0.062 DB00654 0.078 0.045 DB01955 0.069 0.058 DBMET02015 0.119 0.02 DB01440 0.177 0.009 DBMET01477 | DBMET01477 | |
| 0.039 | 0.082 | 0.156 | Sphingosine kinase 2 inhibitor | 0.083 0.014 DBMET02011 0.051 0.045 DB00654 0.156 0.004 DB01955 0.063 0.028 DBMET01480 0.051 0.044 DBMET02014 0.062 0.03 DBMET02015 0.081 0.015 DB01440 0.063 0.029 DBMET01477 | DB01955 | |
| 0.002 | 0.049 | 0.016 | DNA polymerase III subunit alpha inhibitor | 0.016 0.002 DB01955 0.013 0.003 DB01440 0.007 0.004 DBMET01477 | DB01955 | |
| 0.023 | 0.069 | 0.257 | Macrophage elastase inhibitor | 0.047 0.027 DB00654 0.066 0.016 DBMET02014 0.103 0.009 DBMET02015 0.088 0.011 DB01440 0.257 0.004 DBMET01477 | DBMET01477 | |
| 0.026 | 0.073 | 0.103 | Glutamate (mGluR8) antagonist | 0.036 0.025 DB01955 0.042 0.015 DBMET02014 0.049 0.009 DBMET02015 0.062 0.005 DB01440 0.103 0.003 DBMET01477 | DBMET01477 | |
| 0.067 | 0.114 | 0.085 | Thioredoxin reductase inhibitor | 0.084 0.053 DB01955 0.084 0.053 DB01440 0.085 0.049 DBMET01477 | DBMET01477 | |
| 0.054 | 0.102 | 0.25 | Glycine receptor agonist | 0.14 0.008 DBMET02011 0.066 0.064 DB00654 0.21 0.004 DB01955 0.111 0.015 DBMET01480 0.073 0.048 DBMET02014 0.101 0.02 DBMET02015 0.25 0.003 DB01440 0.246 0.003 DBMET01477 | DB01440 | |
| 0.018 | 0.066 | 0.21 | Lysophosphatidic acid 2 receptor antagonist | 0.038 0.013 DBMET02011 0.167 0.003 DB01955 0.028 0.024 DBMET01480 0.21 0.003 DB01440 0.121 0.004 DBMET01477 | DB01440 | |
| 0.027 | 0.077 | 0.18 | Mannosidase inhibitor | 0.081 0.008 DBMET02011 0.18 0.003 DB01955 0.073 0.011 DBMET01480 0.057 0.019 DBMET02014 0.09 0.007 DBMET02015 0.18 0.003 DB01440 0.154 0.004 DBMET01477 | DB01440 | |
| 0.163 | 0.214 | 0.558 | Immunomodulator | 0.4 0.044 DB00654 0.558 0.016 DB01955 0.365 0.055 DBMET02014 0.308 0.078 DBMET02015 0.556 0.016 DB01440 0.448 0.032 DBMET01477 | DB01955 | |
| 0.044 | 0.099 | 0.104 | Elastase 1 inhibitor | 0.091 0.026 DB00654 0.062 0.059 DB01440 0.104 0.018 DBMET01477 | DBMET01477 | |
| 0.07 | 0.124 | 0.106 | T cell inhibitor | 0.084 0.051 DB00654 0.089 0.04 DBMET02014 0.101 0.023 DBMET02015 0.079 0.07 DB01440 0.106 0.02 DBMET01477 | DBMET01477 | |
| 0.019 | 0.078 | 0.047 | Estrogen agonist | 0.047 0.037 DB01955 | DB01955 | |
| 0.033 | 0.092 | 0.153 | Neuraminidase inhibitor | 0.059 0.044 DB00654 0.153 0.005 DB01955 0.061 0.042 DBMET02015 0.099 0.016 DB01440 0.074 0.03 DBMET01477 | DB01955 | |
| 0.005 | 0.066 | 0.348 | Free fatty acid receptor 1 agonist | 0.018 0.012 DB01955 0.069 0.004 DBMET02015 0.141 0.004 DB01440 0.348 0.003 DBMET01477 | DBMET01477 | |
| 0.055 | 0.117 | 0.206 | Monophenol monooxygenase inhibitor | 0.179 0.038 DB00654 0.156 0.045 DB01955 0.096 0.079 DBMET02014 0.149 0.047 DBMET02015 0.184 0.037 DB01440 0.206 0.032 DBMET01477 | DBMET01477 | |
| 0.016 | 0.077 | 0.431 | GP IIb/IIIa receptor antagonist | 0.055 0.03 DBMET02015 0.182 0.008 DB01440 0.431 0.004 DBMET01477 | DBMET01477 | |
| 0.082 | 0.146 | 0.145 | Estrogen antagonist | 0.127 0.043 DBMET02011 0.145 0.025 DB01955 0.12 0.055 DB01440 0.113 0.068 DBMET01477 | DB01955 | |
| 0.048 | 0.114 | 0.641 | Glutamate dehydrogenase inhibitor | 0.12 0.023 DBMET02011 0.077 0.048 DB00654 0.247 0.007 DB01955 0.181 0.012 DBMET01480 0.124 0.022 DBMET02014 0.17 0.013 DBMET02015 0.461 0.003 DB01440 0.641 0.002 DBMET01477 | DBMET01477 | |
| 0.053 | 0.12 | 0.239 | Keratolytic | 0.099 0.031 DBMET02011 0.224 0.007 DB01955 0.092 0.036 DBMET01480 0.098 0.031 DBMET02014 0.114 0.024 DBMET02015 0.239 0.005 DB01440 0.223 0.007 DBMET01477 | DB01440 | |
| 0.014 | 0.081 | 0.053 | Sodium/glucose cotransporter inhibitor | 0.053 0.005 DBMET02011 0.048 0.005 DB01955 0.025 0.019 DB01440 0.025 0.02 DBMET01477 | DBMET02011 | |
| 0.028 | 0.095 | 0.239 | Acyl-CoA dehydrogenase inhibitor | 0.108 0.014 DBMET02011 0.073 0.025 DB00654 0.221 0.004 DB01955 0.172 0.007 DBMET01480 0.096 0.017 DBMET02014 0.112 0.014 DBMET02015 0.213 0.004 DB01440 0.239 0.003 DBMET01477 | DBMET01477 | |
| 0.022 | 0.09 | 0.123 | Membrane dipeptidase inhibitor | 0.045 0.021 DBMET02011 0.04 0.026 DB00654 0.085 0.005 DB01955 0.049 0.016 DBMET01480 0.045 0.02 DBMET02014 0.046 0.019 DBMET02015 0.116 0.003 DB01440 0.123 0.003 DBMET01477 | DBMET01477 | |
| 0.029 | 0.099 | 0.064 | Cholesterol esterase inhibitor | 0.057 0.02 DB00654 0.055 0.023 DB01955 0.064 0.014 DBMET02015 0.047 0.034 DBMET01477 | DBMET02015 | |
| 0.011 | 0.08 | 0.073 | Sodium/glucose cotransporter 2 inhibitor | 0.073 0.004 DBMET02011 0.061 0.005 DB01955 0.025 0.02 DBMET01480 0.027 0.017 DB01440 0.026 0.019 DBMET01477 | DBMET02011 | |
| 0.014 | 0.083 | 0.031 | Plasmepsin I inhibitor | 0.031 0.02 DBMET02015 | DBMET02015 | |
| 0.075 | 0.146 | 0.33 | Folate antagonist | 0.092 0.082 DB01955 0.092 0.081 DBMET02015 0.248 0.005 DB01440 0.33 0.003 DBMET01477 | DBMET01477 | |
| 0.016 | 0.087 | 0.129 | ATP citrate lysase inhibitor | 0.042 0.012 DB00654 0.036 0.016 DB01955 0.029 0.027 DBMET01480 0.07 0.004 DBMET02014 0.129 0.003 DBMET02015 0.056 0.006 DB01440 0.124 0.003 DBMET01477 | DBMET02015 | |
| 0.039 | 0.111 | 0.066 | Cathepsin E inhibitor | 0.06 0.041 DB00654 0.057 0.045 DBMET02014 0.066 0.033 DBMET02015 0.057 0.044 DBMET01477 | DBMET02015 | |
| 0.026 | 0.097 | 0.093 | Neuraminidase (Influenza A) inhibitor | 0.093 0.004 DB01955 0.048 0.027 DBMET02015 0.067 0.009 DB01440 0.056 0.016 DBMET01477 | DB01955 | |
| 0.064 | 0.136 | 0.215 | Thioredoxin inhibitor | 0.152 0.016 DB01440 0.215 0.007 DBMET01477 | DBMET01477 | |
| 0.108 | 0.182 | 0.297 | CF transmembrane conductance regulator agonist | 0.297 0.004 DBMET02011 0.198 0.022 DB01955 0.193 0.026 DBMET01480 0.163 0.056 DB01440 0.195 0.024 DBMET01477 | DBMET02011 | |
| 0.02 | 0.095 | 0.129 | GABA uptake inhibitor | 0.075 0.006 DBMET02011 0.12 0.003 DB01955 0.053 0.014 DBMET01480 0.041 0.025 DBMET02015 0.129 0.003 DB01440 0.115 0.003 DBMET01477 | DB01440 | |
| 0.003 | 0.079 | 0.045 | Phosphoribosylglycinamide formyltransferase inhibitor | 0.011 0.003 DB01440 0.045 0.002 DBMET01477 | DBMET01477 | |
| 0.093 | 0.17 | 0.328 | Amyloid beta aggregation inhibitor | 0.328 0.04 DBMET02011 0.322 0.041 DB01955 0.201 0.077 DB01440 | DBMET02011 | |
| 0.011 | 0.092 | 0.037 | Neuraminidase (Influenza B) inhibitor | 0.02 0.018 DBMET02011 0.023 0.01 DB00654 0.037 0.004 DB01955 0.023 0.011 DBMET01480 0.024 0.009 DBMET02014 0.026 0.007 DBMET02015 0.028 0.005 DB01440 0.031 0.004 DBMET01477 | DB01955 | |
| 0.088 | 0.169 | 0.378 | Protein-tyrosine phosphatase inhibitor | 0.156 0.072 DB01955 0.122 0.112 DBMET02015 0.278 0.024 DB01440 0.378 0.01 DBMET01477 | DBMET01477 | |
| 0.008 | 0.095 | 0.146 | Sphingosine 1-phosphate receptor 3 agonist | 0.041 0.021 DBMET02011 0.146 0.004 DB01955 0.048 0.017 DBMET02015 0.13 0.005 DB01440 0.095 0.007 DBMET01477 | DB01955 | |
| 0.017 | 0.103 | 0.097 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.038 0.019 DBMET02011 0.05 0.009 DB01955 0.097 0.004 DB01440 0.075 0.005 DBMET01477 | DB01440 | |
| 0.008 | 0.096 | 0.239 | Purinergic P2Y12 antagonist | 0.093 0.004 DB01955 0.239 0.003 DB01440 0.172 0.004 DBMET01477 | DB01440 | |
| 0.013 | 0.102 | 0.64 | Fumarate hydratase inhibitor | 0.052 0.013 DBMET02011 0.031 0.028 DB00654 0.121 0.004 DB01955 0.091 0.006 DBMET01480 0.072 0.008 DBMET02014 0.1 0.005 DBMET02015 0.36 0.002 DB01440 0.64 0.001 DBMET01477 | DBMET01477 | |
| 0.018 | 0.107 | 0.043 | Hedgehog signaling activator | 0.026 0.025 DBMET02011 0.043 0.004 DB01955 0.034 0.008 DBMET01480 0.026 0.023 DBMET02014 0.035 0.006 DBMET02015 0.033 0.009 DB01440 0.038 0.005 DBMET01477 | DB01955 | |
| 0.037 | 0.127 | 0.177 | Neuraminidase (influenza) inhibitor | 0.061 0.052 DB00654 0.177 0.005 DB01955 0.107 0.014 DB01440 0.075 0.03 DBMET01477 | DB01955 | |
| 0.028 | 0.119 | 0.698 | Aconitate hydratase inhibitor | 0.089 0.011 DBMET02011 0.053 0.034 DB00654 0.214 0.003 DB01955 0.127 0.005 DBMET01480 0.11 0.007 DBMET02014 0.148 0.004 DBMET02015 0.433 0.002 DB01440 0.698 0.001 DBMET01477 | DBMET01477 | |
| 0.117 | 0.209 | 0.22 | Ca2+-transporting ATPase inhibitor | 0.171 0.012 DBMET02011 0.147 0.05 DB00654 0.209 0.003 DB01955 0.187 0.005 DBMET01480 0.146 0.052 DBMET02014 0.156 0.03 DBMET02015 0.21 0.003 DB01440 0.22 0.002 DBMET01477 | DBMET01477 | |
| 0.061 | 0.154 | 0.179 | Bile acid receptor antagonist | 0.102 0.044 DBMET02011 0.12 0.02 DB00654 0.137 0.01 DB01955 0.097 0.057 DBMET01480 0.101 0.047 DBMET02014 0.121 0.019 DBMET02015 0.179 0.005 DB01440 0.156 0.007 DBMET01477 | DB01440 | |
| 0.017 | 0.111 | 0.114 | Ribonucleotide reductase inhibitor | 0.061 0.036 DB00654 0.082 0.026 DB01955 0.071 0.031 DBMET02015 0.114 0.018 DB01440 0.114 0.018 DBMET01477 | DBMET01477 | |
| 0.092 | 0.186 | 0.197 | NOS3 expression enhancer | 0.174 0.053 DB00654 0.197 0.042 DBMET02014 0.162 0.062 DBMET02015 0.186 0.047 DBMET01477 | DBMET02014 | |
| 0.003 | 0.099 | 0.397 | N-Acetylated alpha-linked acidic dipeptidase inhibitor | 0.063 0.004 DB01440 0.397 0.002 DBMET01477 | DBMET01477 | |
| 0.017 | 0.113 | 0.116 | Ribonucleoside-diphosphate reductase inhibitor | 0.06 0.034 DB00654 0.08 0.025 DB01955 0.069 0.029 DBMET02015 0.116 0.016 DB01440 0.115 0.016 DBMET01477 | DB01440 | |
| 0.06 | 0.156 | 0.116 | Estrogen receptor beta antagonist | 0.116 0.037 DBMET02011 0.11 0.046 DB01955 | DBMET02011 | |
| 0.161 | 0.258 | 0.556 | Toll-Like receptor agonist | 0.25 0.148 DB00654 0.473 0.038 DB01955 0.258 0.141 DBMET02014 0.314 0.102 DBMET02015 0.556 0.023 DB01440 0.535 0.026 DBMET01477 | DB01440 | |
| 0.024 | 0.123 | 0.075 | Beta 2 adrenoreceptor antagonist | 0.049 0.038 DBMET02011 0.075 0.014 DB01955 0.055 0.03 DBMET02015 0.057 0.027 DB01440 0.059 0.025 DBMET01477 | DB01955 | |
| 0.083 | 0.185 | 0.311 | Diuretic | 0.212 0.04 DBMET02011 0.222 0.037 DB01955 0.155 0.073 DBMET02015 0.311 0.021 DB01440 0.311 0.021 DBMET01477 | DBMET01477 | |
| 0.004 | 0.108 | 0.08 | Neutral endopeptidase inhibitor | 0.023 0.014 DB01440 0.08 0.005 DBMET01477 | DBMET01477 | |
| 0.095 | 0.199 | 0.531 | Interleukin antagonist | 0.252 0.061 DB00654 0.247 0.063 DB01955 0.176 0.099 DBMET02014 0.186 0.092 DBMET02015 0.461 0.023 DB01440 0.531 0.017 DBMET01477 | DBMET01477 | |
| 0.017 | 0.125 | 0.06 | Oleamide hydrolase inhibitor | 0.06 0.021 DB00654 0.047 0.03 DB01955 0.039 0.038 DBMET01477 | DB00654 | |
| 0.033 | 0.142 | 0.427 | Sphingosine 1-phosphate receptor 5 agonist | 0.099 0.009 DB01955 0.055 0.034 DBMET02014 0.096 0.009 DBMET02015 0.268 0.004 DB01440 0.427 0.003 DBMET01477 | DBMET01477 | |
| 0.022 | 0.132 | 0.352 | Plasminogen activator inhibitor antagonist | 0.059 0.025 DBMET02011 0.078 0.016 DB01955 0.219 0.004 DB01440 0.352 0.003 DBMET01477 | DBMET01477 | |
| 0.029 | 0.141 | 0.122 | Squalene epoxidase inhibitor | 0.052 0.03 DBMET02011 0.122 0.004 DB01955 0.059 0.021 DBMET01480 0.052 0.031 DBMET02015 0.076 0.011 DB01440 0.057 0.024 DBMET01477 | DB01955 | |
| 0.069 | 0.181 | 0.601 | Aldehyde dehydrogenase inhibitor | 0.226 0.022 DBMET02011 0.107 0.086 DB00654 0.459 0.005 DB01955 0.162 0.041 DBMET01480 0.107 0.086 DBMET02015 0.601 0.004 DB01440 0.413 0.005 DBMET01477 | DB01440 | |
| 0.058 | 0.174 | 0.185 | ABCA1 expression enhancer | 0.085 0.074 DB00654 0.149 0.018 DB01955 0.093 0.06 DBMET02014 0.103 0.046 DBMET02015 0.165 0.014 DB01440 0.185 0.011 DBMET01477 | DBMET01477 | |
| 0.105 | 0.222 | 0.243 | ATPase inhibitor | 0.193 0.044 DB00654 0.243 0.015 DB01955 0.173 0.067 DBMET01480 0.218 0.025 DBMET02014 0.203 0.035 DBMET02015 0.216 0.026 DB01440 0.221 0.023 DBMET01477 | DB01955 | |
| 0.009 | 0.126 | 0.085 | Retinoic acid beta receptor agonist | 0.019 0.015 DBMET02011 0.085 0.003 DB01955 0.044 0.004 DB01440 0.027 0.006 DBMET01477 | DB01955 | |
| 0.032 | 0.152 | 0.154 | Glucosylceramidase inhibitor | 0.067 0.024 DBMET02011 0.154 0.004 DB01955 0.055 0.038 DBMET01480 0.087 0.012 DB01440 0.065 0.026 DBMET01477 | DB01955 | |
| 0.007 | 0.126 | 0.023 | Purinergic P2Y1 agonist | 0.015 0.012 DBMET02011 0.023 0.005 DB01955 0.02 0.007 DBMET01480 0.019 0.008 DB01440 0.02 0.007 DBMET01477 | DB01955 | |
| 0.007 | 0.129 | 0.1 | Retinoid X beta receptor agonist | 0.032 0.008 DB01440 0.1 0.003 DBMET01477 | DBMET01477 | |
| 0.009 | 0.134 | 0.084 | Carbonic anhydrase IV inhibitor | 0.084 0.01 DBMET02011 0.043 0.03 DB01955 0.053 0.023 DB01440 0.071 0.014 DBMET01477 | DBMET02011 | |
| 0.043 | 0.168 | 0.28 | Aminopeptidase B inhibitor | 0.183 0.026 DBMET02011 0.247 0.013 DB01955 0.183 0.026 DBMET01480 0.132 0.046 DBMET02014 0.186 0.025 DBMET02015 0.27 0.011 DB01440 0.28 0.01 DBMET01477 | DBMET01477 | |
| 0.007 | 0.133 | 0.102 | Retinoid X gamma receptor agonist | 0.035 0.009 DB01440 0.102 0.004 DBMET01477 | DBMET01477 | |
| 0.055 | 0.184 | 0.171 | Xanthine oxidase inhibitor | 0.171 0.027 DBMET02011 0.133 0.041 DB01955 0.085 0.08 DBMET01480 0.138 0.039 DB01440 0.161 0.03 DBMET01477 | DBMET02011 | |
| 0.006 | 0.135 | 0.027 | Retinoic acid alpha receptor antagonist | 0.026 0.009 DB01955 0.024 0.01 DB01440 0.027 0.008 DBMET01477 | DBMET01477 | |
| 0.047 | 0.177 | 0.324 | Expectorant | 0.095 0.075 DBMET02011 0.12 0.051 DB00654 0.234 0.015 DB01955 0.102 0.066 DBMET01480 0.134 0.042 DBMET02014 0.176 0.026 DBMET02015 0.324 0.007 DB01440 0.298 0.009 DBMET01477 | DB01440 | |
| 0.007 | 0.138 | 0.024 | DNA polymerase III polC-type inhibitor | 0.024 0.003 DB01955 0.018 0.004 DB01440 | DB01955 | |
| 0.023 | 0.156 | 0.561 | Carbamoyl phosphate synthetase inhibitor | 0.21 0.007 DBMET02011 0.407 0.003 DB01955 0.184 0.008 DBMET01480 0.096 0.022 DBMET02014 0.148 0.011 DBMET02015 0.55 0.002 DB01440 0.561 0.002 DBMET01477 | DBMET01477 | |
| 0.023 | 0.156 | 0.2 | Alpha-mannosidase inhibitor | 0.09 0.008 DBMET02011 0.2 0.003 DB01955 0.084 0.01 DBMET01480 0.051 0.042 DBMET02014 0.073 0.015 DBMET02015 0.153 0.004 DB01440 0.126 0.004 DBMET01477 | DB01955 | |
| 0.023 | 0.158 | 0.127 | Kainate receptor agonist | 0.052 0.012 DBMET02011 0.073 0.004 DB01955 0.067 0.005 DBMET01480 0.048 0.016 DBMET02014 0.05 0.014 DBMET02015 0.078 0.004 DB01440 0.127 0.002 DBMET01477 | DBMET01477 | |
| 0.051 | 0.185 | 0.507 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.162 0.023 DBMET02011 0.129 0.035 DB00654 0.319 0.005 DB01955 0.289 0.007 DBMET01480 0.193 0.017 DBMET02014 0.318 0.005 DBMET02015 0.428 0.003 DB01440 0.507 0.002 DBMET01477 | DBMET01477 | |
| 0.009 | 0.145 | 0.059 | Retinoic acid receptor agonist | 0.059 0.005 DB01955 0.041 0.006 DB01440 0.031 0.009 DBMET01477 | DB01955 | |
| 0.116 | 0.254 | 0.292 | Lipoxygenase inhibitor | 0.176 0.169 DB00654 0.246 0.103 DB01955 0.19 0.151 DBMET02014 0.289 0.077 DB01440 0.292 0.075 DBMET01477 | DBMET01477 | |
| 0.042 | 0.185 | 0.344 | Glutamate (mGluR6) antagonist | 0.09 0.016 DBMET02011 0.14 0.004 DB01955 0.103 0.009 DBMET01480 0.076 0.03 DBMET02014 0.101 0.01 DBMET02015 0.215 0.003 DB01440 0.344 0.002 DBMET01477 | DBMET01477 | |
| 0.005 | 0.148 | 0.119 | Arginase inhibitor | 0.057 0.012 DBMET02011 0.092 0.004 DB01955 0.044 0.019 DBMET01480 0.051 0.014 DBMET02015 0.119 0.003 DB01440 0.118 0.003 DBMET01477 | DB01440 | |
| 0.026 | 0.172 | 0.052 | Glucose-6-phosphate translocase inhibitor | 0.052 0.035 DBMET01477 | DBMET01477 | |
| 0.049 | 0.194 | 0.625 | Triose-phosphate isomerase inhibitor | 0.262 0.006 DBMET02011 0.462 0.003 DB01955 0.301 0.005 DBMET01480 0.143 0.022 DBMET02014 0.234 0.008 DBMET02015 0.616 0.002 DB01440 0.625 0.002 DBMET01477 | DBMET01477 | |
| 0.016 | 0.161 | 0.055 | DNA polymerase III inhibitor | 0.027 0.021 DBMET02011 0.055 0.003 DB01955 0.044 0.004 DB01440 | DB01955 | |
| 0.006 | 0.152 | 0.268 | Leukotriene A4 hydrolase inhibitor | 0.074 0.01 DB01955 0.187 0.004 DB01440 0.268 0.004 DBMET01477 | DBMET01477 | |
| 0.004 | 0.151 | 0.012 | Retinoic acid receptor gamma antagonist | 0.012 0.007 DB01955 | DB01955 | |
| 0.027 | 0.174 | 0.053 | Beta adrenoreceptor agonist | 0.043 0.04 DBMET02011 0.053 0.014 DB01955 0.044 0.035 DBMET02015 0.045 0.032 DB01440 0.045 0.032 DBMET01477 | DB01955 | |
| 0.024 | 0.172 | 0.048 | Cathepsin D inhibitor | 0.048 0.044 DBMET02015 | DBMET02015 | |
| 0.053 | 0.201 | 0.371 | Amylase inhibitor | 0.145 0.066 DBMET02011 0.103 0.093 DB00654 0.346 0.013 DB01955 0.189 0.048 DBMET01480 0.136 0.071 DBMET02014 0.226 0.036 DBMET02015 0.371 0.011 DB01440 0.349 0.013 DBMET01477 | DB01440 | |
| 0.001 | 0.152 | 0.01 | Neurokinin 3 agonist | 0.01 0.009 DBMET01477 | DBMET01477 | |
| 0.002 | 0.154 | 0.135 | Glutamate (mGluR6) agonist | 0.013 0.007 DBMET02011 0.024 0.004 DB01955 0.02 0.004 DBMET01480 0.014 0.006 DBMET02015 0.049 0.002 DB01440 0.135 0.001 DBMET01477 | DBMET01477 | |
| 0.013 | 0.165 | 0.146 | Carbonic anhydrase inhibitor | 0.146 0.017 DBMET02011 0.062 0.044 DB01955 | DBMET02011 | |
| 0.005 | 0.158 | 0.026 | Retinoic acid receptor antagonist | 0.026 0.007 DB01955 0.022 0.009 DB01440 0.024 0.008 DBMET01477 | DB01955 | |
| 0.008 | 0.161 | 0.037 | Urotensin II agonist | 0.037 0.01 DBMET01477 | DBMET01477 | |
| 0.04 | 0.194 | 0.109 | Peroxisome proliferator-activated receptor gamma antagonist | 0.078 0.037 DB00654 0.082 0.031 DB01955 0.076 0.04 DBMET02015 0.102 0.014 DB01440 0.109 0.012 DBMET01477 | DBMET01477 | |
| 0.14 | 0.297 | 0.528 | Toll-Like receptor 7 agonist | 0.449 0.044 DB01955 0.251 0.147 DBMET02014 0.304 0.107 DBMET02015 0.528 0.027 DB01440 0.508 0.03 DBMET01477 | DB01440 | |
| 0.01 | 0.166 | 0.035 | Retinoic acid gamma receptor agonist | 0.035 0.005 DB01955 0.032 0.005 DB01440 0.03 0.006 DBMET01477 | DB01955 | |
| 0.056 | 0.215 | 0.809 | Alpha-N-acetylglucosaminidase inhibitor | 0.468 0.006 DBMET02011 0.137 0.063 DB00654 0.774 0.002 DB01955 0.583 0.004 DBMET01480 0.28 0.018 DBMET02014 0.441 0.007 DBMET02015 0.795 0.002 DB01440 0.809 0.002 DBMET01477 | DBMET01477 | |
| 0.01 | 0.169 | 0.044 | Vanilloid 2 agonist | 0.038 0.005 DB01955 0.035 0.005 DBMET01480 0.031 0.008 DBMET02015 0.031 0.008 DB01440 0.044 0.004 DBMET01477 | DBMET01477 | |
| 0.009 | 0.171 | 0.049 | Retinoid X beta receptor antagonist | 0.024 0.008 DBMET02011 0.032 0.004 DB01955 0.022 0.011 DBMET01480 0.04 0.003 DB01440 0.049 0.003 DBMET01477 | DBMET01477 | |
| 0.008 | 0.17 | 0.088 | Peroxisome proliferator-activated receptor delta agonist | 0.045 0.014 DB01955 0.041 0.016 DBMET02015 0.088 0.007 DB01440 0.086 0.007 DBMET01477 | DB01440 | |
| 0.137 | 0.299 | 0.651 | Tyrosine 3 hydroxylase inhibitor | 0.299 0.033 DBMET02011 0.198 0.139 DB00654 0.434 0.005 DB01955 0.404 0.008 DBMET01480 0.286 0.04 DBMET02014 0.341 0.018 DBMET02015 0.494 0.004 DB01440 0.651 0.003 DBMET01477 | DBMET01477 | |
| 0.063 | 0.23 | 0.542 | Cell adhesion inhibitor | 0.102 0.086 DB00654 0.118 0.067 DB01955 0.112 0.073 DBMET02014 0.158 0.042 DBMET02015 0.391 0.005 DB01440 0.542 0.004 DBMET01477 | DBMET01477 | |
| 0.038 | 0.212 | 0.078 | Beta 2 adrenoreceptor agonist | 0.063 0.039 DBMET02011 0.078 0.01 DB01955 0.061 0.044 DBMET02015 0.065 0.031 DB01440 0.065 0.033 DBMET01477 | DB01955 | |
| 0.05 | 0.226 | 0.297 | Mucolytic | 0.122 0.053 DBMET02011 0.096 0.083 DB00654 0.233 0.008 DB01955 0.131 0.045 DBMET01480 0.12 0.054 DBMET02014 0.149 0.033 DBMET02015 0.297 0.004 DB01440 0.273 0.005 DBMET01477 | DB01440 | |
| 0.009 | 0.187 | 0.048 | Nicotinic acid receptor 2 agonist | 0.048 0.015 DB01955 | DB01955 | |
| 0.031 | 0.21 | 0.098 | Adrenaline antagonist | 0.098 0.055 DBMET02011 | DBMET02011 | |
| 0.007 | 0.186 | 0.11 | Retinoid X receptor agonist | 0.071 0.01 DB01955 0.03 0.029 DBMET01480 0.093 0.005 DB01440 0.11 0.004 DBMET01477 | DBMET01477 | |
| 0.031 | 0.213 | 0.099 | Antiadrenergic | 0.099 0.056 DBMET02011 | DBMET02011 | |
| 0.059 | 0.241 | 0.177 | Calcium channel blocker | 0.177 0.04 DBMET02011 | DBMET02011 | |
| 0.09 | 0.272 | 0.843 | Succinate dehydrogenase inhibitor | 0.344 0.006 DBMET02011 0.58 0.003 DB01955 0.31 0.009 DBMET01480 0.18 0.067 DBMET02014 0.214 0.039 DBMET02015 0.843 0.002 DB01440 0.704 0.002 DBMET01477 | DB01440 | |
| 0.009 | 0.194 | 0.032 | Methylmalonyl-CoA mutase inhibitor | 0.018 0.013 DBMET02011 0.025 0.004 DB01955 0.022 0.006 DBMET01480 0.021 0.008 DBMET02015 0.029 0.003 DB01440 0.032 0.002 DBMET01477 | DBMET01477 | |
| 0.015 | 0.201 | 0.169 | Cholecystokinin B agonist | 0.053 0.014 DB01440 0.169 0.005 DBMET01477 | DBMET01477 | |
| 0.042 | 0.228 | 0.54 | Cell adhesion molecule inhibitor | 0.082 0.051 DB01955 0.085 0.047 DBMET02015 0.323 0.005 DB01440 0.54 0.004 DBMET01477 | DBMET01477 | |
| 0.012 | 0.198 | 0.244 | Peroxisome proliferator-activated receptor delta antagonist | 0.047 0.01 DB01955 0.044 0.012 DBMET02015 0.163 0.004 DB01440 0.244 0.004 DBMET01477 | DBMET01477 | |
| 0.005 | 0.194 | 0.019 | Angiotensin-converting enzyme 2 inhibitor | 0.019 0.01 DBMET01477 | DBMET01477 | |
| 0.06 | 0.251 | 0.358 | Anticoagulant | 0.249 0.039 DB01440 0.358 0.02 DBMET01477 | DBMET01477 | |
| 0.002 | 0.193 | 0.062 | Peroxisome proliferator-activated receptor alpha antagonist | 0.049 0.008 DB01440 0.062 0.007 DBMET01477 | DBMET01477 | |
| 0.008 | 0.199 | 0.104 | Carbonic anhydrase II inhibitor | 0.104 0.018 DBMET02011 0.052 0.042 DB01955 | DBMET02011 | |
| 0.004 | 0.196 | 0.105 | Purinergic P2T antagonist | 0.072 0.007 DB01955 0.105 0.005 DB01440 0.097 0.005 DBMET01477 | DB01440 | |
| 0.025 | 0.217 | 0.202 | Carbonic anhydrase XIII inhibitor | 0.17 0.018 DB01955 0.086 0.046 DBMET01480 0.197 0.014 DB01440 0.202 0.014 DBMET01477 | DBMET01477 | |
| 0.01 | 0.203 | 0.36 | Ornithine carbamoyltransferase inhibitor | 0.157 0.009 DBMET02011 0.327 0.004 DB01955 0.11 0.014 DBMET01480 0.059 0.032 DBMET02015 0.36 0.004 DB01440 0.26 0.005 DBMET01477 | DB01440 | |
| 0.003 | 0.195 | 0.091 | Carbonic anhydrase X inhibitor | 0.021 0.007 DBMET02011 0.052 0.003 DB01955 0.032 0.004 DBMET01480 0.082 0.002 DB01440 0.091 0.001 DBMET01477 | DBMET01477 | |
| 0.003 | 0.195 | 0.091 | Carbonic anhydrase VIII inhibitor | 0.021 0.007 DBMET02011 0.052 0.003 DB01955 0.032 0.004 DBMET01480 0.082 0.002 DB01440 0.091 0.001 DBMET01477 | DBMET01477 | |
| 0.012 | 0.208 | 0.243 | Glutamate (mGluR3) antagonist | 0.088 0.005 DB01955 0.041 0.02 DBMET01480 0.046 0.015 DBMET02014 0.098 0.004 DBMET02015 0.13 0.004 DB01440 0.243 0.003 DBMET01477 | DBMET01477 | |
| 0.01 | 0.208 | 0.141 | Carbonic anhydrase VB inhibitor | 0.097 0.017 DBMET02011 0.135 0.01 DB01955 0.075 0.025 DBMET01480 0.13 0.011 DB01440 0.141 0.01 DBMET01477 | DBMET01477 | |
| 0.137 | 0.336 | 0.805 | Analgesic | 0.805 0.005 DBMET02011 | DBMET02011 | |
| 0.042 | 0.243 | 0.132 | Vanilloid 4 agonist | 0.073 0.056 DBMET02011 0.073 0.056 DB00654 0.107 0.012 DB01955 0.108 0.011 DBMET01480 0.082 0.037 DBMET02014 0.09 0.026 DBMET02015 0.11 0.01 DB01440 0.132 0.004 DBMET01477 | DBMET01477 | |
| 0.023 | 0.225 | 0.734 | Glutamate decarboxylase inhibitor | 0.152 0.013 DBMET02011 0.261 0.004 DB01955 0.167 0.01 DBMET01480 0.091 0.035 DBMET02014 0.13 0.018 DBMET02015 0.533 0.002 DB01440 0.734 0.002 DBMET01477 | DBMET01477 | |
| 0.026 | 0.229 | 0.252 | Aminopeptidase I inhibitor | 0.11 0.023 DBMET02011 0.194 0.007 DB01955 0.126 0.018 DBMET01480 0.13 0.017 DBMET02014 0.178 0.009 DBMET02015 0.228 0.005 DB01440 0.252 0.004 DBMET01477 | DBMET01477 | |
| 0.002 | 0.21 | 0.045 | Aminopeptidase A inhibitor | 0.016 0.014 DB01955 0.016 0.015 DBMET02015 0.025 0.008 DB01440 0.045 0.004 DBMET01477 | DBMET01477 | |
| 0.005 | 0.213 | 0.079 | G protein-coupled receptor agonist | 0.054 0.016 DB01955 0.076 0.009 DBMET02015 0.079 0.008 DB01440 0.069 0.01 DBMET01477 | DB01440 | |
| 0.045 | 0.258 | 0.161 | Lanosterol 14 alpha demethylase inhibitor | 0.088 0.075 DB00654 0.148 0.012 DB01955 0.133 0.019 DBMET01480 0.088 0.076 DBMET02015 0.133 0.019 DB01440 0.161 0.008 DBMET01477 | DBMET01477 | |
| 0.038 | 0.251 | 0.344 | Cystathionine beta-synthase inhibitor | 0.128 0.053 DBMET02011 0.25 0.015 DB01955 0.194 0.026 DBMET01480 0.12 0.058 DBMET02014 0.131 0.05 DBMET02015 0.25 0.015 DB01440 0.344 0.007 DBMET01477 | DBMET01477 | |
| 0.035 | 0.25 | 0.095 | Topoisomerase II inhibitor | 0.095 0.092 DBMET01477 | DBMET01477 | |
| 0.004 | 0.22 | 0.387 | Integrin beta3 antagonist | 0.049 0.006 DB01440 0.387 0.004 DBMET01477 | DBMET01477 | |
| 0.008 | 0.227 | 0.082 | Nicotinic acid receptor agonist | 0.082 0.006 DB01955 0.062 0.01 DB01440 0.076 0.007 DBMET01477 | DB01955 | |
| 0.031 | 0.251 | 0.081 | Adenine nucleotide translocase inhibitor | 0.064 0.022 DB01955 0.067 0.018 DB01440 0.081 0.009 DBMET01477 | DBMET01477 | |
| 0 | 0.224 | 0.006 | Transcortin receptor antagonist | 0.006 0.004 DB01955 | DB01955 | |
| 0.081 | 0.306 | 0.315 | Neurotrophic factor enhancer | 0.185 0.092 DBMET02011 0.197 0.08 DB00654 0.315 0.014 DB01955 0.213 0.065 DBMET01480 0.172 0.108 DBMET02014 0.228 0.052 DBMET02015 0.288 0.021 DB01440 0.294 0.02 DBMET01477 | DB01955 | |
| 0.051 | 0.276 | 0.192 | Estrogen-related receptor beta agonist | 0.121 0.01 DBMET02011 0.192 0.003 DB01955 0.107 0.018 DBMET01480 0.083 0.057 DBMET02015 0.188 0.003 DB01440 0.15 0.004 DBMET01477 | DB01955 | |
| 0.025 | 0.252 | 0.09 | Metalloproteinase-9 inhibitor | 0.071 0.054 DBMET02011 0.068 0.06 DB01955 0.07 0.055 DB01440 0.09 0.038 DBMET01477 | DBMET01477 | |
| 0.004 | 0.236 | 0.099 | Thyroid hormone alpha antagonist | 0.018 0.009 DB01955 0.048 0.004 DB01440 0.099 0.004 DBMET01477 | DBMET01477 | |
| 0.023 | 0.255 | 0.095 | Epoxide hydrolase inhibitor | 0.083 0.039 DB01955 0.094 0.029 DB01440 0.095 0.029 DBMET01477 | DBMET01477 | |
| 0.014 | 0.246 | 0.862 | Alcohol oxidase inhibitor | 0.228 0.005 DBMET02011 0.823 0.003 DB01955 0.332 0.004 DBMET01480 0.085 0.022 DBMET02014 0.198 0.007 DBMET02015 0.836 0.002 DB01440 0.862 0.002 DBMET01477 | DBMET01477 | |
| 0.005 | 0.239 | 0.128 | 5-Alpha-reductase inhibitor | 0.055 0.017 DB01955 0.054 0.017 DBMET02015 0.112 0.009 DB01440 0.128 0.008 DBMET01477 | DBMET01477 | |
| 0.032 | 0.267 | 0.229 | Carbonic anhydrase VI inhibitor | 0.076 0.062 DBMET02011 0.192 0.014 DB01955 0.096 0.042 DBMET01480 0.223 0.011 DB01440 0.229 0.01 DBMET01477 | DBMET01477 | |
| 0.013 | 0.247 | 0.098 | Retinoic acid alpha receptor agonist | 0.036 0.034 DBMET02011 0.098 0.004 DB01955 0.084 0.005 DB01440 0.069 0.006 DBMET01477 | DB01955 | |
| 0.018 | 0.253 | 0.247 | Sphingosine 1-phosphate receptor 4 agonist | 0.111 0.02 DBMET02011 0.184 0.005 DB01955 0.099 0.026 DBMET01480 0.247 0.003 DB01440 0.22 0.004 DBMET01477 | DB01440 | |
| 0.016 | 0.255 | 0.085 | Thymidine kinase inhibitor | 0.044 0.024 DBMET02011 0.085 0.008 DB01955 0.045 0.023 DBMET01480 0.046 0.022 DBMET02015 0.075 0.009 DB01440 0.064 0.012 DBMET01477 | DB01955 | |
| 0.035 | 0.276 | 0.858 | GABA C receptor agonist | 0.337 0.007 DBMET02011 0.562 0.003 DB01955 0.466 0.004 DBMET01480 0.216 0.018 DBMET02014 0.291 0.01 DBMET02015 0.733 0.002 DB01440 0.858 0.001 DBMET01477 | DBMET01477 | |
| 0.104 | 0.346 | 0.367 | RNA-directed DNA polymerase inhibitor | 0.204 0.094 DBMET02011 0.246 0.052 DB00654 0.355 0.023 DB01955 0.29 0.034 DBMET01480 0.171 0.151 DBMET02015 0.285 0.035 DB01440 0.367 0.022 DBMET01477 | DBMET01477 | |
| 0.023 | 0.265 | 0.12 | Metalloproteinase-2 inhibitor | 0.073 0.061 DBMET02011 0.072 0.063 DB01955 0.093 0.042 DB01440 0.12 0.029 DBMET01477 | DBMET01477 | |
| 0.018 | 0.265 | 0.108 | Sphingosine 1-phosphate receptor 3 antagonist | 0.071 0.024 DBMET02011 0.108 0.006 DB01955 0.055 0.046 DBMET01480 0.105 0.007 DB01440 0.09 0.011 DBMET01477 | DB01955 | |
| 0.012 | 0.263 | 0.113 | HIV-1 integrase (Strand Transfer) inhibitor | 0.057 0.044 DB01440 0.113 0.018 DBMET01477 | DBMET01477 | |
| 0.016 | 0.268 | 0.426 | Catalase inhibitor | 0.175 0.02 DBMET02011 0.302 0.006 DB01955 0.152 0.026 DBMET01480 0.072 0.053 DBMET02015 0.426 0.003 DB01440 0.411 0.004 DBMET01477 | DB01440 | |
| 0.014 | 0.267 | 0.374 | Biliverdin reductase inhibitor | 0.113 0.015 DBMET02011 0.228 0.005 DB01955 0.211 0.005 DBMET01480 0.103 0.017 DBMET02014 0.224 0.005 DBMET02015 0.285 0.003 DB01440 0.374 0.002 DBMET01477 | DBMET01477 | |
| 0.051 | 0.313 | 0.194 | Interleukin 12 antagonist | 0.138 0.017 DB01955 0.182 0.007 DB01440 0.194 0.006 DBMET01477 | DBMET01477 | |
| 0.007 | 0.272 | 0.161 | Caspase 2 inhibitor | 0.072 0.007 DB01440 0.161 0.003 DBMET01477 | DBMET01477 | |
| 0.012 | 0.277 | 0.104 | Glutamate (mGluR3) agonist | 0.041 0.009 DBMET02011 0.067 0.003 DB01955 0.039 0.01 DBMET01480 0.034 0.019 DBMET02015 0.101 0.002 DB01440 0.104 0.002 DBMET01477 | DBMET01477 | |
| 0.045 | 0.311 | 0.178 | Antibacterial (Helicobacter pylori) | 0.178 0.029 DB01955 0.112 0.094 DBMET01480 0.17 0.033 DB01440 0.158 0.04 DBMET01477 | DB01955 | |
| 0.024 | 0.29 | 0.172 | 5-Lipoxygenase inhibitor | 0.118 0.051 DB01955 0.133 0.044 DB01440 0.172 0.031 DBMET01477 | DBMET01477 | |
| 0.015 | 0.287 | 0.041 | Neurokinin 2 agonist | 0.041 0.029 DBMET01477 | DBMET01477 | |
| 0.005 | 0.28 | 0.143 | Lysine carboxypeptidase inhibitor | 0.056 0.007 DB01955 0.029 0.017 DBMET01480 0.028 0.017 DBMET02015 0.109 0.004 DB01440 0.143 0.003 DBMET01477 | DBMET01477 | |
| 0.003 | 0.277 | 0.078 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.048 0.01 DBMET02011 0.078 0.005 DB01955 0.054 0.008 DBMET01480 0.075 0.005 DB01440 0.065 0.006 DBMET01477 | DB01955 | |
| 0.012 | 0.289 | 0.05 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.028 0.014 DBMET02011 0.05 0.004 DB01955 0.029 0.013 DBMET01480 0.026 0.021 DBMET02015 0.038 0.006 DB01440 0.032 0.009 DBMET01477 | DB01955 | |
| 0.007 | 0.284 | 0.034 | Catechol O-methyltransferase inhibitor | 0.034 0.02 DBMET01477 | DBMET01477 | |
| 0.035 | 0.312 | 0.311 | GABA B receptor agonist | 0.118 0.008 DBMET02011 0.202 0.003 DB01955 0.102 0.015 DBMET01480 0.089 0.027 DBMET02015 0.311 0.002 DB01440 0.271 0.003 DBMET01477 | DB01440 | |
| 0.008 | 0.287 | 0.07 | Calcitonin receptor agonist | 0.05 0.017 DB01955 0.03 0.027 DBMET01480 0.07 0.013 DB01440 0.068 0.013 DBMET01477 | DB01440 | |
| 0.033 | 0.312 | 0.16 | AMP-activated protein kinase stimulant | 0.138 0.036 DB00654 0.16 0.022 DB01955 0.115 0.053 DBMET02014 0.144 0.032 DBMET02015 0.159 0.023 DB01440 0.157 0.024 DBMET01477 | DB01955 | |
| 0.004 | 0.286 | 0.084 | Uridine phosphorylase inhibitor | 0.049 0.008 DBMET02011 0.084 0.003 DB01955 0.047 0.009 DBMET01480 0.079 0.004 DB01440 0.071 0.004 DBMET01477 | DB01955 | |
| 0.047 | 0.33 | 0.315 | Hematopoietic | 0.098 0.038 DB01955 0.08 0.074 DBMET02015 0.179 0.012 DB01440 0.315 0.005 DBMET01477 | DBMET01477 | |
| 0.014 | 0.298 | 0.072 | Retinoid X receptor antagonist | 0.044 0.018 DBMET02011 0.061 0.005 DB01955 0.039 0.025 DBMET01480 0.068 0.004 DB01440 0.072 0.004 DBMET01477 | DBMET01477 | |
| 0.022 | 0.309 | 0.075 | Bombesin 2 receptor antagonist | 0.06 0.024 DB01955 0.049 0.034 DBMET01480 0.048 0.037 DBMET02015 0.064 0.022 DB01440 0.075 0.018 DBMET01477 | DBMET01477 | |
| 0.069 | 0.356 | 0.364 | DNA damaging | 0.162 0.155 DB00654 0.322 0.049 DB01955 0.174 0.141 DBMET01480 0.364 0.037 DB01440 0.338 0.044 DBMET01477 | DB01440 | |
| 0.005 | 0.291 | 0.037 | Thyroid hormone alpha agonist | 0.02 0.007 DB01440 0.037 0.004 DBMET01477 | DBMET01477 | |
| 0.007 | 0.295 | 0.034 | Caspase 8 inhibitor | 0.021 0.012 DBMET02011 0.02 0.014 DB01955 0.027 0.006 DB01440 0.034 0.004 DBMET01477 | DBMET01477 | |
| 0.012 | 0.302 | 0.105 | HIV-1 integrase (3'-Processing) inhibitor | 0.105 0.024 DBMET01477 | DBMET01477 | |
| 0.003 | 0.296 | 0.029 | Telomerase stimulant | 0.016 0.014 DBMET02011 0.026 0.004 DB01955 0.024 0.004 DBMET01480 0.022 0.006 DB01440 0.029 0.003 DBMET01477 | DBMET01477 | |
| 0.053 | 0.351 | 0.197 | Sphingosine 1-phosphate receptor 4 antagonist | 0.132 0.053 DBMET02011 0.197 0.009 DB01955 0.144 0.039 DBMET01480 0.116 0.081 DBMET02015 0.178 0.015 DB01440 0.178 0.015 DBMET01477 | DB01955 | |
| 0.011 | 0.309 | 0.062 | Ceramide glucosyltransferase inhibitor | 0.036 0.023 DBMET02011 0.062 0.004 DB01955 0.034 0.028 DBMET01480 0.051 0.006 DB01440 0.047 0.009 DBMET01477 | DB01955 | |
| 0.006 | 0.305 | 0.128 | Retinoid X alpha receptor agonist | 0.073 0.009 DB01955 0.035 0.024 DBMET01480 0.103 0.005 DB01440 0.128 0.004 DBMET01477 | DBMET01477 | |
| 0.013 | 0.312 | 0.06 | Retinoid X alpha receptor antagonist | 0.039 0.016 DBMET02011 0.053 0.005 DB01955 0.035 0.023 DBMET01480 0.056 0.004 DB01440 0.06 0.004 DBMET01477 | DBMET01477 | |
| 0.005 | 0.307 | 0.028 | Antibiotic Anthracycline-like | 0.028 0.004 DB01955 0.021 0.009 DBMET01480 0.025 0.005 DB01440 0.026 0.004 DBMET01477 | DB01955 | |
| 0.022 | 0.325 | 0.168 | Glycine receptor antagonist | 0.086 0.048 DBMET02011 0.123 0.016 DB01955 0.125 0.015 DBMET01480 0.088 0.046 DBMET02015 0.123 0.017 DB01440 0.168 0.005 DBMET01477 | DBMET01477 | |
| 0.002 | 0.306 | 0.017 | Purine nucleoside phosphorylase inhibitor | 0.017 0.004 DB01955 0.015 0.005 DB01440 0.013 0.006 DBMET01477 | DB01955 | |
| 0.004 | 0.312 | 0.27 | Vitronectin receptor antagonist | 0.077 0.005 DB01440 0.27 0.003 DBMET01477 | DBMET01477 | |
| 0.028 | 0.336 | 0.265 | Prolactin inhibitor | 0.085 0.073 DB00654 0.179 0.013 DB01955 0.148 0.023 DBMET01480 0.103 0.052 DBMET02014 0.114 0.043 DBMET02015 0.206 0.008 DB01440 0.265 0.004 DBMET01477 | DBMET01477 | |
| 0.015 | 0.323 | 0.094 | CDC25B inhibitor | 0.079 0.028 DB01955 0.081 0.027 DB01440 0.094 0.018 DBMET01477 | DBMET01477 | |
| 0.03 | 0.34 | 0.226 | Glutathione S-transferase inhibitor | 0.109 0.03 DBMET02011 0.176 0.008 DB01955 0.095 0.042 DBMET01480 0.226 0.004 DB01440 0.184 0.007 DBMET01477 | DB01440 | |
| 0.013 | 0.323 | 0.149 | Carbonic anhydrase V inhibitor | 0.08 0.036 DBMET02011 0.121 0.021 DB01955 0.073 0.04 DBMET01480 0.129 0.019 DB01440 0.149 0.015 DBMET01477 | DBMET01477 | |
| 0.029 | 0.339 | 0.397 | UDP-glucose 4-epimerase inhibitor | 0.224 0.015 DBMET02011 0.397 0.006 DB01955 0.342 0.008 DBMET01480 0.125 0.04 DBMET02015 0.307 0.01 DB01440 0.331 0.009 DBMET01477 | DB01955 | |
| 0.005 | 0.315 | 0.129 | Sphingosine 1-phosphate receptor 1 agonist | 0.038 0.035 DBMET02011 0.08 0.006 DB01955 0.059 0.014 DBMET02015 0.129 0.004 DB01440 0.088 0.005 DBMET01477 | DB01440 | |
| 0.036 | 0.347 | 0.278 | Carbonic anhydrase III inhibitor | 0.112 0.051 DBMET02011 0.231 0.011 DB01955 0.136 0.034 DBMET01480 0.267 0.008 DB01440 0.278 0.007 DBMET01477 | DBMET01477 | |
| 0.012 | 0.326 | 0.128 | Glucagon-like peptide 1 agonist | 0.104 0.02 DB01440 0.128 0.012 DBMET01477 | DBMET01477 | |
| 0.026 | 0.342 | 0.133 | Potassium channel large-conductance Ca-activated activator | 0.089 0.029 DB01955 0.112 0.019 DB01440 0.133 0.014 DBMET01477 | DBMET01477 | |
| 0.026 | 0.343 | 0.117 | Nitric-oxide synthase inhibitor | 0.116 0.041 DBMET02011 0.117 0.04 DB01955 0.094 0.07 DBMET01480 0.094 0.07 DB01440 0.113 0.043 DBMET01477 | DB01955 | |
| 0.002 | 0.319 | 0.01 | Purinergic P2Y2 agonist | 0.01 0.008 DB01955 0.01 0.009 DBMET01480 | DBMET01480 | |
| 0.01 | 0.329 | 0.078 | Endothelin-converting enzyme inhibitor | 0.041 0.038 DB01440 0.078 0.018 DBMET01477 | DBMET01477 | |
| 0.014 | 0.334 | 0.173 | Glutamate (mGluR8) agonist | 0.051 0.011 DBMET02011 0.083 0.004 DB01955 0.076 0.004 DBMET01480 0.035 0.033 DBMET02014 0.046 0.014 DBMET02015 0.118 0.002 DB01440 0.173 0.001 DBMET01477 | DBMET01477 | |
| 0.021 | 0.341 | 0.096 | Topoisomerase I inhibitor | 0.085 0.084 DB01440 0.096 0.073 DBMET01477 | DBMET01477 | |
| 0.008 | 0.334 | 0.111 | Glycine transporter 2 inhibitor | 0.066 0.022 DB01955 0.111 0.011 DB01440 0.107 0.012 DBMET01477 | DB01440 | |
| 0.041 | 0.368 | 0.131 | Phosphodiesterase 6D inhibitor | 0.131 0.017 DB01955 0.09 0.075 DBMET01480 0.108 0.039 DBMET02015 0.111 0.035 DB01440 0.113 0.032 DBMET01477 | DB01955 | |
| 0.04 | 0.367 | 0.15 | Cytokine production inhibitor | 0.15 0.062 DBMET02011 0.13 0.079 DB01955 0.12 0.089 DB01440 0.109 0.101 DBMET01477 | DBMET02011 | |
| 0.028 | 0.356 | 0.105 | Chymotrypsin inhibitor | 0.08 0.054 DB01440 0.105 0.033 DBMET01477 | DBMET01477 | |
| 0.024 | 0.353 | 0.116 | Beta 3 adrenoreceptor antagonist | 0.061 0.052 DBMET02011 0.116 0.011 DB01955 0.079 0.024 DB01440 0.073 0.03 DBMET01477 | DB01955 | |
| 0.009 | 0.338 | 0.051 | Carboxypeptidase B inhibitor | 0.037 0.016 DB01955 0.033 0.022 DBMET02015 0.044 0.01 DB01440 0.051 0.006 DBMET01477 | DBMET01477 | |
| 0.01 | 0.341 | 0.065 | Prolyl endopeptidase inhibitor | 0.063 0.021 DB01955 0.047 0.04 DBMET01480 0.058 0.027 DB01440 0.065 0.019 DBMET01477 | DBMET01477 | |
| 0.004 | 0.335 | 0.125 | Phosphoglycerate kinase inhibitor | 0.049 0.014 DBMET02011 0.125 0.005 DB01955 0.043 0.018 DBMET01480 0.119 0.006 DB01440 0.087 0.008 DBMET01477 | DB01955 | |
| 0.011 | 0.343 | 0.234 | Estrogen-related receptor beta antagonist | 0.092 0.003 DBMET02011 0.234 0.001 DB01955 0.106 0.003 DB01440 | DB01955 | |
| 0.13 | 0.465 | 0.41 | Calcium channel L-type activator | 0.41 0.074 DB01955 0.301 0.157 DBMET02015 0.271 0.184 DB01440 0.406 0.077 DBMET01477 | DB01955 | |
| 0.001 | 0.337 | 0.015 | Carboxypeptidase B2 inhibitor | 0.015 0.005 DBMET01477 | DBMET01477 | |
| 0.005 | 0.346 | 0.037 | Integrin beta6 antagonist | 0.022 0.004 DB01440 0.037 0.002 DBMET01477 | DBMET01477 | |
| 0.018 | 0.359 | 0.057 | Autotaxin inhibitor | 0.048 0.044 DB01440 0.057 0.031 DBMET01477 | DBMET01477 | |
| 0.018 | 0.361 | 0.089 | Topoisomerase II alpha inhibitor | 0.089 0.047 DB01955 0.077 0.055 DB01440 | DB01955 | |
| 0.01 | 0.354 | 0.061 | Aminopeptidase N inhibitor | 0.061 0.024 DBMET01477 | DBMET01477 | |
| 0.021 | 0.367 | 0.058 | Heme oxygenase inhibitor | 0.058 0.007 DB01955 0.051 0.012 DBMET01480 0.051 0.012 DBMET02015 0.049 0.014 DB01440 0.054 0.009 DBMET01477 | DB01955 | |
| 0.048 | 0.397 | 0.208 | Hexokinase inhibitor | 0.163 0.065 DB00654 0.199 0.036 DB01955 0.155 0.073 DBMET01480 0.203 0.034 DBMET02014 0.155 0.073 DBMET02015 0.177 0.052 DB01440 0.208 0.031 DBMET01477 | DBMET01477 | |
| 0.015 | 0.364 | 0.081 | Aminopeptidase microsomal inhibitor | 0.081 0.024 DBMET01477 | DBMET01477 | |
| 0.008 | 0.357 | 0.036 | Growth factor receptor-bound protein 2 antagonist | 0.036 0.021 DBMET01477 | DBMET01477 | |
| 0.012 | 0.365 | 0.147 | VCAM antagonist | 0.039 0.028 DB01955 0.064 0.005 DB01440 0.147 0.004 DBMET01477 | DBMET01477 | |
| 0.012 | 0.366 | 0.145 | VCAM-1 antagonist | 0.039 0.028 DB01955 0.064 0.005 DB01440 0.145 0.004 DBMET01477 | DBMET01477 | |
| 0.019 | 0.375 | 0.108 | Nicotinic alpha3beta2 receptor antagonist | 0.056 0.031 DBMET02011 0.108 0.006 DB01955 0.065 0.021 DBMET01480 0.06 0.027 DB01440 0.053 0.037 DBMET01477 | DB01955 | |
| 0.005 | 0.361 | 0.196 | Integrin alphaVbeta3 antagonist | 0.058 0.005 DB01440 0.196 0.003 DBMET01477 | DBMET01477 | |
| 0.004 | 0.361 | 0.069 | Farnesoid X receptor agonist | 0.051 0.014 DB01955 0.06 0.01 DB01440 0.069 0.007 DBMET01477 | DBMET01477 | |
| 0.026 | 0.384 | 0.315 | Chelator | 0.272 0.014 DB01955 0.295 0.011 DB01440 0.315 0.01 DBMET01477 | DBMET01477 | |
| 0.005 | 0.363 | 0.149 | Integrin beta5 antagonist | 0.029 0.009 DB01440 0.149 0.004 DBMET01477 | DBMET01477 | |
| 0.005 | 0.364 | 0.045 | Nicotinic acid receptor 2 antagonist | 0.04 0.005 DB01955 0.034 0.009 DBMET01480 0.028 0.015 DB01440 0.045 0.004 DBMET01477 | DBMET01477 | |
| 0.007 | 0.37 | 0.051 | Angiotensin II receptor antagonist | 0.051 0.006 DBMET02011 0.041 0.013 DB01955 0.039 0.015 DB01440 0.048 0.008 DBMET01477 | DBMET02011 | |
| 0.01 | 0.374 | 0.05 | Dopamine uptake inhibitor | 0.05 0.049 DB01955 | DB01955 | |
| 0.006 | 0.371 | 0.051 | Collagenase inhibitor | 0.051 0.031 DBMET01477 | DBMET01477 | |
| 0.028 | 0.397 | 0.116 | Antineoplastic alkaloid | 0.116 0.039 DBMET01477 | DBMET01477 | |
| 0.013 | 0.383 | 0.088 | Potassium channel (ATP-sensitive) activator | 0.088 0.005 DBMET02011 0.05 0.029 DB01955 0.061 0.015 DBMET01480 0.05 0.03 DBMET01477 | DBMET02011 | |
| 0.012 | 0.383 | 0.372 | Histidine decarboxylase inhibitor | 0.093 0.035 DBMET02011 0.224 0.011 DB01955 0.192 0.014 DBMET01480 0.074 0.047 DBMET02015 0.231 0.01 DB01440 0.372 0.004 DBMET01477 | DBMET01477 | |
| 0.053 | 0.424 | 0.144 | Factor V inhibitor | 0.112 0.048 DB01440 0.144 0.021 DBMET01477 | DBMET01477 | |
| 0.043 | 0.415 | 0.279 | Antiamyloidogenic | 0.279 0.059 DBMET02011 0.219 0.087 DB01955 0.206 0.096 DB01440 0.21 0.093 DBMET01477 | DBMET02011 | |
| 0.005 | 0.378 | 0.064 | LFA antagonist | 0.047 0.006 DB01955 0.064 0.005 DB01440 0.05 0.005 DBMET01477 | DB01440 | |
| 0.06 | 0.433 | 0.11 | Sphingosine 1-phosphate receptor 2 agonist | 0.11 0.074 DB01955 | DB01955 | |
| 0.014 | 0.389 | 0.091 | Potassium channel (Inward rectifier) activator | 0.091 0.005 DBMET02011 0.053 0.03 DB01955 0.064 0.016 DBMET01480 0.053 0.031 DBMET01477 | DBMET02011 | |
| 0.006 | 0.381 | 0.142 | Sphingosine 1-phosphate receptor agonist | 0.088 0.007 DB01955 0.055 0.02 DBMET02015 0.142 0.004 DB01440 0.106 0.005 DBMET01477 | DB01440 | |
| 0.035 | 0.415 | 0.183 | Acetylcholine release stimulant | 0.116 0.055 DBMET02011 0.183 0.005 DB01955 0.143 0.021 DBMET01480 0.155 0.013 DB01440 0.143 0.021 DBMET01477 | DB01955 | |
| 0.017 | 0.398 | 0.095 | Protease 3C (Human rhinovirus) inhibitor | 0.082 0.025 DB01955 0.077 0.029 DBMET01480 0.083 0.025 DB01440 0.095 0.018 DBMET01477 | DBMET01477 | |
| 0.019 | 0.401 | 0.215 | Mediator release inhibitor | 0.153 0.027 DB01955 0.215 0.013 DB01440 0.181 0.018 DBMET01477 | DB01440 | |
| 0.004 | 0.387 | 0.065 | Endothelin receptor antagonist | 0.03 0.017 DB01440 0.065 0.008 DBMET01477 | DBMET01477 | |
| 0.018 | 0.401 | 0.096 | Integrin alpha1beta1 antagonist | 0.055 0.005 DB01440 0.096 0.003 DBMET01477 | DBMET01477 | |
| 0.002 | 0.385 | 0.022 | Integrin alphaVbeta6 antagonist | 0.015 0.009 DB01955 0.02 0.006 DB01440 0.022 0.005 DBMET01477 | DBMET01477 | |
| 0.034 | 0.421 | 0.277 | Cell wall synthesis inhibitor | 0.149 0.067 DBMET02011 0.232 0.02 DB01955 0.171 0.046 DBMET01480 0.255 0.015 DB01440 0.277 0.012 DBMET01477 | DBMET01477 | |
| 0.014 | 0.402 | 0.058 | Vanilloid 3 antagonist | 0.058 0.005 DB01955 0.042 0.018 DBMET01480 0.056 0.005 DB01440 0.058 0.005 DBMET01477 | DBMET01477 | |
| 0.008 | 0.396 | 0.124 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.059 0.041 DB01955 0.057 0.042 DBMET01480 0.071 0.03 DB01440 0.124 0.011 DBMET01477 | DBMET01477 | |
| 0.016 | 0.405 | 0.407 | GABA aminotransferase inhibitor | 0.073 0.057 DBMET02011 0.135 0.011 DB01955 0.104 0.024 DBMET01480 0.077 0.051 DBMET02014 0.103 0.025 DBMET02015 0.207 0.004 DB01440 0.407 0.003 DBMET01477 | DBMET01477 | |
| 0.011 | 0.404 | 0.09 | Protein kinase C eta inhibitor | 0.09 0.02 DB01955 | DB01955 | |
| 0.02 | 0.415 | 0.054 | Factor III inhibitor | 0.054 0.026 DB01955 | DB01955 | |
| 0.009 | 0.404 | 0.15 | NMDA receptor antagonist | 0.094 0.051 DBMET02011 0.094 0.051 DB01955 0.112 0.04 DB01440 0.15 0.024 DBMET01477 | DBMET01477 | |
| 0.01 | 0.406 | 0.04 | Plasmepsin II inhibitor | 0.04 0.031 DB01955 | DB01955 | |
| 0.001 | 0.399 | 0.037 | Carbonic anhydrase XI inhibitor | 0.019 0.004 DB01955 0.017 0.005 DBMET01480 0.029 0.003 DB01440 0.037 0.002 DBMET01477 | DBMET01477 | |
| 0.008 | 0.406 | 0.092 | Carbonic anhydrase XIV inhibitor | 0.073 0.019 DB01955 0.087 0.014 DB01440 0.092 0.013 DBMET01477 | DBMET01477 | |
| 0.01 | 0.41 | 0.219 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.094 0.016 DBMET02011 0.219 0.006 DB01955 0.139 0.009 DBMET01480 0.06 0.035 DBMET02015 0.173 0.008 DB01440 0.181 0.007 DBMET01477 | DB01955 | |
| 0.011 | 0.412 | 0.108 | H+/K+-transporting ATPase inhibitor | 0.108 0.008 DBMET02011 | DBMET02011 | |
| 0.036 | 0.44 | 0.116 | Interleukin 1 antagonist | 0.116 0.095 DBMET01477 | DBMET01477 | |
| 0.106 | 0.512 | 0.632 | 5 Hydroxytryptamine release inhibitor | 0.388 0.086 DBMET02011 0.632 0.007 DB01955 0.453 0.05 DBMET01480 0.293 0.173 DBMET02014 0.429 0.062 DBMET02015 0.583 0.013 DB01440 0.583 0.013 DBMET01477 | DB01955 | |
| 0.002 | 0.411 | 0.043 | Ileal bile acid transport inhibitor | 0.027 0.005 DB01955 0.015 0.014 DBMET02015 0.036 0.004 DB01440 0.043 0.004 DBMET01477 | DBMET01477 | |
| 0.023 | 0.433 | 0.215 | Caspase 3 inhibitor | 0.127 0.051 DBMET02011 0.151 0.027 DB01955 0.102 0.089 DBMET01480 0.198 0.01 DB01440 0.215 0.008 DBMET01477 | DBMET01477 | |
| 0.005 | 0.417 | 0.139 | Integrin alphaVbeta1 antagonist | 0.043 0.005 DB01440 0.139 0.003 DBMET01477 | DBMET01477 | |
| 0.008 | 0.422 | 0.354 | Argininosuccinate synthase inhibitor | 0.086 0.023 DBMET02011 0.196 0.008 DB01955 0.167 0.01 DBMET01480 0.055 0.042 DBMET02014 0.101 0.019 DBMET02015 0.255 0.005 DB01440 0.354 0.003 DBMET01477 | DBMET01477 | |
| 0.031 | 0.446 | 0.242 | Adenylate cyclase inhibitor | 0.121 0.066 DB00654 0.221 0.022 DB01955 0.1 0.085 DBMET01480 0.112 0.074 DBMET02014 0.181 0.03 DBMET02015 0.242 0.02 DB01440 0.236 0.021 DBMET01477 | DB01440 | |
| 0.011 | 0.427 | 0.411 | Phenylalanine 4-hydroxylase inhibitor | 0.102 0.025 DBMET02011 0.301 0.004 DB01955 0.132 0.015 DBMET01480 0.095 0.028 DBMET02014 0.237 0.005 DBMET02015 0.379 0.003 DB01440 0.411 0.003 DBMET01477 | DBMET01477 | |
| 0.019 | 0.437 | 0.47 | Psychostimulant | 0.376 0.027 DB01955 0.222 0.069 DBMET02015 0.47 0.014 DB01440 0.426 0.019 DBMET01477 | DB01440 | |
| 0.028 | 0.449 | 0.196 | Acetylcholine M1 receptor antagonist | 0.196 0.044 DB01955 0.142 0.082 DB01440 0.144 0.08 DBMET01477 | DB01955 | |
| 0.002 | 0.424 | 0.015 | Adenosine A2a receptor agonist | 0.015 0.01 DB01955 | DB01955 | |
| 0.011 | 0.434 | 0.132 | AICAR transformylase inhibitor | 0.054 0.019 DB01955 0.057 0.016 DBMET01480 0.048 0.024 DBMET02015 0.079 0.008 DB01440 0.132 0.003 DBMET01477 | DBMET01477 | |
| 0.071 | 0.495 | 0.429 | Catenin beta inhibitor | 0.138 0.136 DB01955 0.311 0.005 DB01440 0.429 0.004 DBMET01477 | DBMET01477 | |
| 0.003 | 0.429 | 0.083 | Carbonic anhydrase I inhibitor | 0.083 0.024 DBMET02011 0.047 0.046 DBMET01477 | DBMET02011 | |
| 0.003 | 0.431 | 0.023 | Beta 1 adrenoreceptor agonist | 0.023 0.014 DB01955 | DB01955 | |
| 0.024 | 0.455 | 0.1 | Estrogen receptor alpha antagonist | 0.1 0.027 DB01955 0.086 0.04 DB01440 0.086 0.04 DBMET01477 | DB01955 | |
| 0.019 | 0.451 | 0.183 | CD45 antagonist | 0.052 0.031 DB01955 0.048 0.04 DBMET01480 0.083 0.011 DB01440 0.183 0.005 DBMET01477 | DBMET01477 | |
| 0.006 | 0.44 | 0.066 | NMDA 2D receptor antagonist | 0.025 0.022 DB01955 0.041 0.009 DB01440 0.066 0.005 DBMET01477 | DBMET01477 | |
| 0.02 | 0.456 | 0.096 | Histamine H2 receptor antagonist | 0.096 0.038 DB01955 0.079 0.068 DBMET01480 | DB01955 | |
| 0.056 | 0.493 | 0.221 | Sphingosine 1-phosphate receptor 5 antagonist | 0.167 0.037 DBMET02011 0.221 0.005 DB01955 0.167 0.037 DBMET01480 0.14 0.079 DBMET02015 0.205 0.009 DB01440 0.204 0.01 DBMET01477 | DB01955 | |
| 0.005 | 0.445 | 0.064 | Acetylcholine M3 receptor antagonist | 0.064 0.036 DB01955 | DB01955 | |
| 0.015 | 0.455 | 0.099 | Pregnane X receptor antagonist | 0.057 0.04 DBMET02011 0.083 0.005 DB01955 0.076 0.009 DBMET01480 0.084 0.005 DB01440 0.099 0.004 DBMET01477 | DBMET01477 | |
| 0.013 | 0.455 | 0.124 | Sphingosine 1-phosphate receptor 1 antagonist | 0.087 0.012 DB01955 0.124 0.005 DB01440 0.116 0.006 DBMET01477 | DB01440 | |
| 0.004 | 0.446 | 0.038 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.02 0.017 DBMET02011 0.038 0.003 DB01955 0.023 0.01 DBMET01480 0.021 0.013 DBMET02015 0.031 0.004 DB01440 0.028 0.005 DBMET01477 | DB01955 | |
| 0.004 | 0.452 | 0.654 | Integrin antagonist | 0.268 0.005 DB01440 0.654 0.004 DBMET01477 | DBMET01477 | |
| 0.01 | 0.457 | 0.119 | Androgen antagonist | 0.078 0.068 DBMET02011 0.119 0.033 DB01955 0.089 0.055 DB01440 0.101 0.046 DBMET01477 | DB01955 | |
| 0.008 | 0.456 | 0.083 | Matrix metalloproteinase inhibitor | 0.068 0.046 DB01955 0.078 0.038 DB01440 0.083 0.035 DBMET01477 | DBMET01477 | |
| 0.011 | 0.459 | 0.118 | Inducible nitric-oxide synthase inhibitor | 0.104 0.034 DBMET02011 0.096 0.041 DB01955 0.078 0.066 DBMET01480 0.084 0.055 DB01440 0.118 0.026 DBMET01477 | DBMET01477 | |
| 0.002 | 0.451 | 0.018 | Adenosine A2 receptor agonist | 0.018 0.009 DB01955 | DB01955 | |
| 0.014 | 0.464 | 0.084 | Sirtuin 1 inhibitor | 0.078 0.037 DB01955 0.08 0.036 DB01440 0.084 0.032 DBMET01477 | DBMET01477 | |
| 0.028 | 0.482 | 0.238 | DOPA decarboxylase inhibitor | 0.157 0.018 DBMET02011 0.199 0.007 DB01955 0.185 0.009 DBMET01480 0.118 0.048 DBMET02015 0.196 0.007 DB01440 0.238 0.004 DBMET01477 | DBMET01477 | |
| 0.027 | 0.482 | 0.355 | NADH dehydrogenase inhibitor | 0.145 0.019 DBMET02011 0.326 0.006 DB01955 0.222 0.009 DBMET01480 0.08 0.075 DBMET02014 0.114 0.032 DBMET02015 0.286 0.007 DB01440 0.355 0.005 DBMET01477 | DBMET01477 | |
| 0.018 | 0.476 | 0.188 | Aminoacyl-tRNA synthetase inhibitor | 0.188 0.012 DB01955 0.155 0.018 DB01440 0.13 0.025 DBMET01477 | DB01955 | |
| 0.004 | 0.462 | 0.037 | Kainate receptor 3 antagonist | 0.037 0.005 DBMET01477 | DBMET01477 | |
| 0.004 | 0.465 | 0.046 | Cholesterol ester transfer protein antagonist | 0.046 0.009 DB01955 0.039 0.013 DB01440 0.041 0.012 DBMET01477 | DB01955 | |
| 0.003 | 0.464 | 0.043 | Estrogen-related receptor gamma agonist | 0.02 0.011 DBMET02011 0.043 0.003 DB01955 0.035 0.004 DB01440 0.024 0.006 DBMET01477 | DB01955 | |
| 0.023 | 0.484 | 0.141 | Proteasome inhibitor | 0.125 0.061 DB01955 0.095 0.094 DBMET01480 0.113 0.071 DB01440 0.141 0.052 DBMET01477 | DBMET01477 | |
| 0.004 | 0.469 | 0.101 | 5-Alpha-reductase 2 inhibitor | 0.025 0.01 DB01955 0.08 0.006 DB01440 0.101 0.005 DBMET01477 | DBMET01477 | |
| 0.009 | 0.475 | 0.035 | Protein kinase C beta I inhibitor | 0.035 0.018 DB01955 | DB01955 | |
| 0.018 | 0.485 | 0.139 | Acetylcholine muscarinic antagonist | 0.139 0.051 DB01955 0.099 0.092 DBMET01477 | DB01955 | |
| 0.015 | 0.483 | 0.204 | Cathepsin G inhibitor | 0.079 0.044 DB01955 0.066 0.059 DBMET01480 0.132 0.024 DB01440 0.204 0.016 DBMET01477 | DBMET01477 | |
| 0.041 | 0.51 | 0.332 | Cyclic AMP phosphodiesterase inhibitor | 0.332 0.031 DB01955 0.192 0.1 DBMET01480 0.159 0.137 DBMET02015 0.289 0.046 DB01440 0.302 0.041 DBMET01477 | DB01955 | |
| 0.006 | 0.475 | 0.07 | Matrix metalloproteinase (membrane-type) inhibitor | 0.054 0.04 DB01955 0.063 0.03 DB01440 0.07 0.025 DBMET01477 | DBMET01477 | |
| 0.005 | 0.474 | 0.062 | Thyroid hormone agonist | 0.034 0.009 DB01955 0.053 0.004 DB01440 0.062 0.004 DBMET01477 | DBMET01477 | |
| 0.02 | 0.491 | 0.108 | Exportin-1 inhibitor | 0.064 0.058 DB00654 0.093 0.013 DB01955 0.108 0.006 DBMET01480 0.079 0.027 DB01440 0.105 0.007 DBMET01477 | DBMET01480 | |
| 0.004 | 0.479 | 0.092 | Complement C3a chemotactic receptor antagonist | 0.051 0.026 DB01440 0.092 0.01 DBMET01477 | DBMET01477 | |
| 0.031 | 0.506 | 0.208 | Sphingosine 1-phosphate receptor 2 antagonist | 0.153 0.038 DBMET02011 0.206 0.006 DB01955 0.151 0.039 DBMET01480 0.208 0.006 DB01440 0.208 0.006 DBMET01477 | DBMET01477 | |
| 0.007 | 0.482 | 0.134 | Integrin alpha5beta1 antagonist | 0.06 0.012 DB01440 0.134 0.005 DBMET01477 | DBMET01477 | |
| 0.005 | 0.487 | 0.021 | CXC chemokine 5 receptor antagonist | 0.017 0.014 DB01955 0.017 0.015 DBMET01480 0.021 0.007 DBMET01477 | DBMET01477 | |
| 0.009 | 0.492 | 0.145 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.145 0.02 DB01955 0.091 0.043 DBMET01480 0.142 0.021 DB01440 0.142 0.021 DBMET01477 | DB01955 | |
| 0.02 | 0.503 | 0.136 | Cholinergic antagonist | 0.136 0.061 DB01955 0.099 0.098 DB01440 | DB01955 | |
| 0.01 | 0.494 | 0.138 | Carbonic anhydrase VA inhibitor | 0.11 0.021 DB01955 0.077 0.039 DBMET01480 0.119 0.018 DB01440 0.138 0.013 DBMET01477 | DBMET01477 | |
| 0.012 | 0.496 | 0.056 | Neurotensin receptor antagonist | 0.056 0.025 DBMET01477 | DBMET01477 | |
| 0.003 | 0.491 | 0.031 | Endothelin B receptor antagonist | 0.019 0.013 DB01440 0.031 0.009 DBMET01477 | DBMET01477 | |
| 0.004 | 0.491 | 0.086 | Phosphorylase inhibitor | 0.068 0.021 DB01955 0.086 0.015 DB01440 0.084 0.016 DBMET01477 | DB01440 | |
| 0.092 | 0.582 | 0.561 | 5 Hydroxytryptamine uptake stimulant | 0.241 0.09 DBMET02011 0.39 0.016 DB01955 0.4 0.014 DBMET01480 0.215 0.124 DBMET02014 0.306 0.042 DBMET02015 0.437 0.009 DB01440 0.561 0.003 DBMET01477 | DBMET01477 | |
| 0.006 | 0.498 | 0.076 | Amidase inhibitor | 0.071 0.047 DB01955 0.067 0.053 DB01440 0.076 0.042 DBMET01477 | DBMET01477 | |
| 0.011 | 0.512 | 0.425 | Alcohol dehydrogenase inhibitor | 0.115 0.039 DBMET02011 0.295 0.005 DB01955 0.11 0.042 DBMET01480 0.163 0.017 DBMET02015 0.425 0.004 DB01440 0.359 0.004 DBMET01477 | DB01440 | |
| 0.003 | 0.505 | 0.048 | Methionyl aminopeptidase 1 inhibitor | 0.036 0.017 DB01955 0.032 0.023 DBMET01480 0.031 0.023 DB01440 0.048 0.007 DBMET01477 | DBMET01477 | |
| 0.007 | 0.511 | 0.118 | Alpha 2 adrenoreceptor agonist | 0.118 0.01 DBMET02011 | DBMET02011 | |
| 0.013 | 0.517 | 0.079 | Heparanase inhibitor | 0.065 0.017 DB01955 0.051 0.041 DBMET01480 0.071 0.011 DB01440 0.079 0.007 DBMET01477 | DBMET01477 | |
| 0.006 | 0.511 | 0.031 | ICAM 1 antagonist | 0.031 0.006 DB01955 0.027 0.009 DB01440 0.027 0.009 DBMET01477 | DB01955 | |
| 0.018 | 0.524 | 0.131 | Acetylcholine antagonist | 0.131 0.062 DB01955 | DB01955 | |
| 0.005 | 0.514 | 0.03 | Melatonin 2 agonist | 0.03 0.028 DB01955 | DB01955 | |
| 0.014 | 0.524 | 0.167 | Macrophage migration inhibitory factor inhibitor | 0.069 0.068 DBMET02011 0.158 0.013 DB01955 0.167 0.011 DB01440 0.143 0.017 DBMET01477 | DB01440 | |
| 0.003 | 0.514 | 0.085 | Integrin beta7 antagonist | 0.032 0.009 DB01440 0.085 0.004 DBMET01477 | DBMET01477 | |
| 0.002 | 0.518 | 0.139 | Kynurenine 3 monooxygenase inhibitor | 0.027 0.018 DB01955 0.06 0.005 DB01440 0.139 0.003 DBMET01477 | DBMET01477 | |
| 0.01 | 0.526 | 0.099 | Cytokine production stimulant | 0.064 0.01 DBMET02011 0.099 0.004 DB01955 0.053 0.022 DBMET01480 0.063 0.011 DB01440 0.056 0.018 DBMET01477 | DB01955 | |
| 0.005 | 0.522 | 0.042 | Toll-Like receptor 8 agonist | 0.019 0.017 DBMET02011 0.042 0.004 DB01955 0.024 0.007 DB01440 0.019 0.018 DBMET01477 | DB01955 | |
| 0.001 | 0.518 | 0.077 | Kainate receptor 1 antagonist | 0.018 0.017 DB01955 0.03 0.01 DB01440 0.077 0.004 DBMET01477 | DBMET01477 | |
| 0.006 | 0.533 | 0.141 | Glutamate (mGluR1) agonist | 0.03 0.01 DBMET02011 0.095 0.004 DB01955 0.03 0.009 DBMET01480 0.141 0.003 DB01440 0.135 0.003 DBMET01477 | DB01440 | |
| 0.019 | 0.555 | 0.097 | Calcium channel (voltage-sensitive) blocker | 0.097 0.089 DBMET02011 | DBMET02011 | |
| 0.007 | 0.543 | 0.102 | Acetylcholine nicotinic antagonist | 0.102 0.038 DB01955 0.082 0.052 DB01440 0.077 0.057 DBMET01477 | DB01955 | |
| 0.001 | 0.539 | 0.028 | Nicotinic acid receptor 1 antagonist | 0.023 0.007 DB01955 0.019 0.01 DBMET01480 0.028 0.005 DBMET01477 | DBMET01477 | |
| 0.008 | 0.547 | 0.106 | Adenylate cyclase 1 inhibitor | 0.106 0.004 DB01955 0.077 0.009 DBMET01480 0.078 0.009 DB01440 0.079 0.008 DBMET01477 | DB01955 | |
| 0.015 | 0.554 | 0.167 | Purinergic P2X1 antagonist | 0.055 0.052 DBMET02011 0.122 0.011 DB01955 0.119 0.012 DBMET01480 0.104 0.015 DBMET02015 0.118 0.012 DB01440 0.167 0.005 DBMET01477 | DBMET01477 | |
| 0.011 | 0.551 | 0.146 | Glutamate (mGluR group III) antagonist | 0.061 0.012 DB01955 0.052 0.019 DBMET01480 0.088 0.006 DB01440 0.146 0.004 DBMET01477 | DBMET01477 | |
| 0.021 | 0.561 | 0.263 | Dual specificity phosphatase inhibitor | 0.127 0.126 DB01440 0.263 0.035 DBMET01477 | DBMET01477 | |
| 0.003 | 0.546 | 0.147 | VLA-4 antagonist | 0.071 0.009 DB01440 0.147 0.004 DBMET01477 | DBMET01477 | |
| 0.003 | 0.547 | 0.122 | NMDA receptor subunit 3A antagonist | 0.059 0.017 DB01955 0.082 0.011 DB01440 0.122 0.007 DBMET01477 | DBMET01477 | |
| 0.002 | 0.548 | 0.098 | Carbonic anhydrase XII inhibitor | 0.098 0.02 DBMET02011 | DBMET02011 | |
| 0.004 | 0.556 | 0.052 | Matrix metalloproteinase 1 inhibitor | 0.052 0.038 DB01955 | DB01955 | |
| 0.003 | 0.555 | 0.075 | Guanylate cyclase inhibitor | 0.049 0.022 DBMET02011 0.075 0.004 DB01955 0.066 0.007 DBMET01480 0.07 0.005 DB01440 0.074 0.004 DBMET01477 | DB01955 | |
| 0.028 | 0.583 | 0.179 | Histone deacetylase SIRT1 inhibitor | 0.116 0.096 DB01440 0.179 0.04 DBMET01477 | DBMET01477 | |
| 0.005 | 0.56 | 0.087 | Androgen agonist | 0.087 0.02 DB01955 0.07 0.031 DBMET01480 0.065 0.035 DB01440 0.085 0.021 DBMET01477 | DB01955 | |
| 0.001 | 0.557 | 0.018 | Thyroid hormone beta agonist | 0.012 0.005 DB01440 0.018 0.004 DBMET01477 | DBMET01477 | |
| 0.001 | 0.558 | 0.02 | Integrin alphaVbeta5 antagonist | 0.015 0.005 DB01440 0.02 0.004 DBMET01477 | DBMET01477 | |
| 0.009 | 0.569 | 0.102 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.102 0.01 DB01955 0.067 0.024 DBMET01480 0.061 0.028 DB01440 0.075 0.018 DBMET01477 | DB01955 | |
| 0.006 | 0.569 | 0.078 | Acetylcholine M5 receptor antagonist | 0.078 0.025 DB01955 | DB01955 | |
| 0.003 | 0.568 | 0.058 | Angiotensin AT1 receptor antagonist | 0.052 0.015 DBMET02011 0.054 0.013 DB01955 0.039 0.035 DBMET01480 0.051 0.016 DB01440 0.058 0.008 DBMET01477 | DBMET01477 | |
| 0.007 | 0.572 | 0.101 | Diacylglycerol O-acyltransferase inhibitor | 0.066 0.021 DB01955 0.093 0.009 DB01440 0.101 0.007 DBMET01477 | DBMET01477 | |
| 0.002 | 0.568 | 0.118 | Kainate receptor 2 antagonist | 0.058 0.012 DB01955 0.039 0.023 DBMET01480 0.076 0.007 DB01440 0.118 0.004 DBMET01477 | DBMET01477 | |
| 0.008 | 0.576 | 0.13 | HIV-1 integrase inhibitor | 0.085 0.035 DB01440 0.13 0.012 DBMET01477 | DBMET01477 | |
| 0.019 | 0.59 | 0.321 | Electrolyte absorption antagonist | 0.093 0.068 DBMET02011 0.2 0.008 DB01955 0.155 0.018 DBMET01480 0.101 0.056 DBMET02015 0.228 0.005 DB01440 0.321 0.004 DBMET01477 | DBMET01477 | |
| 0.029 | 0.6 | 0.243 | Transcription factor STAT3 inhibitor | 0.231 0.1 DB00654 0.201 0.133 DB01955 0.185 0.156 DBMET01480 0.243 0.089 DBMET01477 | DBMET01477 | |
| 0.008 | 0.581 | 0.12 | Phosphodiesterase 5A inhibitor | 0.12 0.019 DBMET02011 | DBMET02011 | |
| 0.018 | 0.592 | 0.111 | DNA helicase inhibitor | 0.064 0.022 DB01440 0.111 0.004 DBMET01477 | DBMET01477 | |
| 0.001 | 0.577 | 0.083 | 5-Alpha-reductase 1 inhibitor | 0.019 0.011 DB01955 0.066 0.006 DB01440 0.083 0.005 DBMET01477 | DBMET01477 | |
| 0.017 | 0.593 | 0.197 | Cathepsin H inhibitor | 0.163 0.038 DB01955 0.175 0.032 DBMET01480 0.119 0.076 DBMET02015 0.148 0.047 DB01440 0.197 0.023 DBMET01477 | DBMET01477 | |
| 0.003 | 0.579 | 0.138 | Purinergic P2Y antagonist | 0.091 0.01 DB01955 0.138 0.006 DB01440 0.108 0.008 DBMET01477 | DB01440 | |
| 0.004 | 0.58 | 0.064 | Metalloproteinase-3 inhibitor | 0.052 0.03 DB01955 0.062 0.023 DB01440 0.064 0.022 DBMET01477 | DBMET01477 | |
| 0.004 | 0.581 | 0.056 | Kainate receptor 4 antagonist | 0.056 0.006 DBMET01477 | DBMET01477 | |
| 0.003 | 0.581 | 0.033 | Acid ceramidase inhibitor | 0.033 0.006 DB01955 0.03 0.009 DBMET01480 | DB01955 | |
| 0.004 | 0.584 | 0.055 | Acetylcholine M2 receptor antagonist | 0.055 0.049 DB01955 | DB01955 | |
| 0.003 | 0.586 | 0.146 | NMDA receptor subunit 3B antagonist | 0.069 0.016 DB01955 0.098 0.011 DB01440 0.146 0.006 DBMET01477 | DBMET01477 | |
| 0.004 | 0.588 | 0.033 | Histone deacetylase 7 inhibitor | 0.033 0.029 DB01955 0.033 0.03 DBMET01477 | DBMET01477 | |
| 0.003 | 0.588 | 0.044 | Purinergic P2Y15 antagonist | 0.029 0.018 DBMET02011 0.044 0.005 DB01955 0.044 0.005 DBMET01480 0.031 0.015 DB01440 0.042 0.006 DBMET01477 | DBMET01480 | |
| 0.014 | 0.598 | 0.191 | Potassium channel (Ca-activated) activator | 0.16 0.025 DB01955 0.082 0.073 DBMET01480 0.186 0.018 DB01440 0.191 0.016 DBMET01477 | DBMET01477 | |
| 0.019 | 0.605 | 0.175 | ErbB-3 antagonist | 0.101 0.04 DB01440 0.175 0.013 DBMET01477 | DBMET01477 | |
| 0.029 | 0.618 | 0.358 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.182 0.091 DBMET02011 0.295 0.025 DB01955 0.284 0.029 DBMET01480 0.306 0.022 DB01440 0.358 0.011 DBMET01477 | DBMET01477 | |
| 0.023 | 0.612 | 0.186 | Nav1.1 sodium channel blocker | 0.186 0.022 DB01955 | DB01955 | |
| 0.005 | 0.596 | 0.047 | Liver X receptor agonist | 0.047 0.026 DB01955 | DB01955 | |
| 0.003 | 0.596 | 0.091 | Cholecystokinin B antagonist | 0.091 0.005 DBMET01477 | DBMET01477 | |
| 0.007 | 0.6 | 0.115 | Phosphodiesterase V inhibitor | 0.115 0.021 DBMET02011 | DBMET02011 | |
| 0.009 | 0.604 | 0.128 | Glutamate (mGluR7) antagonist | 0.094 0.014 DB01955 0.102 0.01 DBMET01480 0.07 0.042 DBMET02015 0.089 0.019 DB01440 0.128 0.004 DBMET01477 | DBMET01477 | |
| 0.006 | 0.602 | 0.069 | p53 inhibitor | 0.035 0.025 DB01955 0.058 0.01 DB01440 0.069 0.005 DBMET01477 | DBMET01477 | |
| 0.011 | 0.611 | 0.156 | Glutamate (mGluR4) antagonist | 0.07 0.01 DB01955 0.058 0.015 DBMET01480 0.107 0.005 DB01440 0.156 0.004 DBMET01477 | DBMET01477 | |
| 0.018 | 0.619 | 0.341 | DNA methyltransferase I inhibitor | 0.228 0.056 DB01955 0.145 0.11 DBMET01480 0.293 0.029 DB01440 0.341 0.015 DBMET01477 | DBMET01477 | |
| 0.01 | 0.61 | 0.139 | Phospholipase D inhibitor | 0.12 0.006 DB01955 0.097 0.016 DBMET01480 0.129 0.005 DB01440 0.139 0.004 DBMET01477 | DBMET01477 | |
| 0.046 | 0.647 | 0.178 | Growth factor agonist | 0.178 0.09 DB01955 | DB01955 | |
| 0.006 | 0.608 | 0.796 | Porphobilinogen synthase inhibitor | 0.124 0.027 DBMET02011 0.318 0.005 DB01955 0.281 0.006 DBMET01480 0.131 0.025 DBMET02015 0.599 0.003 DB01440 0.796 0.002 DBMET01477 | DBMET01477 | |
| 0.018 | 0.62 | 0.258 | HIV-1 integrase (Overall Integration) inhibitor | 0.088 0.067 DBMET02011 0.211 0.009 DB01955 0.157 0.023 DBMET01480 0.108 0.048 DBMET02015 0.207 0.01 DB01440 0.258 0.005 DBMET01477 | DBMET01477 | |
| 0.007 | 0.609 | 0.078 | Acetylcholine agonist | 0.078 0.068 DB01955 | DB01955 | |
| 0.002 | 0.607 | 0.098 | Dihydropteroate synthase inhibitor | 0.041 0.025 DBMET02011 0.071 0.008 DB01955 0.056 0.013 DBMET01480 0.078 0.007 DB01440 0.098 0.005 DBMET01477 | DBMET01477 | |
| 0.005 | 0.611 | 0.12 | Nicotinic alpha4beta2 receptor antagonist | 0.12 0.017 DB01955 0.088 0.042 DBMET01480 0.077 0.053 DB01440 0.075 0.056 DBMET01477 | DB01955 | |
| 0.002 | 0.609 | 0.082 | Geranyltranstransferase inhibitor | 0.039 0.038 DBMET02011 0.082 0.005 DB01955 0.057 0.016 DBMET01480 0.065 0.01 DB01440 0.078 0.005 DBMET01477 | DB01955 | |
| 0.008 | 0.615 | 0.07 | Erythropoietin receptor agonist | 0.039 0.029 DB01440 0.07 0.014 DBMET01477 | DBMET01477 | |
| 0.009 | 0.616 | 0.127 | Sphingosine 1-phosphate receptor antagonist | 0.1 0.022 DB01955 0.127 0.01 DB01440 0.126 0.011 DBMET01477 | DB01440 | |
| 0.004 | 0.612 | 0.059 | Acetylcholine muscarinic agonist | 0.059 0.035 DB01955 | DB01955 | |
| 0.011 | 0.62 | 0.068 | Transcription factor AP-1 inhibitor | 0.068 0.033 DBMET01477 | DBMET01477 | |
| 0.009 | 0.619 | 0.08 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.046 0.02 DBMET02011 0.072 0.004 DB01955 0.075 0.004 DBMET01480 0.056 0.01 DB01440 0.08 0.004 DBMET01477 | DBMET01477 | |
| 0.002 | 0.612 | 0.088 | Free fatty acid receptor 1 antagonist | 0.057 0.006 DB01955 0.034 0.023 DBMET01480 0.044 0.013 DBMET02015 0.073 0.004 DB01440 0.088 0.004 DBMET01477 | DBMET01477 | |
| 0.011 | 0.622 | 0.353 | GABA C receptor antagonist | 0.155 0.028 DBMET02011 0.296 0.004 DB01955 0.232 0.008 DBMET01480 0.107 0.068 DBMET02015 0.235 0.008 DB01440 0.353 0.004 DBMET01477 | DBMET01477 | |
| 0.014 | 0.626 | 0.151 | Glucagon-like peptide 1 receptor antagonist | 0.066 0.007 DB01440 0.151 0.004 DBMET01477 | DBMET01477 | |
| 0.002 | 0.615 | 0.084 | Carbonic anhydrase IX inhibitor | 0.084 0.025 DBMET02011 | DBMET02011 | |
| 0.003 | 0.617 | 0.036 | Endothelin A receptor antagonist | 0.036 0.009 DBMET01477 | DBMET01477 | |
| 0.023 | 0.638 | 0.588 | Peroxidase inhibitor | 0.264 0.044 DBMET02011 0.571 0.005 DB01955 0.441 0.015 DBMET01480 0.115 0.105 DBMET02015 0.521 0.008 DB01440 0.588 0.005 DBMET01477 | DBMET01477 | |
| 0.011 | 0.628 | 0.039 | HCV polyprotein inhibitor | 0.039 0.013 DBMET01477 | DBMET01477 | |
| 0.003 | 0.621 | 0.084 | Dopamine D5 agonist | 0.076 0.007 DB01955 0.076 0.007 DBMET01480 0.046 0.021 DB01440 0.084 0.005 DBMET01477 | DBMET01477 | |
| 0.004 | 0.622 | 0.113 | Alpha adrenoreceptor agonist | 0.113 0.023 DBMET02011 | DBMET02011 | |
| 0.002 | 0.621 | 0.122 | Kainate receptor antagonist | 0.049 0.022 DB01955 0.065 0.014 DB01440 0.122 0.005 DBMET01477 | DBMET01477 | |
| 0.005 | 0.625 | 0.078 | Protein kinase C alpha inhibitor | 0.078 0.035 DB01955 | DB01955 | |
| 0 | 0.622 | 0.016 | Integrin alpha5beta6 antagonist | 0.006 0.005 DB01955 0.006 0.005 DBMET01480 0.009 0.004 DB01440 0.016 0.002 DBMET01477 | DBMET01477 | |
| 0.033 | 0.655 | 0.602 | Superoxide dismutase inhibitor | 0.305 0.049 DBMET02011 0.602 0.007 DB01955 0.391 0.028 DBMET01480 0.172 0.153 DBMET02015 0.539 0.01 DB01440 0.539 0.01 DBMET01477 | DB01955 | |
| 0.039 | 0.668 | 0.408 | Insulysin inhibitor | 0.315 0.05 DB01955 0.279 0.073 DBMET01480 0.188 0.177 DBMET02014 0.296 0.061 DBMET02015 0.364 0.03 DB01440 0.408 0.021 DBMET01477 | DBMET01477 | |
| 0.003 | 0.632 | 0.057 | Kainate receptor 5 antagonist | 0.057 0.005 DBMET01477 | DBMET01477 | |
| 0.004 | 0.633 | 0.068 | Dihydrofolate reductase inhibitor | 0.049 0.02 DB01955 0.062 0.009 DB01440 0.068 0.007 DBMET01477 | DBMET01477 | |
| 0.003 | 0.636 | 0.271 | Integrin alpha4 antagonist | 0.101 0.006 DB01440 0.271 0.004 DBMET01477 | DBMET01477 | |
| 0.026 | 0.659 | 0.081 | Calcium channel P-type blocker | 0.081 0.014 DB01955 0.075 0.02 DBMET01480 0.068 0.032 DBMET01477 | DB01955 | |
| 0.005 | 0.639 | 0.032 | Liver X receptor alpha antagonist | 0.032 0.016 DBMET01477 | DBMET01477 | |
| 0.003 | 0.639 | 0.105 | Cannabinoid CB1 receptor agonist | 0.105 0.018 DB01955 0.065 0.039 DB01440 | DB01955 | |
| 0.019 | 0.655 | 0.772 | Aldehyde oxidase inhibitor | 0.412 0.045 DBMET02011 0.772 0.005 DB01955 0.507 0.032 DBMET01480 0.242 0.085 DBMET02015 0.708 0.008 DB01440 0.73 0.006 DBMET01477 | DB01955 | |
| 0.003 | 0.639 | 0.112 | Cholecystokinin A antagonist | 0.112 0.007 DBMET01477 | DBMET01477 | |
| 0.018 | 0.657 | 0.211 | Thiol protease inhibitor | 0.14 0.08 DBMET02011 0.205 0.037 DB01955 0.133 0.09 DBMET01480 0.211 0.036 DB01440 0.193 0.042 DBMET01477 | DB01440 | |
| 0.01 | 0.649 | 0.06 | Aggrecanase 1 inhibitor | 0.06 0.009 DBMET01477 | DBMET01477 | |
| 0.033 | 0.674 | 0.239 | Glutamate release inhibitor | 0.139 0.013 DB01955 0.125 0.019 DBMET01480 0.154 0.009 DB01440 0.239 0.004 DBMET01477 | DBMET01477 | |
| 0.002 | 0.643 | 0.179 | Glutamate (mGluR1a) agonist | 0.029 0.009 DBMET02011 0.13 0.003 DB01955 0.036 0.007 DBMET01480 0.178 0.002 DB01440 0.179 0.002 DBMET01477 | DBMET01477 | |
| 0.003 | 0.645 | 0.013 | Integrin alphaLbeta2 antagonist | 0.013 0.01 DBMET01477 | DBMET01477 | |
| 0.063 | 0.705 | 0.303 | Nitric-oxide synthase stimulant | 0.211 0.073 DBMET02011 0.278 0.018 DB01955 0.303 0.011 DBMET01480 0.171 0.149 DBMET02015 0.232 0.046 DB01440 0.276 0.019 DBMET01477 | DBMET01480 | |
| 0.018 | 0.661 | 0.337 | DNA methylase inhibitor | 0.223 0.064 DB01955 0.141 0.126 DBMET01480 0.277 0.035 DB01440 0.337 0.019 DBMET01477 | DBMET01477 | |
| 0.004 | 0.648 | 0.099 | Neutrophil collagenase inhibitor | 0.07 0.04 DB01955 0.09 0.026 DB01440 0.099 0.022 DBMET01477 | DBMET01477 | |
| 0.004 | 0.651 | 0.237 | Phosphodiesterase 3B inhibitor | 0.237 0.004 DB01955 0.114 0.009 DB01440 | DB01955 | |
| 0.003 | 0.652 | 0.052 | Inosine monophosphate dehydrogenase inhibitor | 0.033 0.03 DB01440 0.052 0.014 DBMET01477 | DBMET01477 | |
| 0.005 | 0.659 | 0.089 | Acetylcholine M4 receptor antagonist | 0.089 0.038 DB01955 | DB01955 | |
| 0.003 | 0.658 | 0.065 | Leukocyte elastase inhibitor | 0.047 0.026 DB01440 0.065 0.016 DBMET01477 | DBMET01477 | |
| 0.009 | 0.663 | 0.071 | Botulinum neurotoxin type A inhibitor | 0.059 0.039 DB01955 0.056 0.043 DBMET01480 0.071 0.024 DBMET01477 | DBMET01477 | |
| 0.009 | 0.666 | 0.097 | Ryanodine receptor antagonist | 0.068 0.02 DB01955 0.075 0.012 DBMET01480 0.069 0.019 DB01440 0.097 0.005 DBMET01477 | DBMET01477 | |
| 0.002 | 0.659 | 0.012 | Free fatty acid receptor 2 antagonist | 0.012 0.004 DBMET01477 | DBMET01477 | |
| 0.003 | 0.661 | 0.091 | Potassium channel Kv1.3 blocker | 0.091 0.01 DB01955 0.052 0.027 DB01440 0.042 0.039 DBMET01477 | DB01955 | |
| 0.001 | 0.664 | 0.011 | Angiotensin AT2 receptor agonist | 0.011 0.007 DB01955 | DB01955 | |
| 0.004 | 0.668 | 0.037 | Histone deacetylase 9 inhibitor | 0.037 0.03 DB01955 | DB01955 | |
| 0.002 | 0.666 | 0.038 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.038 0.017 DB01955 | DB01955 | |
| 0.003 | 0.668 | 0.096 | NMDA 2A receptor antagonist | 0.047 0.04 DB01955 0.051 0.037 DB01440 0.096 0.014 DBMET01477 | DBMET01477 | |
| 0.004 | 0.669 | 0.056 | Nicotinic receptor alpha3 subunit antagonist | 0.056 0.021 DB01955 0.042 0.033 DB01440 | DB01955 | |
| 0.002 | 0.669 | 0.083 | Glucagon receptor antagonist | 0.041 0.013 DB01440 0.083 0.005 DBMET01477 | DBMET01477 | |
| 0.005 | 0.674 | 0.058 | Caspase 6 inhibitor | 0.04 0.008 DB01440 0.058 0.004 DBMET01477 | DBMET01477 | |
| 0.005 | 0.675 | 0.027 | Baculoviral IAP repeat-containing protein 4 inhibitor | 0.027 0.021 DBMET01477 | DBMET01477 | |
| 0.011 | 0.683 | 0.119 | Beta glucuronidase inhibitor | 0.119 0.047 DB01955 0.103 0.066 DBMET01480 0.092 0.084 DB01440 0.102 0.067 DBMET01477 | DB01955 | |
| 0.011 | 0.683 | 0.231 | Dual specificity phosphatase 3 inhibitor | 0.231 0.047 DBMET01477 | DBMET01477 | |
| 0.006 | 0.681 | 0.281 | NMDA receptor agonist | 0.059 0.048 DBMET02011 0.119 0.013 DB01955 0.092 0.023 DBMET01480 0.197 0.005 DB01440 0.281 0.003 DBMET01477 | DBMET01477 | |
| 0.003 | 0.678 | 0.037 | Thymidine phosphorylase inhibitor | 0.037 0.007 DB01955 0.031 0.011 DBMET01480 0.024 0.023 DB01440 0.028 0.015 DBMET01477 | DB01955 | |
| 0.003 | 0.678 | 0.044 | Carbonic anhydrase VII inhibitor | 0.042 0.038 DB01955 0.044 0.036 DBMET01477 | DBMET01477 | |
| 0.009 | 0.686 | 0.069 | Adenosine A3 receptor antagonist | 0.067 0.063 DB01955 0.069 0.06 DBMET01477 | DBMET01477 | |
| 0.005 | 0.686 | 0.078 | Estrogen-related receptor gamma antagonist | 0.05 0.004 DBMET02011 0.078 0.002 DB01955 0.036 0.007 DBMET01480 0.052 0.003 DB01440 0.038 0.006 DBMET01477 | DB01955 | |
| 0.002 | 0.685 | 0.024 | 5 Hydroxytryptamine 4 agonist | 0.024 0.019 DB01955 | DB01955 | |
| 0.008 | 0.691 | 0.06 | Fatty acid synthase inhibitor | 0.052 0.048 DB01955 0.051 0.05 DBMET01480 0.06 0.036 DBMET01477 | DBMET01477 | |
| 0.005 | 0.688 | 0.022 | Tryptophan hydroxylase 1 inhibitor | 0.022 0.005 DBMET01477 | DBMET01477 | |
| 0.004 | 0.69 | 0.042 | Protein kinase C beta II inhibitor | 0.042 0.009 DB01955 | DB01955 | |
| 0.002 | 0.692 | 0.043 | Acetylcholine M1 receptor agonist | 0.043 0.03 DB01955 | DB01955 | |
| 0.004 | 0.697 | 0.032 | Liver X receptor antagonist | 0.032 0.02 DBMET01477 | DBMET01477 | |
| 0.017 | 0.712 | 0.179 | Nav1.4 sodium channel blocker | 0.117 0.055 DB01440 0.179 0.024 DBMET01477 | DBMET01477 | |
| 0.009 | 0.704 | 0.252 | Uric acid excretion stimulant | 0.147 0.024 DB01955 0.197 0.014 DB01440 0.252 0.007 DBMET01477 | DBMET01477 | |
| 0.012 | 0.71 | 0.124 | MDM2 inhibitor | 0.067 0.048 DBMET02011 0.108 0.005 DB01955 0.077 0.025 DBMET01480 0.067 0.048 DBMET02015 0.124 0.004 DB01440 0.119 0.004 DBMET01477 | DB01440 | |
| 0.015 | 0.713 | 0.07 | Immunoglobulin Fc receptor antagonist | 0.07 0.011 DB01955 0.066 0.015 DBMET01480 0.053 0.046 DB01440 0.065 0.017 DBMET01477 | DB01955 | |
| 0.003 | 0.702 | 0.149 | Cholecystokinin antagonist | 0.149 0.005 DBMET01477 | DBMET01477 | |
| 0.009 | 0.707 | 0.318 | Creatine kinase inhibitor | 0.172 0.016 DBMET02011 0.318 0.004 DB01955 0.217 0.008 DBMET01480 0.263 0.005 DB01440 0.301 0.004 DBMET01477 | DB01955 | |
| 0.004 | 0.702 | 0.119 | GABA B receptor antagonist | 0.064 0.01 DB01955 0.044 0.028 DBMET01480 0.092 0.005 DB01440 0.119 0.004 DBMET01477 | DBMET01477 | |
| 0.001 | 0.7 | 0.02 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.019 0.004 DB01955 0.017 0.005 DBMET01480 0.013 0.009 DB01440 0.02 0.004 DBMET01477 | DBMET01477 | |
| 0.008 | 0.707 | 0.184 | Falcipain 3 inhibitor | 0.184 0.023 DB01955 0.126 0.05 DBMET01480 0.123 0.052 DB01440 0.141 0.041 DBMET01477 | DB01955 | |
| 0 | 0.701 | 0.009 | Progesterone receptor A antagonist | 0.009 0.007 DBMET01480 | DBMET01480 | |
| 0.003 | 0.704 | 0.062 | Cholecystokinin agonist | 0.062 0.005 DBMET01477 | DBMET01477 | |
| 0.004 | 0.708 | 0.04 | Factor XIIIa inhibitor | 0.04 0.023 DB01955 0.033 0.031 DB01440 0.038 0.025 DBMET01477 | DB01955 | |
| 0.01 | 0.716 | 0.28 | GABA C receptor rho-1 antagonist | 0.122 0.038 DBMET02011 0.231 0.005 DB01955 0.202 0.008 DBMET01480 0.195 0.009 DB01440 0.28 0.004 DBMET01477 | DBMET01477 | |
| 0.015 | 0.724 | 0.23 | Carbonic anhydrase XV inhibitor | 0.1 0.067 DBMET02011 0.23 0.014 DB01955 0.13 0.04 DBMET01480 0.132 0.039 DB01440 0.152 0.03 DBMET01477 | DB01955 | |
| 0.004 | 0.717 | 0.095 | AMPA 2 receptor antagonist | 0.095 0.005 DBMET01477 | DBMET01477 | |
| 0.002 | 0.716 | 0.038 | Acetylcholine M4 receptor agonist | 0.038 0.016 DB01955 | DB01955 | |
| 0.014 | 0.729 | 0.124 | mTOR complex 2 inhibitor | 0.124 0.016 DB01955 0.102 0.031 DBMET01480 0.085 0.057 DB01440 0.091 0.045 DBMET01477 | DB01955 | |
| 0.003 | 0.72 | 0.086 | MAO B inhibitor | 0.086 0.07 DB01955 | DB01955 | |
| 0.012 | 0.73 | 0.201 | Interleukin 8 antagonist | 0.179 0.019 DB01955 0.112 0.073 DBMET01480 0.201 0.012 DB01440 0.2 0.013 DBMET01477 | DB01440 | |
| 0.018 | 0.738 | 0.261 | Hypoxia-inducible factor 1 alpha inhibitor | 0.191 0.163 DB01955 0.183 0.174 DB01440 0.261 0.091 DBMET01477 | DBMET01477 | |
| 0.003 | 0.723 | 0.145 | NMDA 2C receptor antagonist | 0.091 0.019 DB01955 0.061 0.044 DBMET01480 0.122 0.01 DB01440 0.145 0.007 DBMET01477 | DBMET01477 | |
| 0.016 | 0.738 | 0.279 | 15-Lipoxygenase inhibitor | 0.248 0.166 DB01955 0.223 0.189 DB01440 0.279 0.144 DBMET01477 | DBMET01477 | |
| 0.005 | 0.727 | 0.032 | Glucosylceramidase stimulant | 0.032 0.009 DB01955 0.028 0.018 DBMET01480 0.027 0.021 DB01440 0.026 0.024 DBMET01477 | DB01955 | |
| 0.011 | 0.735 | 0.104 | Phosphodiesterase VI inhibitor | 0.104 0.018 DB01955 0.073 0.055 DB01440 | DB01955 | |
| 0.004 | 0.729 | 0.101 | MAO inhibitor | 0.101 0.09 DB01955 | DB01955 | |
| 0.001 | 0.729 | 0.018 | Integrin beta2 antagonist | 0.014 0.007 DB01955 0.017 0.005 DB01440 0.018 0.005 DBMET01477 | DBMET01477 | |
| 0.009 | 0.738 | 0.081 | Dihydroorotate oxidase inhibitor | 0.078 0.011 DB01955 0.077 0.012 DBMET01480 0.054 0.04 DB01440 0.081 0.01 DBMET01477 | DBMET01477 | |
| 0.008 | 0.737 | 0.249 | 12-Lipoxygenase inhibitor | 0.204 0.147 DB01955 0.249 0.11 DBMET01477 | DBMET01477 | |
| 0.003 | 0.736 | 0.023 | Factor XIII inhibitor | 0.023 0.01 DBMET01480 | DBMET01480 | |
| 0.003 | 0.738 | 0.103 | Xanthine dehydrogenase inhibitor | 0.103 0.015 DB01955 0.088 0.02 DB01440 0.074 0.029 DBMET01477 | DB01955 | |
| 0.006 | 0.741 | 0.127 | CYP2A6 inhibitor | 0.07 0.059 DB01955 0.127 0.024 DBMET01480 0.091 0.04 DBMET01477 | DBMET01480 | |
| 0.004 | 0.741 | 0.023 | Phosphodiesterase 6A inhibitor | 0.023 0.019 DB01955 | DB01955 | |
| 0.008 | 0.744 | 0.603 | Ferrochelatase inhibitor | 0.173 0.029 DBMET02011 0.383 0.004 DB01955 0.356 0.004 DBMET01480 0.218 0.018 DBMET02015 0.452 0.003 DB01440 0.603 0.002 DBMET01477 | DBMET01477 | |
| 0.05 | 0.787 | 0.198 | Heat shock protein 70 antagonist | 0.164 0.023 DB01955 0.153 0.04 DBMET01480 0.139 0.079 DBMET02015 0.171 0.017 DB01440 0.198 0.007 DBMET01477 | DBMET01477 | |
| 0.002 | 0.739 | 0.039 | Sirtuin 2 inhibitor | 0.039 0.018 DB01955 | DB01955 | |
| 0.002 | 0.741 | 0.08 | Integrin alpha4beta7 antagonist | 0.033 0.008 DB01440 0.08 0.004 DBMET01477 | DBMET01477 | |
| 0.005 | 0.744 | 0.239 | Phosphodiesterase III inhibitor | 0.239 0.005 DB01955 0.119 0.015 DB01440 | DB01955 | |
| 0.005 | 0.744 | 0.054 | Melatonin receptor 1A agonist | 0.054 0.006 DB01955 0.033 0.025 DBMET01480 0.037 0.017 DB01440 0.034 0.022 DBMET01477 | DB01955 | |
| 0.011 | 0.751 | 0.061 | CXC chemokine 1 receptor antagonist | 0.061 0.021 DBMET01477 | DBMET01477 | |
| 0.011 | 0.756 | 0.198 | Nav1.2 sodium channel blocker | 0.198 0.035 DB01955 0.116 0.088 DB01440 | DB01955 | |
| 0.003 | 0.75 | 0.056 | Dopamine D2 agonist | 0.056 0.023 DB01955 | DB01955 | |
| 0.016 | 0.764 | 0.238 | Transcription factor STAT inhibitor | 0.18 0.168 DB00654 0.204 0.133 DB01955 0.238 0.095 DBMET01477 | DBMET01477 | |
| 0.004 | 0.756 | 0.11 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.079 0.039 DBMET02011 0.098 0.015 DB01955 0.11 0.009 DBMET01480 0.076 0.045 DB01440 0.095 0.017 DBMET01477 | DBMET01480 | |
| 0.001 | 0.753 | 0.032 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.028 0.009 DB01955 0.026 0.012 DBMET01480 0.027 0.011 DB01440 0.032 0.007 DBMET01477 | DBMET01477 | |
| 0.012 | 0.765 | 0.149 | Granulocyte macrophage colony stimulating factor agonist | 0.088 0.056 DBMET02011 0.146 0.006 DB01955 0.13 0.011 DBMET01480 0.128 0.011 DB01440 0.149 0.005 DBMET01477 | DBMET01477 | |
| 0.006 | 0.761 | 0.166 | M17 leucyl aminopeptidase inhibitor | 0.166 0.047 DBMET01477 | DBMET01477 | |
| 0.007 | 0.763 | 0.144 | Histamine N-methyltransferase inhibitor | 0.144 0.016 DB01955 0.122 0.028 DBMET01480 0.1 0.046 DB01440 0.122 0.028 DBMET01477 | DB01955 | |
| 0.003 | 0.76 | 0.051 | Delayed rectifier potassium channel blocker | 0.051 0.011 DB01955 0.036 0.029 DBMET01480 | DB01955 | |
| 0.003 | 0.76 | 0.023 | Geranylgeranyltransferase inhibitor | 0.023 0.015 DB01955 0.02 0.019 DB01440 0.022 0.016 DBMET01477 | DB01955 | |
| 0.008 | 0.766 | 0.111 | Phosphodiesterase 1C inhibitor | 0.111 0.008 DBMET02011 0.082 0.018 DB01955 | DBMET02011 | |
| 0.005 | 0.763 | 0.186 | Protein kinase C gamma inhibitor | 0.186 0.017 DB01955 0.095 0.086 DBMET01480 0.138 0.039 DB01440 0.119 0.054 DBMET01477 | DB01955 | |
| 0.004 | 0.763 | 0.076 | HCV NS3/NS4A protease inhibitor | 0.047 0.037 DB01955 0.046 0.04 DBMET01480 0.056 0.024 DB01440 0.076 0.012 DBMET01477 | DBMET01477 | |
| 0.002 | 0.761 | 0.026 | Methionyl aminopeptidase 2 inhibitor | 0.026 0.017 DB01955 | DB01955 | |
| 0.004 | 0.765 | 0.227 | Cytidine deaminase inhibitor | 0.227 0.036 DB01955 0.142 0.082 DBMET01480 0.127 0.093 DB01440 0.129 0.092 DBMET01477 | DB01955 | |
| 0.001 | 0.762 | 0.073 | Fructose-1,6-bisphosphatase inhibitor | 0.072 0.011 DB01955 0.053 0.022 DBMET01480 0.072 0.011 DB01440 0.073 0.01 DBMET01477 | DBMET01477 | |
| 0.014 | 0.775 | 0.262 | Neurotensin receptor agonist | 0.191 0.04 DB01955 0.183 0.047 DBMET01480 0.209 0.031 DB01440 0.262 0.019 DBMET01477 | DBMET01477 | |
| 0.003 | 0.767 | 0.068 | Histamine H2 receptor agonist | 0.055 0.018 DB01955 0.068 0.011 DBMET01480 0.045 0.027 DBMET01477 | DBMET01480 | |
| 0.002 | 0.769 | 0.051 | Carnitine palmitoyltransferase inhibitor | 0.045 0.011 DB01955 0.051 0.008 DB01440 0.05 0.008 DBMET01477 | DB01440 | |
| 0.021 | 0.789 | 0.091 | Toll-Like receptor 3 antagonist | 0.091 0.066 DB01955 | DB01955 | |
| 0.005 | 0.772 | 0.027 | Follicle-stimulating hormone antagonist | 0.027 0.005 DB01955 | DB01955 | |
| 0.005 | 0.775 | 0.068 | Dopamine beta hydroxylase inhibitor | 0.063 0.012 DB01955 0.062 0.013 DBMET01480 0.049 0.033 DB01440 0.068 0.009 DBMET01477 | DBMET01477 | |
| 0.003 | 0.774 | 0.058 | Liver X receptor alpha agonist | 0.058 0.013 DB01955 0.048 0.021 DB01440 0.05 0.019 DBMET01477 | DB01955 | |
| 0.002 | 0.774 | 0.074 | AMPA 3 receptor antagonist | 0.036 0.016 DB01440 0.074 0.005 DBMET01477 | DBMET01477 | |
| 0.004 | 0.776 | 0.06 | Cannabinoid CB1 receptor antagonist | 0.06 0.045 DB01955 | DB01955 | |
| 0.002 | 0.778 | 0.051 | Glutamate (mGluR group II) antagonist | 0.043 0.022 DB01955 0.039 0.026 DB01440 0.051 0.015 DBMET01477 | DBMET01477 | |
| 0.002 | 0.779 | 0.139 | NMDA receptor glycine site agonist | 0.106 0.014 DB01955 0.097 0.018 DBMET01480 0.114 0.011 DB01440 0.139 0.005 DBMET01477 | DBMET01477 | |
| 0.008 | 0.786 | 0.2 | Toll-Like receptor antagonist | 0.2 0.03 DB01955 0.155 0.053 DB01440 0.115 0.092 DBMET01477 | DB01955 | |
| 0.003 | 0.781 | 0.063 | Oxytocin agonist | 0.063 0.014 DB01955 0.054 0.021 DBMET01480 0.057 0.019 DB01440 0.06 0.017 DBMET01477 | DB01955 | |
| 0.003 | 0.787 | 0.065 | Cannabinoid receptor antagonist | 0.065 0.056 DB01955 | DB01955 | |
| 0.008 | 0.792 | 0.158 | Histone deacetylase class III inhibitor | 0.102 0.088 DB01440 0.158 0.038 DBMET01477 | DBMET01477 | |
| 0.004 | 0.788 | 0.055 | Phosphodiesterase 2A inhibitor | 0.055 0.028 DB01955 | DB01955 | |
| 0.002 | 0.786 | 0.055 | Liver X receptor beta antagonist | 0.036 0.015 DB01955 0.037 0.014 DB01440 0.055 0.007 DBMET01477 | DBMET01477 | |
| 0.007 | 0.792 | 0.244 | Mannose-6-phosphate isomerase inhibitor | 0.123 0.095 DBMET02011 0.238 0.015 DB01955 0.221 0.021 DBMET01480 0.22 0.021 DB01440 0.244 0.013 DBMET01477 | DBMET01477 | |
| 0.003 | 0.788 | 0.062 | Cannabinoid CB2 receptor antagonist | 0.062 0.028 DB01955 | DB01955 | |
| 0.003 | 0.792 | 0.054 | 5 Hydroxytryptamine 4 antagonist | 0.054 0.031 DB01955 | DB01955 | |
| 0.008 | 0.799 | 0.183 | Pregnane X receptor agonist | 0.13 0.1 DBMET02011 0.183 0.017 DB01955 0.152 0.05 DBMET01480 0.173 0.023 DB01440 0.172 0.025 DBMET01477 | DB01955 | |
| 0.003 | 0.794 | 0.123 | AMPA 4 receptor antagonist | 0.044 0.02 DB01955 0.042 0.023 DBMET01480 0.053 0.013 DB01440 0.123 0.004 DBMET01477 | DBMET01477 | |
| 0.016 | 0.808 | 0.188 | Histone acetyltransferase inhibitor | 0.188 0.088 DB01955 0.169 0.114 DBMET01480 0.146 0.145 DB01440 0.188 0.087 DBMET01477 | DBMET01477 | |
| 0.006 | 0.799 | 0.082 | Aldosterone antagonist | 0.082 0.01 DB01955 0.052 0.027 DBMET01480 0.064 0.017 DB01440 0.062 0.018 DBMET01477 | DB01955 | |
| 0.003 | 0.796 | 0.043 | Integrin alpha2beta1 antagonist | 0.03 0.013 DB01955 0.028 0.015 DBMET01480 0.029 0.014 DB01440 0.043 0.005 DBMET01477 | DBMET01477 | |
| 0.003 | 0.799 | 0.065 | Phosphodiesterase II inhibitor | 0.065 0.027 DB01955 | DB01955 | |
| 0.014 | 0.809 | 0.079 | Transcription factor RelA inhibitor | 0.079 0.018 DBMET01480 0.063 0.046 DBMET01477 | DBMET01480 | |
| 0.005 | 0.801 | 0.106 | Protein kinase C beta inhibitor | 0.106 0.011 DB01955 0.08 0.03 DB01440 0.076 0.037 DBMET01477 | DB01955 | |
| 0.001 | 0.797 | 0.026 | 5 Hydroxytryptamine 1D agonist | 0.026 0.023 DB01955 | DB01955 | |
| 0.002 | 0.798 | 0.051 | Epoxide hydrolase 1 inhibitor | 0.034 0.016 DBMET01480 0.031 0.021 DB01440 0.051 0.005 DBMET01477 | DBMET01477 | |
| 0.002 | 0.799 | 0.048 | Carnitine palmitoyltransferase 1 inhibitor | 0.044 0.012 DB01955 0.048 0.009 DB01440 0.048 0.009 DBMET01477 | DBMET01477 | |
| 0.001 | 0.799 | 0.035 | NMDA receptor glycine site antagonist | 0.035 0.01 DBMET01477 | DBMET01477 | |
| 0.002 | 0.801 | 0.078 | Prostaglandin-E synthase inhibitor | 0.078 0.04 DBMET01477 | DBMET01477 | |
| 0.002 | 0.801 | 0.049 | Liver X receptor beta agonist | 0.049 0.011 DB01955 0.035 0.02 DB01440 0.033 0.023 DBMET01477 | DB01955 | |
| 0.003 | 0.803 | 0.068 | Dopamine D1 antagonist | 0.068 0.041 DB01955 | DB01955 | |
| 0.005 | 0.806 | 0.04 | Adenosine uptake inhibitor | 0.04 0.013 DB01955 0.038 0.016 DBMET01480 | DB01955 | |
| 0.003 | 0.804 | 0.039 | Cholecystokinin A agonist | 0.039 0.005 DBMET01477 | DBMET01477 | |
| 0.005 | 0.807 | 0.082 | Potassium channel intermediate-conductance Ca-activated blocker | 0.073 0.024 DB01955 0.076 0.02 DBMET01480 0.066 0.031 DB01440 0.082 0.016 DBMET01477 | DBMET01477 | |
| 0.001 | 0.804 | 0.025 | Integrin alpha4beta1 antagonist | 0.017 0.011 DB01440 0.025 0.008 DBMET01477 | DBMET01477 | |
| 0.002 | 0.805 | 0.057 | Adenosine A1 receptor antagonist | 0.057 0.042 DB01955 | DB01955 | |
| 0 | 0.806 | 0.008 | DNA topoisomerase III inhibitor | 0.008 0.004 DBMET01480 | DBMET01480 | |
| 0.007 | 0.815 | 0.089 | Phosphodiesterase 1A inhibitor | 0.089 0.013 DBMET02011 0.07 0.025 DB01955 0.057 0.049 DBMET01480 | DBMET02011 | |
| 0.008 | 0.816 | 0.068 | Carnitine palmitoyltransferase 1B inhibitor | 0.068 0.012 DBMET01477 | DBMET01477 | |
| 0.001 | 0.81 | 0.074 | AMPA 1 receptor antagonist | 0.025 0.024 DB01440 0.074 0.008 DBMET01477 | DBMET01477 | |
| 0.004 | 0.813 | 0.086 | Epithelial sodium channel blocker | 0.086 0.01 DB01955 0.057 0.033 DBMET01480 0.064 0.023 DB01440 0.064 0.023 DBMET01477 | DB01955 | |
| 0.001 | 0.811 | 0.032 | Inosine monophosphate dehydrogenase 2 inhibitor | 0.021 0.013 DB01440 0.032 0.007 DBMET01477 | DBMET01477 | |
| 0.01 | 0.822 | 0.123 | MAP kinase kinase 7 inhibitor | 0.085 0.034 DBMET02011 0.123 0.004 DB01955 0.091 0.022 DBMET01480 0.108 0.008 DB01440 0.101 0.012 DBMET01477 | DB01955 | |
| 0.003 | 0.816 | 0.076 | Integrin alpha2 antagonist | 0.042 0.018 DB01955 0.04 0.021 DBMET01480 0.05 0.011 DB01440 0.076 0.005 DBMET01477 | DBMET01477 | |
| 0.014 | 0.827 | 0.12 | D-Ala-D-Ala ligase inhibitor | 0.1 0.029 DB01955 0.116 0.015 DBMET01480 0.089 0.047 DB01440 0.12 0.013 DBMET01477 | DBMET01477 | |
| 0.002 | 0.816 | 0.056 | Peptide deformylase inhibitor | 0.034 0.018 DB01955 0.036 0.016 DB01440 0.056 0.008 DBMET01477 | DBMET01477 | |
| 0.001 | 0.816 | 0.034 | TRPM8 blocker | 0.034 0.032 DB01955 | DB01955 | |
| 0.003 | 0.818 | 0.13 | Diacylglycerol O-acyltransferase 1 inhibitor | 0.033 0.017 DB01440 0.13 0.005 DBMET01477 | DBMET01477 | |
| 0.001 | 0.817 | 0.028 | Glutamate (mGluR2) antagonist | 0.028 0.023 DB01955 0.028 0.024 DBMET01477 | DBMET01477 | |
| 0.002 | 0.819 | 0.104 | Acetylcholine M5 receptor agonist | 0.104 0.018 DB01955 0.096 0.023 DBMET01480 0.062 0.053 DBMET01477 | DB01955 | |
| 0.003 | 0.821 | 0.085 | Collagenase 3 inhibitor | 0.065 0.036 DB01955 0.078 0.026 DB01440 0.085 0.021 DBMET01477 | DBMET01477 | |
| 0.015 | 0.834 | 0.287 | MAP3K9 inhibitor | 0.168 0.037 DBMET02011 0.287 0.004 DB01955 0.202 0.014 DB01440 | DB01955 | |
| 0 | 0.824 | 0.02 | Angiotensin AT1B receptor antagonist | 0.013 0.011 DB01955 0.013 0.011 DB01440 0.02 0.006 DBMET01477 | DBMET01477 | |
| 0.002 | 0.826 | 0.075 | Neuronal nicotinic receptor antagonist | 0.075 0.04 DB01955 | DB01955 | |
| 0.002 | 0.825 | 0.044 | Calcium-sensing receptor agonist | 0.027 0.017 DB01955 0.031 0.013 DB01440 0.044 0.006 DBMET01477 | DBMET01477 | |
| 0.003 | 0.829 | 0.067 | Dihydroorotase inhibitor | 0.067 0.013 DB01955 0.041 0.037 DBMET01480 0.045 0.031 DB01440 0.058 0.017 DBMET01477 | DB01955 | |
| 0.008 | 0.836 | 0.11 | Phosphodiesterase I inhibitor | 0.11 0.034 DBMET02011 0.102 0.042 DB01955 | DBMET02011 | |
| 0.002 | 0.832 | 0.115 | Thymidylate synthase inhibitor | 0.068 0.012 DB01955 0.049 0.029 DBMET01480 0.095 0.005 DB01440 0.115 0.004 DBMET01477 | DBMET01477 | |
| 0.023 | 0.853 | 0.103 | CC chemokine 5 receptor agonist | 0.093 0.031 DB01955 0.103 0.019 DBMET01480 0.098 0.024 DBMET01477 | DBMET01480 | |
| 0.009 | 0.841 | 0.258 | Antiobesity | 0.258 0.149 DBMET01477 | DBMET01477 | |
| 0.011 | 0.844 | 0.27 | GABA C receptor rho-2 antagonist | 0.159 0.062 DBMET02011 0.259 0.01 DB01955 0.248 0.012 DBMET01480 0.207 0.025 DB01440 0.27 0.008 DBMET01477 | DBMET01477 | |
| 0.004 | 0.837 | 0.034 | Complement factor 1s inhibitor | 0.025 0.018 DB01955 0.034 0.005 DBMET01480 0.028 0.01 DBMET01477 | DBMET01480 | |
| 0.001 | 0.835 | 0.029 | Cyclin T1 inhibitor | 0.029 0.005 DB01955 0.021 0.01 DBMET01480 | DB01955 | |
| 0.021 | 0.855 | 0.591 | GABA C receptor rho-3 antagonist | 0.397 0.063 DBMET02011 0.567 0.012 DB01955 0.587 0.009 DBMET01480 0.492 0.028 DB01440 0.591 0.008 DBMET01477 | DBMET01477 | |
| 0.002 | 0.839 | 0.05 | Nicotinic receptor alpha7 subunit antagonist | 0.05 0.043 DB01955 | DB01955 | |
| 0.012 | 0.849 | 0.064 | Carbonic anhydrase II stimulant | 0.064 0.019 DBMET01477 | DBMET01477 | |
| 0.004 | 0.843 | 0.114 | Urease inhibitor | 0.114 0.051 DB01955 0.109 0.057 DBMET01480 0.114 0.051 DBMET01477 | DBMET01477 | |
| 0.008 | 0.848 | 0.083 | Phosphodiesterase 1B inhibitor | 0.083 0.021 DBMET02011 0.065 0.036 DB01955 | DBMET02011 | |
| 0.013 | 0.852 | 0.25 | Neuropeptide Y2 antagonist | 0.231 0.076 DB01955 0.2 0.119 DBMET01480 0.214 0.097 DB01440 0.25 0.057 DBMET01477 | DBMET01477 | |
| 0.001 | 0.841 | 0.029 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.027 0.02 DB01955 0.029 0.018 DBMET01477 | DBMET01477 | |
| 0.014 | 0.854 | 0.181 | Glutamate (mGluR7) agonist | 0.124 0.026 DB01955 0.119 0.031 DBMET01480 0.138 0.017 DB01440 0.181 0.005 DBMET01477 | DBMET01477 | |
| 0.005 | 0.845 | 0.083 | Potassium channel (Tandem pore domain) blocker | 0.083 0.028 DB01955 0.079 0.036 DBMET01480 0.075 0.047 DBMET01477 | DB01955 | |
| 0.014 | 0.857 | 0.133 | Transcription factor STAT6 inhibitor | 0.133 0.04 DB01955 0.122 0.057 DBMET01480 0.108 0.085 DB01440 0.129 0.045 DBMET01477 | DB01955 | |
| 0.002 | 0.847 | 0.073 | Cannabinoid receptor agonist | 0.073 0.039 DB01955 | DB01955 | |
| 0.002 | 0.848 | 0.047 | Cannabinoid CB2 receptor agonist | 0.047 0.045 DB01955 | DB01955 | |
| 0.001 | 0.847 | 0.034 | Dopamine autoreceptor agonist | 0.034 0.011 DB01955 | DB01955 | |
| 0.008 | 0.855 | 0.229 | Thyroid hormone antagonist | 0.203 0.16 DB01955 0.229 0.138 DB01440 0.224 0.142 DBMET01477 | DB01440 | |
| 0.003 | 0.851 | 0.225 | Calpain inhibitor | 0.223 0.092 DB01955 0.192 0.121 DBMET01480 0.179 0.136 DB01440 0.225 0.09 DBMET01477 | DBMET01477 | |
| 0.008 | 0.856 | 0.204 | Thyroid hormone beta antagonist | 0.186 0.167 DB01955 0.204 0.15 DB01440 0.198 0.155 DBMET01477 | DB01440 | |
| 0.013 | 0.861 | 0.17 | Tumour necrosis factor antagonist | 0.17 0.076 DB01955 0.145 0.107 DB01440 0.165 0.082 DBMET01477 | DB01955 | |
| 0.005 | 0.855 | 0.141 | Neuropeptide Y1 antagonist | 0.136 0.089 DB01955 0.127 0.107 DBMET01480 0.141 0.08 DBMET01477 | DBMET01477 | |
| 0.004 | 0.858 | 0.082 | Heat shock protein 90 beta antagonist | 0.082 0.02 DB01955 | DB01955 | |
| 0.003 | 0.857 | 0.053 | 5 Hydroxytryptamine 7 agonist | 0.053 0.045 DBMET01480 | DBMET01480 | |
| 0.003 | 0.859 | 0.061 | Tryptophan 5 hydroxylase inhibitor | 0.04 0.015 DB01955 0.038 0.02 DBMET01480 0.043 0.011 DB01440 0.061 0.004 DBMET01477 | DBMET01477 | |
| 0.001 | 0.859 | 0.102 | Urate transporter 1 inhibitor | 0.048 0.02 DB01440 0.102 0.005 DBMET01477 | DBMET01477 | |
| 0.003 | 0.861 | 0.045 | CF transmembrane conductance regulator antagonist | 0.045 0.015 DB01955 0.04 0.026 DBMET01480 | DB01955 | |
| 0.001 | 0.86 | 0.031 | Myristoyl transferase inhibitor | 0.031 0.013 DB01955 | DB01955 | |
| 0.007 | 0.866 | 0.229 | Amyloid beta precursor protein antagonist | 0.229 0.041 DB01955 0.189 0.065 DB01440 0.151 0.101 DBMET01477 | DB01955 | |
| 0.002 | 0.862 | 0.097 | Glutamate (mGluR4) agonist | 0.032 0.028 DB01955 0.033 0.025 DBMET01480 0.04 0.015 DB01440 0.097 0.004 DBMET01477 | DBMET01477 | |
| 0 | 0.862 | 0.005 | Reverse transcriptase (HBV) inhibitor | 0.005 0.003 DB01955 | DB01955 | |
| 0.005 | 0.868 | 0.143 | Mcl-1 antagonist | 0.143 0.097 DBMET01477 | DBMET01477 | |
| 0.001 | 0.868 | 0.018 | Alpha 2b adrenoreceptor agonist | 0.018 0.015 DB01955 | DB01955 | |
| 0.003 | 0.871 | 0.152 | Carbonic anhydrase stimulant | 0.075 0.028 DB01955 0.066 0.035 DBMET01480 0.085 0.023 DB01440 0.152 0.011 DBMET01477 | DBMET01477 | |
| 0.01 | 0.879 | 0.159 | Nav1.3 sodium channel blocker | 0.159 0.042 DB01955 | DB01955 | |
| 0.002 | 0.872 | 0.028 | Follicle-stimulating hormone agonist | 0.028 0.011 DB01955 | DB01955 | |
| 0.004 | 0.877 | 0.192 | Interleukin 1 beta converting enzyme inhibitor | 0.128 0.029 DB01955 0.171 0.011 DB01440 0.192 0.007 DBMET01477 | DBMET01477 | |
| 0.001 | 0.875 | 0.019 | Nicotinic alpha4 receptor agonist | 0.019 0.008 DB01955 0.016 0.012 DBMET01480 | DB01955 | |
| 0.002 | 0.878 | 0.052 | Cathepsin L inhibitor | 0.052 0.047 DB01955 | DB01955 | |
| 0.002 | 0.878 | 0.05 | GABA receptor antagonist | 0.05 0.045 DBMET01477 | DBMET01477 | |
| 0.003 | 0.88 | 0.097 | Potassium channel (ATP-sensitive) blocker | 0.061 0.059 DBMET02011 0.097 0.017 DB01955 | DB01955 | |
| 0.01 | 0.888 | 0.164 | DNA repair enzyme inhibitor | 0.151 0.03 DB01955 0.13 0.055 DBMET01480 0.15 0.032 DB01440 0.164 0.021 DBMET01477 | DBMET01477 | |
| 0.004 | 0.883 | 0.255 | DNA directed DNA polymerase inhibitor | 0.255 0.189 DB01955 | DB01955 | |
| 0.004 | 0.884 | 0.134 | Myeloperoxidase inhibitor | 0.134 0.015 DB01955 0.081 0.065 DBMET01480 0.095 0.041 DB01440 0.091 0.047 DBMET01477 | DB01955 | |
| 0.002 | 0.882 | 0.084 | NMDA 2 receptor antagonist | 0.084 0.041 DBMET01477 | DBMET01477 | |
| 0.003 | 0.886 | 0.086 | Secretase beta inhibitor | 0.086 0.029 DB01955 0.073 0.045 DBMET01477 | DB01955 | |
| 0.01 | 0.894 | 0.229 | 3C-like protease (Human coronavirus) inhibitor | 0.178 0.067 DB01955 0.229 0.037 DBMET01480 0.17 0.074 DBMET01477 | DBMET01480 | |
| 0.003 | 0.888 | 0.155 | Glutamate (mGluR group III) agonist | 0.042 0.031 DB01955 0.043 0.03 DBMET01480 0.063 0.017 DB01440 0.155 0.005 DBMET01477 | DBMET01477 | |
| 0.001 | 0.887 | 0.042 | Nicotinic alpha4beta2 receptor agonist | 0.042 0.007 DB01955 0.036 0.011 DBMET01480 | DB01955 | |
| 0.003 | 0.89 | 0.04 | AMPA receptor agonist | 0.04 0.018 DBMET01477 | DBMET01477 | |
| 0.004 | 0.892 | 0.041 | Carbonic anhydrase I stimulant | 0.041 0.023 DBMET01477 | DBMET01477 | |
| 0.007 | 0.897 | 0.069 | Topoisomerase II beta inhibitor | 0.055 0.026 DB01955 0.047 0.038 DBMET01480 0.069 0.017 DBMET01477 | DBMET01477 | |
| 0.003 | 0.894 | 0.275 | Pyruvate kinase inhibitor | 0.138 0.127 DBMET01480 0.139 0.126 DB01440 0.275 0.054 DBMET01477 | DBMET01477 | |
| 0.008 | 0.901 | 0.044 | Phosphodiesterase 6C inhibitor | 0.044 0.04 DB01955 | DB01955 | |
| 0.002 | 0.895 | 0.082 | Glutamate (mGluR1a) antagonist | 0.082 0.008 DB01955 0.053 0.019 DB01440 0.04 0.03 DBMET01477 | DB01955 | |
| 0 | 0.894 | 0.018 | Alpha 2a adrenoreceptor agonist | 0.018 0.011 DBMET01480 | DBMET01480 | |
| 0.001 | 0.896 | 0.046 | DNA gyrase subunit B inhibitor | 0.046 0.017 DBMET01477 | DBMET01477 | |
| 0.003 | 0.899 | 0.315 | Calpain 2 inhibitor | 0.315 0.105 DB01955 0.232 0.162 DBMET01480 0.208 0.181 DB01440 0.238 0.158 DBMET01477 | DB01955 | |
| 0.001 | 0.898 | 0.06 | Diamine oxidase inhibitor | 0.06 0.01 DB01955 0.039 0.024 DBMET01480 | DB01955 | |
| 0.001 | 0.899 | 0.018 | Cyclin D2 inhibitor | 0.018 0.004 DB01955 0.013 0.01 DBMET01480 | DB01955 | |
| 0.003 | 0.902 | 0.062 | Histone deacetylase SIRT3 inhibitor | 0.062 0.044 DBMET01480 | DBMET01480 | |
| 0 | 0.901 | 0.016 | CC chemokine 9 receptor antagonist | 0.016 0.013 DBMET01480 | DBMET01480 | |
| 0.003 | 0.904 | 0.157 | GABA receptor agonist | 0.129 0.049 DB01955 0.147 0.038 DB01440 0.157 0.032 DBMET01477 | DBMET01477 | |
| 0.002 | 0.902 | 0.043 | 5 Hydroxytryptamine 2B agonist | 0.043 0.02 DB01955 0.037 0.032 DBMET01480 | DB01955 | |
| 0.032 | 0.933 | 0.268 | 5 Hydroxytryptamine 3E antagonist | 0.172 0.13 DBMET02011 0.244 0.019 DB01955 0.268 0.01 DBMET01480 0.185 0.092 DB01440 0.204 0.055 DBMET01477 | DBMET01480 | |
| 0.028 | 0.929 | 0.167 | MAP kinase kinase 5 inhibitor | 0.167 0.094 DB01955 | DB01955 | |
| 0.002 | 0.903 | 0.057 | RNA-directed RNA polymerase inhibitor | 0.036 0.022 DB01955 0.042 0.017 DB01440 0.057 0.01 DBMET01477 | DBMET01477 | |
| 0.003 | 0.906 | 0.176 | MAP kinase kinase 1 inhibitor | 0.121 0.034 DBMET02011 0.176 0.009 DB01955 0.094 0.064 DBMET01480 0.104 0.051 DB01440 0.083 0.081 DBMET01477 | DB01955 | |
| 0.003 | 0.909 | 0.19 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.152 0.14 DB01955 0.179 0.114 DBMET01480 0.19 0.106 DBMET01477 | DBMET01477 | |
| 0.002 | 0.908 | 0.032 | Dipeptidyl peptidase II inhibitor | 0.032 0.024 DBMET01477 | DBMET01477 | |
| 0.001 | 0.908 | 0.047 | Vascular adhesion protein 1 inhibitor | 0.047 0.018 DB01955 0.036 0.031 DBMET01480 | DB01955 | |
| 0.004 | 0.912 | 0.264 | 5 Hydroxytryptamine 1E antagonist | 0.193 0.139 DB01955 0.264 0.06 DBMET01480 0.186 0.147 DBMET01477 | DBMET01480 | |
| 0.004 | 0.912 | 0.055 | Purinergic P2 antagonist | 0.055 0.054 DB01440 | DB01440 | |
| 0.001 | 0.91 | 0.069 | Nerve growth factor antagonist | 0.045 0.025 DB01955 0.061 0.009 DBMET01480 0.041 0.033 DB01440 0.069 0.005 DBMET01477 | DBMET01477 | |
| 0 | 0.91 | 0.019 | Egl nine homolog 3 inhibitor | 0.019 0.004 DBMET01477 | DBMET01477 | |
| 0.001 | 0.911 | 0.03 | CXC chemokine 2 receptor antagonist | 0.03 0.014 DB01955 0.027 0.018 DBMET01477 | DB01955 | |
| 0 | 0.914 | 0.041 | Nicotinic alpha3beta4 receptor agonist | 0.041 0.009 DBMET01480 | DBMET01480 | |
| 0.003 | 0.916 | 0.088 | Protocollagen prolyl hydroxylase inhibitor | 0.028 0.018 DB01440 0.088 0.004 DBMET01477 | DBMET01477 | |
| 0.001 | 0.915 | 0.066 | Aryl hydrocarbon receptor antagonist | 0.066 0.043 DB01955 0.06 0.054 DBMET01480 | DB01955 | |
| 0.003 | 0.917 | 0.232 | Anticonvulsant | 0.157 0.121 DB01440 0.232 0.064 DBMET01477 | DBMET01477 | |
| 0.001 | 0.914 | 0.022 | Imidazoline I1 receptor antagonist | 0.022 0.012 DBMET01480 | DBMET01480 | |
| 0.001 | 0.916 | 0.073 | AMPA receptor antagonist | 0.073 0.02 DBMET01477 | DBMET01477 | |
| 0 | 0.916 | 0.006 | CC chemokine 6 receptor agonist | 0.006 0.005 DBMET01480 | DBMET01480 | |
| 0.024 | 0.94 | 0.512 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.329 0.175 DBMET02011 0.472 0.048 DB01955 0.512 0.029 DBMET01480 0.368 0.131 DB01440 0.469 0.05 DBMET01477 | DBMET01480 | |
| 0.002 | 0.919 | 0.046 | Purinergic P2X4 antagonist | 0.046 0.032 DBMET01480 | DBMET01480 | |
| 0.007 | 0.924 | 0.143 | NADPH oxidase inhibitor | 0.137 0.065 DB01955 0.111 0.094 DB01440 0.143 0.059 DBMET01477 | DBMET01477 | |
| 0 | 0.917 | 0.029 | Egl nine homolog 1 inhibitor | 0.029 0.004 DBMET01477 | DBMET01477 | |
| 0.001 | 0.919 | 0.024 | Protease (Human cytomegalovirus) inhibitor | 0.024 0.012 DBMET01480 0.022 0.016 DBMET01477 | DBMET01480 | |
| 0.002 | 0.921 | 0.194 | MAP kinase kinase inhibitor | 0.194 0.03 DB01955 | DB01955 | |
| 0.003 | 0.922 | 0.092 | Cyclin D1 inhibitor | 0.092 0.01 DB01955 0.058 0.047 DBMET01480 | DB01955 | |
| 0.001 | 0.921 | 0.043 | HCV NS5B polymerase inhibitor | 0.028 0.026 DB01955 0.031 0.023 DB01440 0.043 0.012 DBMET01477 | DBMET01477 | |
| 0.021 | 0.941 | 0.132 | MAP kinase kinase 4 inhibitor | 0.132 0.107 DB01955 | DB01955 | |
| 0.002 | 0.923 | 0.15 | Alkaline phosphatase inhibitor | 0.15 0.06 DB01955 0.107 0.105 DBMET01480 0.114 0.093 DB01440 0.118 0.089 DBMET01477 | DB01955 | |
| 0.003 | 0.927 | 0.134 | Heat shock protein 90 alpha antagonist | 0.134 0.106 DB01955 | DB01955 | |
| 0.001 | 0.926 | 0.052 | Histamine agonist | 0.052 0.037 DB01955 | DB01955 | |
| 0.001 | 0.926 | 0.056 | Histamine H1 receptor agonist | 0.045 0.028 DB01955 0.056 0.012 DBMET01480 0.043 0.032 DBMET01477 | DBMET01480 | |
| 0.001 | 0.926 | 0.021 | Glutaminyl-peptide cyclotransferase inhibitor | 0.021 0.016 DB01955 | DB01955 | |
| 0.004 | 0.929 | 0.168 | Nav1.6 sodium channel blocker | 0.168 0.036 DB01955 0.132 0.078 DBMET01480 0.112 0.109 DB01440 0.132 0.078 DBMET01477 | DB01955 | |
| 0.004 | 0.931 | 0.127 | Heat shock protein 90 antagonist | 0.127 0.102 DB01955 | DB01955 | |
| 0.002 | 0.931 | 0.13 | Caspase 7 inhibitor | 0.104 0.025 DB01955 0.078 0.065 DBMET01480 0.117 0.016 DB01440 0.13 0.011 DBMET01477 | DBMET01477 | |
| 0.001 | 0.932 | 0.174 | Aryl hydrocarbon receptor agonist | 0.174 0.118 DBMET01480 | DBMET01480 | |
| 0.001 | 0.931 | 0.038 | Cyclin E2 inhibitor | 0.038 0.014 DB01955 | DB01955 | |
| 0.001 | 0.932 | 0.059 | Glutamate (mGluR1) antagonist | 0.05 0.048 DB01955 0.059 0.04 DBMET01477 | DBMET01477 | |
| 0.001 | 0.932 | 0.031 | MAP3K8 inhibitor | 0.029 0.022 DB01955 0.031 0.016 DBMET01480 | DBMET01480 | |
| 0.001 | 0.934 | 0.045 | Glutamate (mGluR group I) agonist | 0.044 0.038 DB01955 0.045 0.036 DBMET01477 | DBMET01477 | |
| 0.002 | 0.935 | 0.107 | Toll-Like receptor 9 antagonist | 0.107 0.101 DBMET01480 | DBMET01480 | |
| 0.002 | 0.936 | 0.048 | Potassium channel Kv1.1 blocker | 0.048 0.014 DBMET01480 | DBMET01480 | |
| 0.001 | 0.935 | 0.071 | Cyclin-dependent kinase 6 inhibitor | 0.071 0.03 DB01955 0.06 0.041 DBMET01480 | DB01955 | |
| 0.001 | 0.934 | 0.028 | Endothelial nitric-oxide synthase inhibitor | 0.028 0.026 DBMET01480 0.028 0.026 DBMET01477 | DBMET01477 | |
| 0.002 | 0.937 | 0.074 | Potassium channel (Inward rectifier) blocker | 0.074 0.015 DB01955 | DB01955 | |
| 0.001 | 0.938 | 0.12 | Protein kinase C zeta inhibitor | 0.12 0.032 DB01955 0.092 0.062 DB01440 0.091 0.064 DBMET01477 | DB01955 | |
| 0.001 | 0.937 | 0.07 | Alpha 1d adrenoreceptor agonist | 0.046 0.019 DB01955 0.07 0.007 DBMET01480 0.041 0.025 DBMET01477 | DBMET01480 | |
| 0.003 | 0.94 | 0.065 | Cyclin B2 inhibitor | 0.065 0.027 DB01955 | DB01955 | |
| 0.002 | 0.94 | 0.266 | MAP kinase kinase 2 inhibitor | 0.266 0.047 DB01955 0.147 0.124 DBMET01480 0.145 0.126 DB01440 0.138 0.132 DBMET01477 | DB01955 | |
| 0.001 | 0.939 | 0.037 | Protein kinase (CK2) beta inhibitor | 0.037 0.016 DB01955 0.034 0.021 DBMET01480 0.034 0.022 DBMET01477 | DB01955 | |
| 0.001 | 0.94 | 0.076 | Toll-Like receptor 8 antagonist | 0.076 0.019 DB01955 | DB01955 | |
| 0.001 | 0.941 | 0.121 | Protein kinase (CK2) alpha inhibitor | 0.121 0.062 DB01955 0.105 0.072 DB01440 0.115 0.066 DBMET01477 | DB01955 | |
| 0.005 | 0.946 | 0.078 | Corticotropin releasing factor 2 receptor antagonist | 0.064 0.038 DB01955 0.069 0.029 DBMET01480 0.078 0.019 DBMET01477 | DBMET01477 | |
| 0.001 | 0.944 | 0.053 | MAP3K5 inhibitor | 0.053 0.01 DB01955 0.05 0.012 DB01440 0.049 0.013 DBMET01477 | DB01955 | |
| 0.002 | 0.945 | 0.055 | MAP kinase kinase 9 inhibitor | 0.055 0.04 DB01955 | DB01955 | |
| 0.003 | 0.946 | 0.155 | Beta amyloid protein antagonist | 0.129 0.058 DB01955 0.116 0.072 DB01440 0.155 0.037 DBMET01477 | DBMET01477 | |
| 0.004 | 0.948 | 0.246 | MAP kinase 1 inhibitor | 0.246 0.238 DB01955 | DB01955 | |
| 0.003 | 0.947 | 0.074 | 5 Hydroxytryptamine 3 agonist | 0.074 0.032 DB01955 0.072 0.034 DBMET01480 | DB01955 | |
| 0.001 | 0.946 | 0.099 | Protein kinase (CK2) inhibitor | 0.099 0.065 DB01955 0.091 0.072 DBMET01477 | DB01955 | |
| 0.001 | 0.949 | 0.096 | Bromodomain-containing protein 2 inhibitor | 0.096 0.045 DB01955 0.089 0.056 DBMET01480 | DB01955 | |
| 0.001 | 0.949 | 0.122 | Glutamate receptor agonist | 0.078 0.055 DB01955 0.089 0.046 DB01440 0.122 0.026 DBMET01477 | DBMET01477 | |
| 0.005 | 0.954 | 0.167 | MAP kinase 3 inhibitor | 0.167 0.045 DB01955 0.132 0.103 DBMET01480 0.131 0.104 DB01440 0.131 0.104 DBMET01477 | DB01955 | |
| 0.002 | 0.951 | 0.058 | CC chemokine 4 receptor antagonist | 0.058 0.018 DB01955 0.045 0.037 DBMET01480 0.044 0.038 DB01440 0.049 0.028 DBMET01477 | DB01955 | |
| 0.003 | 0.952 | 0.054 | Cyclin B inhibitor | 0.054 0.04 DB01955 | DB01955 | |
| 0 | 0.95 | 0.028 | 5 Hydroxytryptamine 6 agonist | 0.028 0.022 DBMET01480 | DBMET01480 | |
| 0.002 | 0.952 | 0.186 | 5 Hydroxytryptamine 3A agonist | 0.132 0.047 DB01955 0.186 0.019 DBMET01480 0.126 0.051 DBMET01477 | DBMET01480 | |
| 0 | 0.951 | 0.037 | Potassium channel small-conductance Ca-activated activator | 0.037 0.017 DBMET01480 | DBMET01480 | |
| 0.002 | 0.953 | 0.076 | I kappa B kinase inhibitor | 0.076 0.067 DB01955 | DB01955 | |
| 0.001 | 0.952 | 0.066 | Fibroblast growth factor 2 antagonist | 0.066 0.045 DB01955 | DB01955 | |
| 0.001 | 0.953 | 0.085 | MAP kinase kinase kinase inhibitor | 0.085 0.081 DB01955 | DB01955 | |
| 0.002 | 0.956 | 0.208 | I kappa B kinase epsilon inhibitor | 0.208 0.064 DB01955 0.163 0.106 DBMET01480 | DB01955 | |
| 0.003 | 0.958 | 0.069 | Cyclin B1 inhibitor | 0.069 0.033 DB01955 | DB01955 | |
| 0.001 | 0.956 | 0.159 | Focal adhesion kinase 2 inhibitor | 0.159 0.116 DB01955 | DB01955 | |
| 0.001 | 0.956 | 0.09 | Interleukin-1 receptor-associated protein kinase 4 inhibitor | 0.09 0.057 DB01955 | DB01955 | |
| 0.002 | 0.957 | 0.142 | Cyclin-dependent kinase 8 inhibitor | 0.142 0.088 DB01955 | DB01955 | |
| 0.002 | 0.958 | 0.088 | Polo-like kinase-1 inhibitor | 0.088 0.066 DB01955 | DB01955 | |
| 0 | 0.958 | 0.019 | Complement factor D inhibitor | 0.019 0.011 DB01955 | DB01955 | |
| 0.004 | 0.964 | 0.148 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.148 0.015 DB01955 | DB01955 | |
| 0.004 | 0.964 | 0.086 | Cyclin B3 inhibitor | 0.086 0.035 DB01955 | DB01955 | |
| 0.004 | 0.964 | 0.144 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.144 0.136 DB01955 | DB01955 | |
| 0.001 | 0.962 | 0.135 | LIM domain kinase 1 inhibitor | 0.135 0.115 DB01955 | DB01955 | |
| 0.003 | 0.971 | 0.17 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | 0.17 0.081 DB01955 | DB01955 | |
| 0.004 | 0.976 | 0.151 | CDC-like kinase 3 inhibitor | 0.151 0.018 DB01955 | DB01955 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |